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A B S T R A C T 
Stem cell research has raised great interest in the scientific community as it has the 
potential to form multiple cell types and it is believed they hold the key to curing 
many diseases. However, there is a need for better understanding of how to 
control these cells and further research investigating methods for controlling and 
directing these cells is required. 
Pluripotent stem cells transplanted into immune-deficient mice 'spontaneously' 
differentiate and proliferate to form a complex mass of differentiated and 
undifferentiated cells, teratomas - teratoma assay. Such tumours are generally 
haphazard in their organisation however; they do contain some structures similar to 
those observed in the embryo. Teratoma formation is a useful model to explore the 
developmental potential o f stem cells and study aspects of tissue development. 
Examination of how the anatomical location into which human pluripotent stem 
cells are grafted influences their grov^ t^h in situ allows investigation of how these 
cells are affected by different areas within the body: cells grafted into the liver 
rapidly produce large tumours containing predominantly immature cells whereas, 
subcutaneous implants were significantly slower growing and formed tumours 
composed of differentiated tissues. These different growth patterns indicate how 
environmental cues within the niche affect stem cell behaviour. One factor which 
contributes to the maintenance of a niche is the extracellular matrix (ECM). To 
investigate how endogenous ECM affects teratoma behaviour, co-transplantation is 
carried out with stem cells and ECM components. The ECM extract Matrigel™ 
dramatically increased the success rate of teratoma formation and size with no 
detectable affect on teratoma composition when compared to controls and removal 
of the grov^^h factors from the co-transplanted ECM extract had no effect on 
teratoma success rate, growth rate, or composition. 
To study the effects o f the ECM in vitro, components of the ECM are often used to 
coat glass or plastic surfaces to enhance cell attachment in vitro. Fragments of 
ECM molecules can be immobilised on surfaces in order to mimic the effects seen 
by whole molecules. In this study a novel technology developed by Orla Protein 
Technologies for the immobilisation of peptide sequences fi-om ECM proteins is 
evaluated. By examining: the adherence of cultured PCI 2; neurite outgrowth from 
PC 12 cells; and neuronal differentiation of neural stem/progenitor cells (NSPCs) it 
is shovra that peptides fi-om collagen I , collagen IV, fibronectin and laminin can 
mimic surfaces coated with ECM proteins. Collectively, this data demonstrates 
that peptides fi-om ECM proteins can be immobilised in a fimctional fashion to 
control cell behaviour. 
Surfaces with adsorbed proteins and biomimetic surfaces presenting peptide motifs 
from ECM proteins are used to investigate and explain observafions from in vivo 
teratoma experiments. In vivo, Matrigel™ increases the gene expression of the 
pluripotent stem cell marker Oct4, increasing the pluripotent cell percentage and 
thus increases the likelihood of teratoma formarion. In vitro, Matrigel also 
increases the gene expression of the proliferative marker Ki67, indicating that large 
teratomas from by the co-transplantation of stem cells with Matrigel™ could be 
due to increased cell proliferation. 
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C H A P T E R 1 - USING T H E E X T R A C E L L U L A R M A T R I X AND 
P E P T I D E MOTIFS T O C O N T R O L C E L L B E H A V I O U R 
1.1 Introduction 
The field of stem cell research has raised much media interest, with numerous 
scientific groups claiming that stem cells hold the solution to a myriad of 
problems. Proposed uses include: investigating cellular events accompanying 
embryonic development ' "; producing model systems to explain biological 
observations or hypotheses ;^ cell replacement therapy "*; tissue engineering •^*; and 
to cure various diseases Despite these claims, to date there are only a few 
examples where clinical success has been achieved. The main obstacle that must 
be overcome is how to control stem cells and until this is ftilly understood the fu l l 
potential of stem cells wi l l not be ascertained. In vivo experimentation can be used 
to investigate potential factors that can influence cell behaviour. For example, 
stem cells can be transplanted into animal hosts and the development of the 
transplanted cells investigated, allowing potential factors that control stem cell 
behaviour to be identified. However, the in vivo environment is highly complex 
and makes the assessment of how each individual factor is affecting the cells 
difficult. Factors identified from in vivo experiments can be used in vitro and 
presented to cells in a controlled fashion to investigate how individual components 
of the in vivo environment affect cell behaviour. 
Experimentation carried out in an in vivo environment can provide information of 
how multiple factors, working collectively, affect development. However, given 
the vast range of factors present in vivo that can contribute to the control of cellular 
development, when using such a complex system observations are based upon all 
of the possible factors working in combination. This makes the evaluation of the 
effect of each individual component difficult. In vitro systems can be used to 
examine individual components in an environment where all the variables are 
controllable by the investigator and the effects of one component of interest can be 
observed without the effects of other interacting components. The in vitro system 
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is a simplified version of the in vivo environment however, care is needed and 
efforts should be made to mimic the in vivo environment to ensure it is a 
representative environment and not an artificial environment. Many approaches 
have been used including: recreation of a 3D shape '^ ' ^ co-culture addition of 
exogenous molecules to the culture media cells secreting factors and the 
coating o f surfaces with molecules 
The focus of this thesis is how the extracellular matrix (ECM) can be used to 
control cell behaviour. The effect on stem cell behaviour in alternative anatomical 
locations is investigated and from this, potential factors are proposed that control 
cell behaviour. Focus is given to how the ECM controls cell behaviour in vivo and 
in vitro. The study of how both individual and combined peptide motifs affect cell 
behaviour is investigated to identify specific motifs that control cell behaviour. 
1.2 The potential application of stem cells and their sources 
1.2.1 The potential therapeutic applications of stem cells 
It is proposed that stem cells can be derived from an embryo, propagated and 
differentiated in a controlled manner to form specific cell types for transplantation 
into a patient (figure 1.1,1)'". An alternative strategy would be the isolation and 
selective differentiation of selected stem cell populations within the body and 
transplantation of these cells into the patient. For example, neural cells can be 
isolated from the hippocampus and have been proposed for use in cell therapy 
to repair handicaps incurred post stroke (figure 1.1,2). An alternative source of 
stem cells is the bone marrow. Bone marrow can be harvested from the pelvis or 
the sternum and mesenchymal stem cells can be isolated and have been proposed 
for tissue engineering to making bone (figure 1.1, 3). These applications 
depend upon the controlled growth and differentiation of the stem cell populations 
(figure 1.1, "?" red arrows). There is a need to gain a greater understanding of the 
processes that control stem cell behaviour before these cells can be controlled 
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efficiently. One proposed method is the creation of biomaterials, both synthetic 
and natural to direct stem cell growth and differentiation 23 
Neural 
progenitors 
Embryonic 
stem cells o 
Neural 
Neural 
cells 
Muscle 
cells 
Pancreatic 
Mesenchymal 
stem cells 
Adipose 
Figure 1.1 The sources and potential therapeutic uses of stem cells. Diagram shows some 
potential sources of stem cells and their proposed differentiated derivatives. Blue arrows indicate 
the isolation of stem cells. Red arrows indicate the proliferation and selective differentiation. "?" 
highlight the stages where knowledge is lacking on how to control stem cell behaviour. Black 
arrows indicate transplantation. 
1.2.2 Stem cells and development 
Development of animals starts with egg fertilisation, from this zygote all of the 
estimated >200 different cell types found within the body must be made. Every 
cell within the body is divided into one of two classes, germ cells (the spermatozoa 
and ova) and somatic cells (every other cell type within the body). Further cell 
type classification of somatic cells is carried out by grouping into one of three 
germ layers: ectoderm; endoderm; and mesoderm (Figure 1.2). The zygote 
undergoes numerous developmental stages initially giving rise to the foetus and 
finally resulting in the adult. As development progresses cells become more 
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specialised and their proliferation and capacity to form other cell types decreases. 
In the adult it is clear that the capacity of cells to form other cell types does not 
completely diminish as tissues with a high turnover, such as the skin, need to be 
maintained. Many tissues are envisaged as being composed of two cell 
populations: post-mitotic specialised cells responsible for the physiological activity 
o f the tissue; and the other population retains its capacity to proliferate, 
differentiate and maintain the tissue. The populations of cells responsible for the 
maintenance of tissues are termed stem cells and are defined as cells that both 
retain capacity to self renew and give rise to more developmentally restricted 
progeny which in tum produces distinct differentiated cell types. There are 
numerous sources o f stem cells, including embryonic and somatic. 
Gastrula 
Zygote Blastocyst 
GERM CELLS 
ECTODERM 
Epidermis Neurons Pigment 
skin cells cells 
Egg Sperm 
ENDODERM 
C ^ r 
i 
Gut Alveolar Panceratic Thyroid 
cells cells cells 
MESODERM 
Bone Cardiac Kidney Red blood Skeletal Cartilage 
muscle tubule cells cells muscle 
Figure 1.2 The origin of the three germ layers. Diagram shows examples of the different cell 
types that form within the body. All cell types within the body are grouped into one of the three 
germ layers, ectoderm, mesoderm and endoderm. The diagram shows examples of cell types from 
each of the germ layers. 
1.2.3 Stem cell plasticity 
The differentiation capacity of a stem cell, teraied potency, is a measure of the 
number of different cell types that can be formed from the single cell A l l the 
cell types within the body can be classified as one of the three germ layers; 
endoderm (gut epithelium); mesoderm (cartilage, bone, smooth muscle and striated 
muscle); and ectoderm (neural epithelium, embryonic ganglia and stratified 
squamous epithehum) (Figure 1.1). Totipotent (from the Latin totus, meaning 
entire) cells can form cells from all three germ layers and also the extraembryonic 
tissues that support development An example of a totipotent cell is that of the 
zygote, it is from this single cell that all cell types within the body originate. A 
more restricted stem cell is pluripotent cell (from the Latin pluris, meaning many) 
which can form many of the cell types from the three germ layers Embryonic 
stem cells, derived from the blastocyst, are an example of pluripotent stem cells 
and their developmental potential has been demonstrated both in vitro, with 
embryoid bodies expressing RNA for markers of the three germ layers (a-
fetoprotein, muscle and neurofilament 68) and in vivo by the formation of a 
teratoma with gut, muscle and neural tissues The examples discussed so far are 
from embryonic cells. Stem cells have also been isolated from somatic tissues 
which are more resfricted in developmental potential and are usually multipotent 
(from the Latin miiltus, meaning several), in situ they are responsible for 
maintaining tissues. An example of multipotent stem cells are neural stem cells, 
derived from specific regions of the brain 
1.2.4 Embryonal carcinoma stem cells 
One source of pluripotent stem cells is teratocarcinomas, these can arise 
spontaneously in either the ovary or testis. The earliest reference to a 
teratocarcinoma was 600 - 900 B.C. and can be found in writings at the Chaldean 
Royal Library of Nineveh where a prophecy for the friture states: "When a woman 
gives birth to an infant that has three feet, two in their normal position (attached to 
the body), and the third between them, there will be great prosperity in the land" 
-5 
In the ovary, an oocyte can undergo spontaneous parthenogenesis (from the 
greek parthenos "virgin" and genesis "creation") in situ and behave as i f it had 
been fertilised. For a brief period these develop as a normal embryo but 
subsequently they become disorganised and form a teratocarcinoma. In the testis, 
primordial germ cells undergo abnormal proliferation and form an embryonic 
ectoderm-like strucmre that subsequently becomes disorganised. The majority o f 
these spontaneous tumours are benign teratomas, although occasionally they 
contain undifferentiated cells - embryonal carcinoma (EC) stem cells (Figure 1.3) 
27 
Investigations into deriving stem cells from teratomas began in 1954 when Stevens 
and Little discovered that in - 1 % of male mice (129 strain) teratomas 
spontaneously formed in the testes Later, in 1964, Stevens and Little showed 
that by transplanting embryos of the genital ridge from strain 129 mice to the testes 
of adult mice it was possible to induce the formation of a teratoma It was 
proved in 1964, by Kleinsmith and Pierce that a teratoma contained 
undifferentiated EC stem cells. Kleinsmith and Pierce showed a single EC stem 
cell transplanted into a host could give rise to the formation of a heterogeneous 
structure: a teratoma 
Figure 1.3 Teratocarcinomas are highly heterogeneous in composition. A) Low power 
examination of tumour demonstrating heterogeneity, collagen can be seen clearly in black. B) 
Primitive neural cells. C) Skin. D) Endodermal cysts. E) Trophoblasts with embryonal 
carcinoma cells to the left. From; Teratocarcinomas as a Model System for the Study of 
Embryogenesis and Neoplasisa Martin GR, Cell (5) 229-243 (1975). 
1.2.5 Embryonic stem cells 
Teratomas are not the only source of stem cells and in 1981 Evans and Kaufman 
were able to derive pluripotent cells from a mouse embryo Later, in 1998 the 
Thomson group derived stem cells from human embryos and the cells were shown 
to be pluripotent, these cells became known as embryonic stem (ES) cells ES 
cells are derived from 'spare' embryos that have been donated from in vitro 
fertilisation (IVF). This is ethically controversial and ES cells have also been 
- 7 
isolated from arrested embryos produced during in vitro culture for IVF ^^ During 
either process, the cells are derived from embryos, which are made up o f an inner 
cell mass (ICM) surrounded by a layer of protective specialised tissue called the 
trophectoderm, a region of -100 cells in total, 30-34 of which are present in the 
ICM, immunosurgery is used to separate the ICM from the trophectoderm. The 
cells of the ICM are isolated and plated onto a mitotically inactivated murine 
embryonic fibroblast (MEF) feeder layer and propagated. The colonies that arise 
are then selected on the basis of their undifferentiated morphology and are 
expanded. ES cells can be cultured in a pluripotent undifferentiated state 
ES cells are usually derived via a two step in vitro method using day 5-7 cultured 
embryos. More recently an 8 day culture process with three steps to the in vitro 
culmre has been used to increase the success rate of ES cell derivitisation By 
growing the blastocyst to the 8 day stage the ICM is larger and contains more cells 
than the 5-7 day alternatives and hence the derivitisation of stem cells is greater. 
These cells were then fiilly characterised in vitro and in vivo in a similar fashion to 
that used by Thomson et al. (1998) and the cells were shown to be true ES cells. 
8 cell stage embryo 
Cultured blastocyst 
Immuno-surgery 
Cells dissoiated 
Cells replated 
EScell colonies produced LgJloYO) (Sfo\?l9 
Isolated inner cell mass 
Inner cell mass cell 
Trophoblast cell 
ES cells 
Irradiated mouse fibroblast 
feeder cell 
Figure 1.4 The isolation of embryonic stem cells from the blastocyst Schematic diagram 
showing how the inner cell mass is removed from an embryo and cultured in vitro to form 
embryonic stem cells. 
1.2.6 Maintaining embryonic stem cellpluripotency 
Pluripotent stem cells spontaneously differentiate, this key behaviour needs to be 
minimised so that they can be expanded in an undifferentiated state without the 
risk of undesired differentiation occurring. Work carried out by Austin Smith 
demonstrated that ES cell pluripotency could be maintained when the cells were 
cultured in the presence of medium conditioned by buffalo rat liver (BRL) cells. 
The conditioned media from BRL cells was found to contain a polypeptide factor 
that had ES cell differentiation inhibitory activity (DIA) The polypeptide factor 
within BRL conditioned media was found to be related in structure and fimction to 
the leukaemia inhibitory factor (LIF) that induces differentiation in M l myeloid 
leukaemic cells. ES cells were found to present receptors for LIF. Culture of cells 
in the presence of LIF could maintain pluripotency with 90% of cells displaying a 
cell surface stem cell specific antigen, whereas the control maintained in the 
absence of LIF could only maintain pluripotency of 1% . LIF expression is 
known to be high in murine embryonic fibroblasts (MEFs) so by culturing cells on 
MEFs this provides a source of LIF Increasing the concentration of LIF added 
to ES culture media increases the percentage of undifferentiated cells for example, 
when 0, 5, 10 or 20ng/ml are added the percentage of undifferentiated cells 
increases as the concentration increases (34, 43, 67, 83% undifferentiated) 
Maintenance o f stem cell pluripotency occurs by LIF binding to its heterodimer 
receptor LIF receptor (LIFR) and gpl30. Stabilisation of this receptor complex 
activates Janus-associated (JAK) tyrosine kinases which cause the recruitment and 
dimerisation of signal transducer and activator of transcription 3 (STAT3). 
STAT3 is able to translocate into the nucleus where it can control genes required 
for regulating self-renewal 
1.2.7 The relationship of embryonal carcinoma stem cells to the inner cell mass 
and embryonic stem cells 
During embryogenesis, at the pluripotent cleavage stage, cells split to give rise to 
two cell types: the pluripotent inner cell mass (which forms the foetus); and the 
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differentiated extraembryonic trophectoderm (which protects the ICM, aids 
implantation and the establishment of the foetal relationship with the mother). The 
pluripotent cells of the ICM go on to give rise to two cell types: the pluripotent 
foetus-forming primary ectoderm; and the differentiated extraembryonic primary 
endoderm. In an analogous fashion, some EC stem cell lines give rise to primary 
endoderm-like cells as their first differentiated derivatives in vitro. EC stem cells 
are the malignant counterpart of ES cells and considered to mimic development in 
a similar fashion. Direct evidence that EC stem cells are related to the ICM comes 
from studies where antibodies which have been raised against primitive 
teratocarcinoma cells were not reactive against differentiated teratoma cells or 
mouse cells. However, they were reactive to the 4- to 8- cell morulae Further 
evidence that EC stem cells are similar to ES cells comes from their antigen 
expression, undifferentiated EC positive for TRA-I-60 SSEA3 as too are ES 
cells 
Conclusive proof that EC stem cells are related to the I C M is demonstrated when 
murine EC stem cells are transferred into the mouse blastocyst and participate in 
normal development. Animals produced by the transfer of EC stem cells into the 
blastocyst showed patches of agouti hairs in their normal albino coloured ftir. EC 
stem cells were derived from animals and when grafted onto chimeras were 
maintained significantly longer than on control animals . Furthermore, a single 
EC stem cell transplanted into an embryo gives rise to an adult with tissues such 
as: brain; heart; kidneys; and liver that expresses glucose phosphate isomerase 
(GPI) and isocitrate dehydrogenase (IDH) allelic variants which are the same as 
the transferred EC cells Using GFP EC stem cells transferred into the 
blastocyst it has since been confirmed that the EC stem cells do contribute to 
formation of organs such as the liver. The stage in development during which the 
cells are transferred has been shown to affect their behaviour. The rate o f tumour 
development in animals produced from blastocysts with EC stem cells increases as 
the developmental stage prior to EC cell transfer into the blastocyst progresses 
frirther. When EC stem cells are transferred into E8 blastocysts (the active stage of 
organogenesis) only 8% develop tumours, whereas transplantation during organ 
growth at E l2 results in 69% developing tumours This suggests that EC stem 
cells can respond to factors present in the blastocyst during development however 
as development progresses these factors are lost and can no longer control these 
cells. This gives strength to the argument that EC stem cells represent the ICM as 
they can respond to factors that control the ICM. 
Although EC stem cells are similar to ES and hence the ICM there are some 
drawbacks to using these cells: as they are derived from mmours they could 
potentially be tumourigenic in vivo; they have chromosomal abnormalities and 
some cell lines are nuUipotent (from the Latin nullus, meaning none) and have a 
reduced differentiation capacity It is for these reasons that many consider 
them as a "caricature" of ES cells. It is important to study both ES and EC stem 
cells alongside each other to gain a true picture of the mechanisms that control cell 
behaviour. 
1.2.8 EC stem cells as a model system to study development 
EC stem cells are frequently used as a model system to study development. EC 
stem cells have been used to extensively study neuronal development as strong 
similarities exist between cells in vivo and EC stem cells. For example, the 
transcription factor neuroD is known to be involved in neural development 
during differentiation of NTERA2 EC cells, neuroDl expression is found to 
increase to a maximum following 7 days retinoic acid treatment, after which, its 
expression declines In agreement with this neuroDl expression has been shown 
to be transiently expressed in the EC stem cell line PI9, aggregates have a 
maximal expression at day 6 retinoic acid treatment A similar trend for neuroD 
RNA expression is observed in vivo, in the mouse embryo, it is first detected at 
e9.0-9.5 and a strong expression is seen at el 1.5, by el4.5 neuroD expression then 
ceases to be seen 
Another aspect of neuronal development that EC stem cells have been used to 
study is their response to retinoic acid. Retinoic acid is involved in controlling 
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early development and regulation of the levels affect development. In Xenopus 
embryos, endogenous levels of all-trans-retinoic acid are similar in the doral and 
ventricle halves of the early neurla, whereas in the late neurla, levels are much 
higher in the ventricle half than the doral All-trans-retinoic acid is the 
biologically active derivative of vitamin A and is known to have a wide range of 
biological effects. The effects of retinoic acid and other retinoids are mediated by 
two families of receptors: retinoic acid receptors (RARs); and retinoid X receptors 
(RXRs). Activation of the receptors results in gene transcription through a retinoic 
acid response element (RARE). There are three RARs (RARa, P, y) and three 
RXRs (RXRa, P, y). Using an RA resistant subclone (NTERA2/D1-R1), over 
expression of RARy results in a retinoic acid induced neural phenotype 
1.2.9 Neural stem cells 
The study of pluripotent stem cells is important, however, other stem cell types 
should not be over looked. In addition to pluripotent stem cells more 
developmentally restricted stem cells can be isolated from the body, including 
neural stem cells. It was believed for a long time that the adult neural system had 
no scope for self repair and that in adulthood new neural cells were not generated. 
However, in 1992 Reynolds and Weiss demonstrated that cells could be isolated 
from the striatum of the adult brain and differentiate into neurons and astrocytes 
Stem cells were isolated from the hippocampus of Fischer 344 rats [embryonic day 
16(E16)]. The hippocampi were removed, mechanically dissociated then plated 
onto laminin coated tissue culture plates. The cultures were analysed using 
immunocytochemistry and found to be almost purely neural due to the absence of 
astrocyte, oligodendrocyte and fibroblast markers (GFAP, galactocerebroside, 
vimentin, and fibronectin) These cells were shown to be multipotent in vivo. 
When labelled, cells were transplanted into the hippocampus of adult Fisher 344 
rats. The cells were found to be multipotent, forming both glial and neuronal cell 
types. Cells that survived within the granule cell layer of the hippocampus 
displayed neuronal characteristics whereas cells outside of this region displayed 
markers and the morphology of glial cells. This showed that the cells were 
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multipotent in nature and that cell fate could be controlled by endogenous signals 
experienced by the cell. 
An alternative source of neural stem/progenitor cells is the forebrain subependyma 
Tissue can be isolated from the subependyma of 8-12 week old rats and 
enzymatically dissociated, the resultant cell suspension can be grown in vitro as 
undifferentiated neurospheres. The neurospheres consist of mainly (-96%) 
imdifferentiated cells and upon, foetal bovine serum induced, differentiation, the 
following is observed: p i l l positive neurons (~11%); GFAP positive astrocytes 
(-13%); RIP positive oligodendrocytes (-41%); and a fraction continue to express 
nestin (-35%)^' . 
1.3 Understanding how to control cell behaviour 
1.3.1 Using stem cells as model systems to study cell behaviour 
Stem cells are widely accepted as a model system to study the cellular events 
accompanying development Their study in vitro and in vivo provides a method 
of studying how their behaviour is affected when the cells are subjected to certain 
factors. In vivo experimentation enables potential factors to be identified and these 
can then be used in vitro to control cell behaviour. 
1.3.2 Cell behaviour is similar in vitro and in vivo 
There are similarities between cell behaviour in vitro and in vivo. It is possible to 
mimic how cells behave in vivo by changing the in vitro environment, for example, 
aggregates of cells can be made in vitro to mimic how cells interact with each 
other in vivo. Aggregates are clumps of cells that have cell packing densities 
similar to cells in vivo and viable cells toward the outer with necrotic regions in the 
centre where there is deprivation of oxygen, glucose and nutrients. These 
spheroids mimic tumours in vivo better than standard 2D cell cultures ''^'^^ EC 
stem cells can be grown as spheroids and their behaviour becomes more 
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reminiscent of the in vivo environment with the formation of neural rosettes and 
pseudostratified layers. This model system has been used to demonstrate that the 
ECM proteins collagen IV and laminin become upregulated during development of 
the spheres and become polarised, confined to the basal membrane and absent 
from the opposite or lateral membranes of neural rosettes ^ . These results mimic 
the in vivo observation of laminin and collagen IV involvement with neural tube 
formation 
1.3.3 ES cells behave similar in vivo as they do in vitro 
When cells are transplanted in vivo their behaviour mimics the effects seen in vitro. 
Telomerase is an enzyme that protects the ends of chromosomes from degradation 
during replication, it consists o f two units, a telomerase RNA component (TR) 
containing a template for telomere elongation and a telomerase reverse 
transcriptase unit (TERT) that possess catalytic activity. Modulation of TERT is 
associated with regulation of cell growth. TERT over expressing ES cells grow 
faster in culture than wi ld type ES cells. Apoptosis is similar in both TERT over 
expressing ES cells and wild type ES cells so the faster growth is not due to 
reduced cell death in the over expressing cells. However, upon examination of 
DNA synthesis by bromodeoxyuridine (BrdU) incorporation, over expressing 
TERT cells have increased levels when compared to control cells. It would be 
expected that i f the in vivo environment mimics in vitro cell culture upon 
transplantation of over expressing TERT cells into immunocompromised animals, 
large teratomas would be produced. Indeed, transplantation of over expressing 
TERT cells produces large heterogeneous teratomas (figure 1.5, A) whereas, 
transplantation of wild type cells results in heterogeneous teratomas that are -50% 
of the size (figure 1.5,B)'''^ 
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Figure 1.5 Over expression of T E R T results in large teratomas. A) Teratoma produced by 
over expressing TERT cell line hES-NCLl TERT. B) Teratoma produced by hES-NCLl. 
Histological staining: Weigerts Haematoxylin, scale bar= 1mm 
1.3.4 In vivo transplantation of stem cells to form teratomas 
The in vitro environment is artificial and not entirely representative o f the natural 
in vivo environment. The mouse model is routinely used to investigate 
development however analysis of results is difficuh as many species specific 
differences exist. It is not always possible to use study cells in vivo, for example, it 
is not ethical to use invasive methods to study human cell behaviour during 
development. One model system that can be used is transplantation of human stem 
cells into immunocompromised animals, which can be used to investigate their 
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behaviour Upon transplantation of pluripotent stem cells into 
immunocompromised animals 'spontaneous' differentiation occurs and the cells 
form a teratoma. Analysis of teratoma composition provides information on how 
cell behaviour has been affected. This model system can be used to study how 
different factors affect teratoma formation. There are limitations of this system 
that should be considered including: the teratoma is a haphazard arrangement; in 
situ cells are arranged in a specific fashion; and their proximity to each other is 
controlled; this is not the case in a teratoma. The length of time of development 
is also a limitation as due to regulatory limits teratomas cannot be grown 
indefinitely. A further drawback of this system is that the human cells are 
transplanted into a non-human animal and non-human factors and cells can 
therefore interact with the human cells. With these limitations in mind, the 
teratoma model system provides a good insight into human development. Study of 
this system w i l l allow identification of factors controlling cell behaviour. 
The rate at which a teratoma grows and develops depends upon a number of 
factors: anatomical location; cell types; any addition factors included in the 
transplantation; and any treatment to the cells prior to transplantation. In the case 
of EC stem cells, the teratoma produced is similar to the teratocarcinoma from 
which the cells are derived although due to regulations these cannot be developed 
as much as a teratocarcinoma and hence are far less mature. Teratomas are 
thought to encapsulate early embryogenesis and are a model system to study 
development and the control of cell behaviour. Following transplantation of ES 
cells, teratomas arise that are highly heterogeneous (figure 1.6, A) and composed 
of cell types from all three germ layers, including: gut (endoderm, figure 1.6, B); 
kidney (mesoderm, figure 1.6, C); neural (ectoderm, figure 1.6, D); cartilage 
(mesoderm, figure 1.6, E); and bone (mesoderm, figure 1.5, 6) 
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Figure 1.6 Embryonic stem cells produce teratomas following transplantation. Teratomas are 
composed of: bone (b); cartilage (c); gut (g); muscle (m); glomerular (gm); tubules (tb); and neural 
ganglion (ng). Histological staining: Weigerts Haematoxylin (A, D-F), Haematoxylin and Eosin 
(B, C). Scale bars: (A) 500nm; (C) 100^m; (D-F) 200nm. 
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Studies have used histological analysis to define the cell composition of teratomas 
However, to gain conclusive proof of the identity of the cell types present, 
immunohistochemical analysis is required to demonstrate the antigen expression of 
cells. Using antibodies against all three germ layers, true pluripotency can be 
demonstrated. Teratomas produce from hES cells are positive for: endoderm 
antibodies such as a-Fetoprotein and CDX2-positive cells (figure 1.7, A, D); 
ectoderm antibodies such as nestin, neurofilament 200 (NF200), glial fibrillary 
acidic protein (GFAP) and microtubule associated protein 2 (MAP2) (figure 1.7, 
B, F, G, H); and mesoderm antibodies such as smooth muscle actin (SMA) (figure 
1.7, C) 
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Figure 1.7 Immunohistochemical analysis of teratomas formed from grafted colonies of hES 
cells. h E S - N C L I T E R T cells were found to be pluripotent and teratomas formed were composed of 
cell types from all three germ layers. A) a-Fetoprotein-positive cells (endoderm). B): Nestin-
positive cells (ectoderm). C): Smooth muscle actin-positive cells (mesoderm). D) CDX2-positive 
cells (endoderm). E ) Pan Epithelial keratin-positive cells. F) NF200. G) GFAP. H) MAP2. I): 
Proliferative populations of cells were shown by expression of a marker for cell proliferation Ki67. 
Antibody-positive regions are shown in red-purple. All negative controls showed minimal levels of 
background staining. J) Image corresponding to A. Scale bars: (A-C, J) SO i^m; (D, F , H) 160^m; 
(E, G, I) 40|Lim. 
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1.3.5 Identification of factors within the in vivo environment that affect cell 
behaviour 
One method of identifying factors controlling cell behaviour is to study 
transplantation of cells into alternative anatomical locations and investigate the 
effects on cells. It would be logical that v^ h^en stem cells are transplanted into a 
location the factors within that particular niche are correct for directing cells to 
produce cell types required within the location and hence wi l l direct the stem cells 
towards cell types similar to those in the location. 
Within the body, there are niches, which are sets of factors acting together to 
maintain the correct environment to control cells so that their development is 
correct for that location. These factors include the ECM, growth factors, soluble 
molecules, cell-cell interactions, mechanical strength and 3D shape. It would be 
expected that when cells are transplanted into different locations, the factors within 
the niche wi l l act together and direct the differentiation of the transplanted cells in 
a similar fashion to that of the endogenous cells. Transplantation of ES cells into 
different anatomical locations within the body, such as subcutaneously, 
intramuscular, under the kidney capsule and intratesticular result in different 
teratoma formation efficiencies, with the kidney capsule proving to be ideal for 
teratoma formation. Furthermore, following ES cell transplantation, 
immunohistochemical analysis demonstrates that different cell types form in 
different transplantation locations ''^. 
1.3.6 Transplantation of cells into different locations within the brain 
When EC NTERA2.cl.Dl (NT2) cells are transplanted into peripheral sites such as 
the muscle or liver, tumour formation is observed, the cells have a high 
proliferation capacity and the tumour becomes large and finally, lethal. In a 
similar fashion, transplantation of cells into subarachnoid space, superficial 
neocortex or the lateral ventricles results in tumour formation. Unlike the other 
locations tested, transplantation in to the caudoputamen does not result in tumour 
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formation and the animals can live up to 15 months post transplantation. The NT2 
cells ceased proliferating, ceased undergoing apoptosis and spontaneously 
differentiated into post mitotic neuron-like cells. The investigators concluded that 
there were factor(s) in the CP that modulated the behaviour of the NT2 cells but 
did not suggest what these factors were or how this modulation occurred 
When comparing different sites within the CNS, transplantation into different sites 
has been found to have little effect on maturity but a large effect on the network of 
processes. Cells transplanted into the caudoputamen extend processes similar to 
those of the host caudoputamen extending through the caudate. Whereas, cells 
confined to the neocortex produced processes confined almost exclusively to the 
immediate vicinity of the cell body ''^ In support of this, an additional study of 
how the transplantation site within the brain effects cell behaviour has shown that 
NT2N cells transplanted into white matter extend long processes whereas when 
transplanted into the gray matter the processes are shorter 
1.3.7 Transplantation into the Knee Joint 
Transplantation of stem cells into locations which are rich in one particular cell 
type could direct the transplanted cells toward the predominant cell type. The knee 
joint, for example, is rich in cartilage and therefore this environment should have 
the correct signals and structure to promote the production of cartilage. When 
comparing ES cells transplanted into the knee joints of mice to the same cells 
transplanted subcutaneously, teratomas formed in both sites with no difference in 
the amount of cartilage formed. The ratio of cartilage to teratoma was however 
found to be greater for the knee transplantation compared to that of the 
subcutaneous site. In some cases the teratomas that grew completely destroyed the 
joint. The knee transplantation therefore showed enhanced cartilage formation but 
was not ideal as other tissues were also formed. The investigators also found 
evidence of what they believed to be fissue derived from all three germ layers 
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The investigators did not indicate what they believe to be the reason why the knee 
was not ideal or explained the formation of other cell types as well as the expected 
cartilage. The physical transplantation of the ES cells may have disrupted the 
structure of the site and led to cells gaining access to areas not normally possible or 
it may be due to the nature of the knee environment which could only express the 
correct signalling molecules for cartilage differentiation at specific times during 
development. A possible theory for the growth of the teratoma cells is that, 
perhaps, the local environment did not provide a strict enough pressure to 
selectively differentiate the cells. 
A later study by the same group demonstrated that the mechanical forces 
experienced by ES cells influences their behaviour. ES cells transplanted into the 
knee joint of rats that had their limb immobilised developed teratomas. In contrast, 
when the limbs were allowed to move freely, no teratoma development was 
observed 
1.3.8 The ECM affects teratoma behaviour 
Studies where stem cells are transplanted into different anatomical locations 
indicate that the niche in which cells are transplanted affects their behaviour. One 
of the factors within the niche is the ECM, which could be directing and 
controlling the transplanted cells. The ECM occupies the intracellular space where 
it provides physical support to tissues. The ECM not only acts as a scaffold but it 
is highly dynamic and plays an important role in controlling cell behaviour. The 
ECM provides the base of the control of cells and tissues. 
1.4 The extracellular matrix and its regulation 
1.4.1 The extracellular matrix 
The ECM is a meshwork of proteins and carbohydrates that occupies the 
intercellular space. The ECM is laid down by cells and its composition and 
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relative concentration of constituents is different depending on the location within 
the body. In humans the ECM has a key role in the control of development. One 
process that the ECM controls is branching, there are numerous organs that have 
resulted from branching of epithelial cells and include: salivary glands; airways of 
the lungs; and the urine-collecting ducts of the kidneys. Branched epithelia arise 
from unbranched precursors and control over this process comes from a multitude 
of different factors, including soluble factors: HGF; FGFs; TGFpl ; GDNF; BMPs 
and extracellular components such as: entactin; collagens; laminins; and 
fibronectin The study of branching provides evidence that the ECM has a key 
role in controlling cell attachment. In particular, down regulation of fibronectin 
inhibits branching and addition of exogenous fibronectin rescues this e f fec t " . The 
effects o f fibronectin are mediated through the integrin receptor asPi and 
fibronectin translocation into the bud increases cell-matrix interactions and 
promotes cleft formation 
Further evidence that the ECM is essential for normal development comes from 
the observation that defective collagen IV production and secretion results in a 
mutant phenotype of F9 teratocarcinoma cells Some of the main components of 
the ECM that are frequently investigated include: collagens; laminins; and 
fibronectins. 
Two classes of molecules make up the ECM - Polysaccharides (specifically 
glycosaminoglycans (GAGs)) and fibrous proteins (such as collagens and 
laminins). The GAGs provide a gel-like structure and the fibrous proteins give the 
resulting gel tensile strength and further functionality. The interactions which 
occur between these molecules are important in the correct assembly of the ECM, 
presentation of the molecules within the ECM and the frinction of the ECM. The 
proteins that make up the ECM are known to interact with each other both directly 
and in interactions mediated by other cells, they are also known to interact with 
additional cell receptors for example, cell surface heparan sulphate proteoglycan 
can bind laminin, collagen IV, fibronectin and nidogen 
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1.4.2 Collagens 
Collagens are the major constituent of all ECMs and are fibrous proteins composed 
of three a subunits wound in a triple helical structure forming a rigid collagen 
superhelix. Collagens are secreted into the extracellular space and form polymers 
termed collagen fibrils. There are at least 19 proteins which are now formally 
defined as collagens. The most frequent studies of collagens are carried out using 
collagen I and collagen IV. Collagen I is the major structural component of 
connective tissue and bone and is most prevalent in the dermis, tendons and bone. 
Collagen I is a 300 kDa triple helical structure composed of two a I (I) chains and 
one a2(I) chain. Collagen I is known to undergo spontaneous assembly 
Collagen IV is the major collagen found in the basement membrane. Collagen IV 
assembles into a meshwork that constitutes a major part of the basal laminae. 
Collagen matrix formation in vitro is easily achieved as collagen can be extracted 
fi-om tissues in an acidic solution, which can then be neutralised and heated to 
produce a gel Although collagen gel formation is straightforward in the in vitro 
environment, the in vivo assembly of collagen into the ECM is a more complex 
process. Fibronectin is a key component in the assembly of collagen into the ECM 
in vivo as seen when blocking the 60k fragment from fibronectin inhibits the 
correct assembly of collagen into the ECM 
One potential mechanism for collagen assembly is seen by the mechanism where 
integrin attachment of fibronectin to the cell's surface mediates the formafion of 
the collagen network. Following the binding of integrin and fibronectin cryptic 
domains are exposed and collagen I , procollagen and collagen V bind to the 
exposed domains. The integrin a2pl becomes active and binds to collagen 
inducing a conformational change that facilitates fibril formation 
Collagen has the ability to form a mesh and it is the 3D effect of collagen on cell 
behaviour that has been most extensively studied. However, there is evidence to 
suggest that peptide motifs within these molecules can control cell attachment. 
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Synthetic mimics for collagen can be produced from peptides containing RGD that 
self assemble to form a structure mimicing natural collagen Although the 3D 
structure of collagen is important in controlling cell behaviour, the peptide motifs 
found in collagens can be used to control cell behaviour independently of the 
natural 3D structure of collagen From the non collagenous domain the 
peptide CNYYSNSYSFWLASLNPER inhibits cell attachment when cells are 
grown in media containing the soluble peptide whereas surfaces with adsorbed 
collagen peptide increase cell attachment 
1.4.3 Laminins 
Laminins are a group of glycoproteins found in the basement membrane '''•'^ and 
are present in a large range of tissue types Laminins are cruciform-shaped and 
are composed of three subunits: a-chain (~400kD); P-chain (~200kD); and a y-
chain (~200kD). Assembly of the whole molecule is mediated by specific sites in 
the a-helical region of the chains at the carboxyl end. Different variants of the a, 
P, y chains are known and complexes of the chains result in at least 10 different 
possible laminin forms, for instance laminin-1 ( a i p i y l ) or laminin-2 (a2p iy l ) . 
Laminin assembles at cell surfaces via a receptor mediated mechanism. Binding of 
laminin to dystroglycan and the integrin a7pi , increases the concentration of 
laminin above its critical concentration thereby inducing laminin to form a gel at 
the cell surface. 
The effects elicited by laminin are mainly due to interactions between peptide 
motifs in the molecule and membrane receptors on the cell surface. To date, three 
laminin receptors have been identified: 67kDa; llOkDa; and ISOkDa Laminin 
was first shown to bind the 67kDa receptor and this was later identified to be the 
binding site for the YIGSR motif Many laminin derived peptides have been 
identified as having biological activity, for example, 16 peptides have been found 
in the laminin a l chain The most frequently investigated peptides include 
YIGSR I K V A V '"^ and RGD 
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1.4.4 Fibronectins 
Fibronectin is a large glycoprotein composed of two subunits; dimerisation is 
achieved through inter-chain disulfide bonds at the carboxyl terminus. Each 
subunit is -2500 amino acids and folded into five or six domains connected by 
flexible polypeptide linkers. Each subunit consists of type I , type I I and type I I I 
repeating modules. Interactions between cells, matrix components and fibronectin 
are mediated through sets of repeats, which make up domains. 
When cells are grown in culture, fibronectin can be detected both in the culture 
media and at the cell surface. Studies have predicted that 25% '"^ or 50% '"^ 
(depending on the cell type) of the secreted fibronectin synthesised is retained at 
the cell surface. The addition of exogenous fibronectin to culture media of cells 
grown in vitro results in the incorporation of fibronectin into the ECM 
Intravenous injection of fibronectin into the mouse results in co-localisation of 
endogenous and exogenous fibronectin These findings indicate that cells could 
synthesise soluble fibronectin, secrete this fibronectin and then incorporate it into 
the ECM. 
Integrin binding has been proposed as a possible mechanism for the assembly of 
fibronectin into the ECM " ' . Fibronectin is secreted by cells as an inactive 
disulphide bonded dimer. Binding of the integrin a5pi to the RGD motif within 
fibronectin molecules immobilises the fibronectin molecule to the cell surface. 
Binding o f fibronectin to the integrin molecule forms the initiation step which 
allows f ibr i l elongation to occur and activates the fibronectin resulting in a 
conformational change that exposes cryptic domains that can bind to additional 
fibronectin molecules. Fibril elongation occurs as more fibronectin molecules 
become bound together and also to integrin Within the fibronectin molecule, 
there are binding sites for collagen, GAGs, fibrin, integrins and fibronectin. 
Interactions of fibronectin with cells are known to occur through two key motifs, 
RGDS and PHSRN Cell attachment can be increased when cells are cultured 
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on surfaces presenting either RODS or PHSRN. Attachment to surfaces presenting 
RODS could be inhibited by preincubation with either RGDS or PHSRN soluble 
peptides, thus indicating that these two peptides can be competitively inhibited and 
they act via the same receptor ' 
1.4.5 Physical support by the extracellular matrix 
One function of the ECM is to support cells, the ECM is a network of fibers which 
resist stress and maintain correct cell shape. Collagen forms the main structural 
protein within the ECM, collagen I is the most abundant. By examining the 
structure of collagen it is possible to identify how collagen provides support for the 
cell. 
Collagens are known for their capacity to self assemble, for example when an 
initially acidic in vitro environment is neutralised and the temperature is increased 
collagen is able to self assemble to from fibri l gels Collagen I forms the 
primary structural element within the ECM and provides tensile stiffness. 
Collagen I is a triple helix composed of two al(I)-chains and one a2(I)-chain 
Each peptide forms a left-handed helix, with the peptides combining to form one 
single right-handed super helix. Collagen triple helices form a distorted hexagonal 
shape " \ 
Collagen I molecules are approximately 300 nm, interacting with each other at the 
tail to form overlapping regions with gaps between these overlaps. Collagen has a 
high tensile strength and upon application of a force of 20 MPa per unit area a 
collagen fibril w i l l extend by 4%. It is proposed that collagen fibrils resist 
extension by three mechanisms: collagen molecules themselves are known to 
allow for molecular elongation; the gaps between the overlapping regions where 
tail domains interact form kinked regions that can straighten to compensate for an 
applied force increases in the gap regions provide fiarther increases in collagen 
fibril extension; and slippage between laterally adjoining collagen molecules 
allows for further extension ' 
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1.4.6 Interactions between the extracellular matrix, growth factor and cytokines 
Growth factors are peptides and polypeptides secreted by cells to regulate a variety 
of cellular processes. Growth factors are factors produced by the body that can 
regulate cell proliferation and differentiation which produce their effects by 
binding to a corresponding receptor on a cell and then activating signalling 
cascades. Growth factor receptors are made up of extracellular domains that bind 
to the growth factor, a transmembrane domain and an intracellular domain that 
possesses catalytic activity. Upon growth factor binding the active receptor 
complex recruits a myriad of intracellular signalling molecules to bring about 
changes in gene transcription and cytoskeletal changes. This system allows for the 
control of growth factor signalling at both the extracellular and intracellular levels. 
The extracellular matrix interacts directly with other cells and has additional 
indirect effects on cell function including influence on cell behaviour by mediating 
growth factor signalling. Part of the control of growth factor signalling at the 
extracellular level is given by the binding and interaction between growth factors 
and the ECM which can facilitate storage and decrease loss via decreasing 
diffusion. 
Research has demonstrated that the ECM can increase the effects elicited by 
growth factors. Glomerular epithelial cells cultured in the presence of EGF on 
collagen I coated surfaces results in increased proliferation when compared to the 
same cells cultured in the presence of EGF on uncoated surfaces and also 
enchanced the level of the activated EGF receptor 
Tumour necrosis factor alpha ( T F N - a ) is a cytokine that mediates the immune and 
inflammatory response. T F N - a has two receptors, a 55 and a 75kDa, binding to 
these receptors activates numerous signalling cascades, including: N F - K B (a 
transcription factor that controls proteins involved in cell survival, proliferation, 
anti-apoptosis and inflammatory); MAPK/JNK (involved in cell proliferation, 
differentiation and pro-apoptosis); and caspase 3. Many of the processes are 
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counter effective and there is significant cross talk between the processes to control 
the overall effect. TFN-a binds to fibronectin and also to a lesser extent collagen I , 
collagen I I , collagen IV and laminin Bone morphogenic protein 7 (BMP 7) is 
involved in bone homeostasis and osteoblast differentiation and is capable of 
binding to various ECM proteins, including collagen FV 
Hepatocyte growth factor (HGF) is secreted by stromal fibroblasts and becomes 
bound by the ECM. Release of HGF from the ECM is facilitated by urokinase 
ECM degradation In a similar scenario, transforming growth factor p (TGF-P) 
is held within the ECM and is released by plasmin or thrombin Basic 
fibroblast growth factor (bFGF) is secreted by cells and stored in the ECM '^^ 
Thrombin is known to degrade the ECM and release bFGF from the matrix. This 
provides a mechanism for the control of cell proliferation 
1.4.7 Extracellular matrix receptors 
Cell interaction with the ECM is mediated by a family of cell surface proteins -
integrins. Integrins can be isolated from PC 12 cells and reconstituted in lipid 
vesicles, when these vesicles are incubated on collagen IV or laminin coated 
surfaces adhesion is increased when compared to vesicles without integrins present 
Furthermore, synthetic peptides known to bind to surface glycoproteins can be 
used to inhibit cell attachment of PC 12 cells to collagen IV, laminin or fibronectin 
Integrin binding initiates dimerisation of a and p subunits, resulting in a 
conformational change and phosphorylation of the intracellular domain 
subsequently leading to the activation of intracellular signalling pathways to 
control cell behavior '^^''2^. in a process called integrin switching a cell can 
regulate its integrin expression to control its behaviour. By up or down regulating 
specific integrins a cell can switch from proliferative to differentiated 
The integrin p 1 is known to be involved in migration and neurite length; however 
with the loss of this p i integrin, there is not a complete abolishment of activity. In 
addition, depending upon the culture surface, of either laminin or fibronectin, the 
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reduction is different, this demonstrates the existence of multiple mechanisms for 
controlling these processes and also indicates that different proteins act through 
different mechanisms 
1.4.8 Cell response to their environment 
During cell development it is important that cells respond to their surroundings. 
Guidance signals from the exterior of a cell must be translated across the cell 
membrane into the cell where they can control cellular behaviour. Typically, 
extracellular signals initiate gene transcription, leading to remodeling of the 
cytoskeleton and specialised responses such as neurite outgrowth extracellular 
signals can include ECM proteins on the exterior of cells. The first evidence that 
the ECM and subsequent control of the cytoskeleton is important for cell 
behaviour came from A l i et al (1977). Transformed cells lacking fibronectin 
(LETS protein) did not adhere and lacked a defined actin cytoskeleton, addition of 
fibronectin resulted in a defined actin cytoskeleton and restored adhesion 
Further evidence that the ECM controls the cytoskeleton is found in co-labeling 
studies where fibronectin and actin have similar distributions during cell spreading 
It was later demonstrated that adhesion to a surface could control gene 
expression, when monocytes adhered to a surface, their expression of mRNA for 
TFN and c-fhis increased In fact, the ECM has been shown to control the gene 
expression of many cell types, from mammary epithelial cells '''^ to hepatocytes 
136 
The first stage in cells sensing and responding to extracellular signals is receptors 
that can specifically bind to the ligands. Cell adhesion molecules (CAMs) are the 
group of molecules responsible for mediating signals from the exterior of cells. 
There are four subgroups of CAMs: integrins; selectins; immunoglobuhns (Ig); 
and cadherins. Although, CAMs were originally identified for their role in cell 
adhesion, they also have a role in neurite direction. Two CAMs involved in 
neurite direction are: neural cell adhesion molecule (NCAM) (from the Ig group); 
and N-cadherin (from the cadherins group). 
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1.4.9 Integrins 
Integrins integrate signals from cell exteriors to cell interiors. Integrins have an 
extracellular domain that can interact with signalling molecules such as ECM 
proteins and an intercellular domain that can interact with signalling molecules 
inside of the cell. Sixteen different a subunits are known to interact with 8 P 
subunits to form 22 integrin heterodimers. Most of the a-subunits (excluding 
a4,6,v) only associate with one p-subunit (figure 1.8). 
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aM 
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Figure 1.8 Schematic showing integrin heterodimers and their ligands. Coll, collagen, Fb, 
fibrinogen, Fn, fibronectin, F X , factor X, ICAM intercellular adhesion molecule, Ln, Laminin, 
MadCAM mucosal addressin cell adhesion molecule, Opn osteopontin, Tn, tenascin, V C A M , 
vascular cell adhesion molecule, Vn, vitronectin, vWF von Williebrand's factor. From: Milner 
Campbell 2002 J. Neurosci Res 69:286-291 
An example of integrin binding is the binding of integrins to the laminin RGD 
motif There are numerous integrin combinations that can bind to the RGD 
sequence including: a5pi; aSpi; avpi ; avp3; avpS; avp6; avp8; IIbp3; and to a 
lesser extent a2pl ; a3pi ; a4pi ; and a7pl 
Integrin distribution throughout cells is not uniform. Upon solubilisation of PC12 
cells grown on surfaces coated with either collagen 1 or laminin, not all of the 
integrins are solubilised and a fraction of the a l and p i integrins remain bound to 
the ECM protein. Confocal analysis of cells cultured on laminin reveals that the 
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distribution of integrins is polarized and the main localisation was at the periphery 
of the cell surface in contact with the culture surface. Immunocytochemical 
analysis demonstrates a high distribution of the integrin p i uniformly throughout 
the growth cone of dorsal root ganglion neurons 
1.4.10 Control of integrin binding 
Integrins typically have a low affinity to their ligands with dissociation constants 
(Kd) of 10"^  and 10"** mol/litre. Although individual integrins show weak binding, 
the interaction o f thousands of integrins allows an effective strong bond between a 
cell and the ECM. As individual integrin binding is weak the cell is still able to 
break contacts with the ECM and migrate efficiently. The binding efficiency of a 
cell is controlled by modulating the binding activity of individual integrin 
molecules Experimentally, increasing the activation of integrins by the 
addition o f Mn^^ or by constitutively activating R-ras increases the percentage of 
cells presenting neurites when grown on laminin coated surfaces An additional 
level o f integrin control is achieved by a variety of molecules binding to the 
cytoplasmic or extracellular domains of the integrin molecules. For example, 
binding of CD98 to the integrin p i increases integrin activation 
An alternative mechanism proposed for the control of integrins is the mechanism 
by which cells can regulate their integrin expression by controlling the number o f 
integrin receptors present at their surface. It was hypothesised that culturing DRGs 
on surfaces coated with low levels of laminin ( l^g /ml) would result in increased 
levels of the laminin specific integrin a6 RNA and higher total protein 
concentrations in comparison to cells grown on surfaces coated with high levels 
(20^g/ml). However, the results observed showed a decreased in the level of a6 
RNA expression and an increase, of four-five folds, in the level of a6 integrin 
expression under low laminin conditions. By culturing these cells on low laminin 
and high laminin coated surfaces over night the integrin expression at the cell 
surface could be modified, transfer of these cells to new laminin coated surfaces 
resulted in cells previously cultured on low laminin (high levels of cell surface a6 
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integrin expression) having a greater attachment and neurite outgrowth when 
compared to cells previously cultured on high levels of laminin. This observation 
was seen for both cells cultured on new surfaces with high and low levels of 
laminin expression. From these results it was proposed that when cells are 
cultured on surfaces with low levels of ligands the receptor level at the surface is 
maintained by constitutive levels of integrin synthesis, secretion and uptake. 
Whereas, when cells are cultured on high levels of ligands, targeted endocytosis 
and sequestration or degradation is used to remove the receptors from the surfaces 
Integrin function has been studied using genes which have been ablated. For 
example, neural progenitors derived from the forebrain of mice with the p i 
integrin allele removed show a reduction in cell adhesion to laminin and 
fibronectin coated surfaces, increased levels of apoptotic cells in neurospheres and 
reduced migration on laminin and fibronectin coated surfaces 
1.4.11 Linking integrins to the cytoskeleton 
Integrins have two mechanisms by which their effects are mediated: they provide a 
physical link between the ECM and the cytoskeleton; and they activate signaling 
pathways. With the exception of P4, the cytoplasmic domains of integrins are 
short (~30-40 amino acids ) and contain no enzymatic activity hence in order for 
integrins to mediate their effects they must recruit other signaling molecules. 
Binding of cells to an ECM initiates integrin clustering and stimulates 
reorganisation of the cytoskeleton, which in turn reorganises integrins and related 
signaling molecules Mutations in the cytoplasmic domain do not alter 
heterodimer assembly Whereas, deletion of the cytoplasmic tail domain '"^ ^ 
or mutation greatly reduces cell adhesion How contact with the ECM 
modulates cell attachment was first documented when it was noted that the integrin 
mediated binding of platelets to a surface resulted in phosphorylation of a protein 
tyrosine kinase, ppl25FAK (FAK, focal adhesion kinase) 
There are numerous mediators of integrin-actin interactions including integrin-
linked kinase ( ILK) which is localised to cell adhesion sites by PINCH "'^ ILK 
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interacts with the cytoplasmic domain of p i integrin via ILKs COOH-terminal 
domain In turn, affixin and CH-ILKBP bind to both ILK and the actin 
cytoskeleton, linking the transmembrane integrins to the actin cytoskeleton. 
Aggregation of integrins results in the accumulation of at least 20 signal 
transduction molecules, including: c-Src; c-Fyn; RhoA; Racl; Ras; GAP; M E K I ; 
E R K l ; ERK2; and I N K l . Integrin aggregation in combination with integrin 
occupancy, tyrosine phosphorylation and actin cytoskeletal integrity results in the 
redistribution of the following cytoskeletal molecules: F-actin; paxillin; filamin; 
talin; a-actinin; vinculin; and tensin 
1.4.12 Integrin binding modulates growth factor signalling 
Integrin signalling is linked to growth factor signalling. The attachment of 
fibroblasts to surfaces coated in collagen I and fibronectin induces a transient 
tyrosine phosphorylation of platelet derived growth factor (PDGF) beta receptor, 
activating the receptor. This phosphorylation effect is lost with the disruption of 
the actin cytoskeleton using cyclochalasin D. This directly links integrin binding 
to activation of growth factor receptors In combination with integrins, the 
growth factors EOF, FGF and PDGF activate ERK but only when the integrins are 
occupied and clustered 
1.4.13 Integrin signalling cascade 
Following activation of integrins, cells need to activate specific signalling cascades 
to respond. Integrins are known to control neurite outgrowth and studies have 
inhibited neurite outgrowth using both soluble peptide sequences '^ •^  and antibodies 
to competitively block integrins. 
The culture of PC 12 cells with NGF or on laminin results in increased neurite 
outgrowth. In the presence of NGF or laminin, the levels of phosphorylated ERK 
are elevated and a synergistic effect is observed when cells are cultured on laminin 
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coated surfaces with the addition of NGF to the culture media Transfection of 
PC 12 cells with Ras increases the phosphorylation ERX, this in turn results in an 
increase in neurite outgrowth. The culture of PCI2 cells in the presence of NGF 
results in the down regulation of TrkA expression and the culture of PC 12 cells on 
laminin results in the down regulation of integrin P1 receptor when compared to 
poly d lysine. Over expression of p75NTR results in a decrease in neurite 
outgrowth as p75NTR is known to increase Rho GTPase activity which is a known 
inhibitor of neurite outgrowth. The culture of cells on laminin results in a decrease 
of P75NTR expression and decreased levels of Rho activity when compared to 
PDL. The down regulation in p75NTR was found to be linked to an increase in 
PTEN, knocking out PTEN increased p57NTR expression. The primary role of 
PTEN is to negatively regulate the phosphatidylinositol-3-kinase (PI3K) signalling 
cascade. PTEN hydrolyzes phosphoinositide PI(3,4,5)P3 to produce the second 
messenger PI(4,5)P2, which binds to profilin to release G-actin, increasing the 
availability of free monomers for the extension of neurite actin filaments, allowing 
neurite extension 
Investigating cell spreading has provided some insight into how signals from the 
membrane bound integrins are transduced into an effect in the cell. Integrin 
binding to a surface results in the activation of phospholipase A2 (PLA2), this 
converts phospholipids into arachidonic acid (AA), which is oxidized by 
lipoxygenase to a metabolite that activates protein kinase C (PKC). PKC can then 
induce cell spreading 
1.4.14 Mechanotransduction 
Cells within tissues and organs are in contact with each other via CAMs and other 
signalling molecules. Such signalling molecules influence cell behaviour directly 
by interacting with the corresponding receptor on the target cell. I f the cell type of 
interest does not have the correct receptor, no effect wi l l be observed. Thus 
interactions between cells using these direct signalling molecules are highly cell 
specific. In addition to these signalling molecules, physical cues from the 
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surrounding tissues can modulate their behaviour. Tissues are elastic which means 
that when a deforming force is removed they w i l l recoil to assume their original 
conformation, providing the elastic limit is not exceeded. For cells to fimction 
correctly, they must respond to the elasticity of tissues, this is done by the 
reorganization of their cytoskeleton. Although, at first it would appear that cells 
must resist external forces applied to them to remain viable, it is becoming 
apparent that the application of external mechanical forces to a cell can influence 
the cell behaviour. The process by which cells sense their mechanical environment 
and transduce these extracellular signals into a cell response is termed 
mechanotransduction. 
The resistance to stress is measured by the Young's elastic modulus (E). The 
stiffness or elastic modulus is dependent upon the tissue type. For example, brain 
tissue is softer than muscle tissue and muscle tissue is softer than skin The 
liver has a Young's elastic modulus of ~2 kPa whereas plastic and glass used for 
tissue culture have a Young's elastic modulus in the giga pascal range. In cells and 
therefore tissues, the Young's elastic modulus is dependent upon their actin, 
myosin cytoskeleton and their ECM. Posttranslational modifications of collagen, 
including modification by lysyl oxidase, can change the stiffness of a cell. It has 
been found that lysyl oxidases are up-regulated following liver injury '^ ^ and lysyl 
oxidases have been found to increase the E of collagen gels in vitro 
For a cell to respond to mechanical stress, it must have two components: 
something that is changed due to the applied force; and a mechanism to transmit 
this effect from the sensory element to elicit a change. The structure that is 
implicated in mechanotransduction is the ECM/integrin/cytoskeleton network. 
The ECM is linked to the cytoskeleton via integrins and when a force is applied to 
a cell, any of these elements can sense the change from the resting state. It has 
been suggested that upon the application of force, ECM components could 
potentially unfold, thus providing a sensory mechanism. The integrins linking the 
ECM proteins to the cytoskeleton could also provide a mechanism for the sensing 
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of mechanical load Finally, the cytoskeleton could mediate the sensing of 
mechanical load 
The strength of a material which cells come into contact with can affect their 
behaviour. Increasing the stiffness of the collagen gel increases the proliferation of 
rat smooth muscle cells NSC cultured on surfaces with an elastic modulus of 
10-10,000 Pa, show a maximal growth rate at 1,000 Pa, fiirthermore, the stiffness 
of the substrate also affects the differentiation of the NSCs, with stiffer gels 
favouring astrocyte differentiation and weaker gels favouring neural differentiation 
The response to substrate stiffness is cell type dependant. The culture of cells 
on a flexible surface results in decreased proliferation and increased apoptosis. In 
comparison, transformed 3T3 cells do not respond to these changes in surface 
flexibility 
1.4.15 Neurite outgrowth 
For the nervous system to develop, neurons must project their axons over large 
distances to reach their targets. Axon migration is mediated by a specialised 
structure at the leading edge, the growth cone which has the capacity to sense the 
environment and respond to attractive and repulsive cues thereby guiding the axon. 
Growth cones determine the rate and direction of neurite outgrowth, in order for 
growth cones to act in this way they must be able to sense signals from the 
environment and transduce these into cytoskeletal rearrangements. At the 
periphery of the growth cone there is a layer of flat web shaped sheets of 
cytoplasm called lamellipodia, with finger like filopodia extending out. For 
growth cones to mediate the exterior signals into a response they must be able to 
elicit rearrangements in the cytoskeleton. The two main cytoskeletal components 
found in growth cones are actin filaments and microtubules. Actin filaments are 
helical polymers composed of globular actin (G actin) monomers. ATP-actin is 
added to the barbed end of the filament and hydrolysed to ADP-Pi-actin, the 
inorganic phosphate is lost, leaving ADP-actin. ADP-actin can be dissociated 
fi-om the filament from both the pointed and barbed ends however, loss firom the 
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pointed end is kinetically favoured. Microtubules are hollow cylindrical fibers 
composed of a and p-tubulin subunits, similar to actin filaments, microtubule 
subunits are added at one end and lost at the other. 
The rate of neurite advance is linked to the shape of the grov^h cone, with the 
initial extension rate correlating with the length of the filopodia Neurite 
outgrowth of PC 12 cells has been studied and neurite outgrowth has clear stages. 
Rapid extension of the filopodia allows protrusion of the growth cone. I f the 
newly extended lamellipodium does not retract or l i f t o f f the substrate, the 
consolidation phase causes the lamellipodium to thicken as it fills with cytoplasm 
and organelles 
In a steady state, actin filaments undergo assembly where monomeric actin (G-
actin) is polymerized to form F-actin. At the barbed end G-actin is assembled and 
at the pointed end it is disassembled. Monomeric ATP-actin units are added to the 
plus end where they are hydrolysed to ADP-Pi-actin, the inorganic phosphate is 
lost, leaving ADP-actin. This addition of monomeric actin to the plus end and loss 
at the minus end is termed treadmilling. Most of the acfin filaments within the 
filopodia have their barbed ends facing towards the cell membrane. The acfin 
filaments within the filopodia and lamellipodia are continually undergoing cycles 
of expansion and contraction 
In the resting state, the barbed ends of acfin filaments are capped, following 
stimulation, free barbed ends are generated. There are a number of proposed 
mechanisms for the generation of barbed ends including elevation of levels of 
PtdIns(4,5)P2 which results in dissociation of the capping proteins, and 
ADF/cofilin severs filaments with Arp2/3 promoting actin nucleation as shown by 
Condeelis et al. 2001. Growth of actin filaments is rapid as there is a lag in Pi 
disassociafion 
During neurite extension and retraction, the retrograde of G-actin remains 
relatively constant and the main differences are in the assembly of acfin. When 
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filopodia are retracting, actin assembly is low and retrograde flow is high, whereas, 
when filopodia are extending, although retrograde flow is still high the rate of 
assembly is greater and exceeds the retrograde flow 
1.5 Investigating how tlie extracellular matrix and peptide motifs control cell 
behaviour 
7.5. / The extracellular matrix can control cell cycle progression and cell death 
Cell binding to adhesive molecules can mediate cell survival by both increasing 
cell cycle progression and decreasing cell death. Integrin binding can influence 
apoptosis. Melanoma cells cultured in gels composed of collagen 1 and 111 are 
viable, in contrast, melanoma cells lacking the integrin av undergo apoptosis. 
Similary, antibody inhibition of mtegrin avP3 induces apoptosis 
When endothelial cells are seeded onto vitronectin coated surfaces they are able to 
bind and attach to the surface. This binding is mediated via the integrins avp3, 
avp5 and aSpi. When cells are seeded onto vitronectin coated surfaces in the 
presence of RGD peptides, these peptides are able to bind to the integrins 
presented by the cells and inhibit binding. This inhibition results in the failure of 
cell attachment and subsequently the induction of apoptosis 
Cell adhesion to the ECM can control cell cycle progression. Cell cycle 
progression through G l and Gl-S transition is controlled by transcripfional 
repressors. In the presence of the mitogens cyclin D, cyclin E, and cyclin A 
associated cyclin dependent kinase (cdk) activites increase. These act to 
phosphorylate retinoblastoma protein (Rb), which results in the de-repression of 
the genes encoding for E2F, cyclin E and cyclin A. This positive feedback 
continues until phosphorylation of Rb is complete and cyclin A associated cdk 
activity starts to inhibit E2F. Once this has taken place, cells have passed the 
restriction point and are committed to the cell cycle When cells adhere to a 
surface this results in the increase of the expression of cyclin A and cyclin D l . 
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Furthermore, i f cells were transferred from an adhesive condition to a non-
adhesive condition a decrease in the phosphorylation of Rb is seen 
As well as increasing cell cycle progression, cell binding can also inhibit cell 
death. Anoikis is a type of apoptosis that is induced when anchorage dependent 
cells lose their anchorage '^ ^ '^^ this process is known to be controlled by integrin 
signalling. As well as integrin binding, growth factors are important in the control 
of cell behaviour. Anoikis in Schwann cells can be inhibited with addition of 
BDNF to the culture media, although a similar trend is not observed for NGF, NT-
3 or GDNF. Pretreatment of cells with BDNF prior to transplantation protects 
them and results in an increased level of survival 
Integrin signalling is important in the resistance of cells to stress induced 
apoptosis. Following cell stress such as serum withdrawal, the proapoptotic 
protein Bad becomes localised at the mitochondria, this facilitates the leakage of 
cytochrome C out of the mitochondria into the cytoplast. Apaf-1 mediates the 
formation of the apoptosome with caspase 9 and cytrochrome C. Under adhesive 
conditions, integrin ligation results in the activation of the Ras-Raf-MEK-ERK 
cascade. Raf and M E K phosphorylate the proapoptotic protein Bad resulting in its 
displacement from the mitochondria and 14-3-3 proteins result in its sequestration. 
This process prevents the loss of cytochrome C from the mitochondria and 
prevents the formation of the apoptosome with caspase 9 
Integrin binding can regulate cell survival upon binding of p i this activates 
pl30Cas, paxillin, Akt and Src. Both pl30Cas and paxillin inhibit JNK, this 
inhibits apoptosis, whereas Akt and MAPK increase cell survival 
One key pathway in the control of apoptosis is the Rho/ROCK pathway. Rho 
kinase (ROCK) is a downstream effector of Rho which directly phosphorylates 
myosin light chain (MLC) and also inactivates myosin phosphatise thereby 
increasing M L C phosphorylation. MLC mediates cell contraction which is one of 
the triggers to evoke apoptotic cell death. Loss of cell attachment can be 
42 
mimicked by the dissociation of cells cultured as spheres, this dissociation 
increases MLC phosphorylation. This increase in MLC phosphorylation can be 
reversed with the addition of ROCK inhibitor resulting in a decrease in cell death. 
ROCK is known to modulate the cytoskeleton, the interaction between ROCK and 
the cytoskeleton poses a potential mechanism for controlling apoptosis. No 
increase in cell death is observed where the cytoskeleton is disrupted prior to the 
initiation of cell attachment loss. This demonstrates that rearrangement of the 
cytoskeleton by ROCK is necessary for induction of aopotosis 
1.5.2 The extracellular matrix can be used in vitro to control cell behaviour 
The ECM has been demonstrated to be a key factor in controlling cell behaviour in 
vivo, culture of cells on surfaces coated with alternative ECM components allows 
the direct study of how the ECM regulates cell behaviour. It is possible to mimic 
the ECM in vitro by adsorbing ECM components onto culture surfaces When a 
solution of ECM molecules is applied to a surface the proteins come out of the 
solution and adsorb onto the surface. This adsorption is rapid, within two hours 
80% of fibronectin in the solution wil l become adsorbed onto the surface 
There are contradicting reports regarding the regulation of a cells ECM. Some 
groups have demonstrated that, differentiation in vitro is accompanied by marked 
changes in the cells ECM, suggesting that ECM synthesis plays an important role 
in differentiation Whereas, others have shown that the culture of ES cells on 
surfaces with adsorbed collagen I does not suppress the cells tendency to produce 
collagen I , collagen IV, fibronectin or laminin However, suppression of 
collagen production by ES cells using cw-hydroxyproline results in detachment of 
cells from the culture surfaces and this is not rescued when they are grown on 
collagen I coated surfaces, demonstrating that collagen production in these cells is 
necessary for cell attachment Furthermore, the presentation of peptides from 
ECM proteins can modulate ECM secretion and increasing the surface density o f 
the presented RGDS sequences decreases extracellular matrix production in a 
number of different cell types 
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Surfaces coated with ECM proteins are known to influence cell attachment, neurite 
outgrowth and differentiafion. Laminin has been demonstrated to increase both the 
attachment and the number of cell bearing neurites of primary neurons from new 
bom rat brains Using an alternative cell type of dorsal root ganglion (DRG) 
cells, when cultured on laminin, greater neurite outgrowth is observed than on 
collagen IV or fibronecfin Laminin is also known to affect differentiation and 
accelerates neuronal differentiation of EC cells when compared to collagen I , 
collagen IV or fibronecfin ^ '^\ In addition to increasing the rate of differentiafion, 
the ECM has been found to increase the range of cell types formed. When ES cells 
are cultured on collagen IV they can be differentiated into trophoectodermal cells, 
when cultured on collagen I , laminin or fibronectin their differentiafion is more 
restricted As well as investigating how the ECM affects differentiation, how 
the ECM affects the inhibition of differentiation has also been invesfigated. 
Murine ES cells differentiate when cultured on surfaces presenfing laminin or 
fibronectin whereas when cultured on collagen I or collagen IV they maintain their 
undifferenfiated phenotype. The response of the cells is attributed to their integrin 
expression; they express integrins to laminin and fibronectin but not collagen I or 
collagen IV. '^^ 
1.5.3 Basement membrane extracts 
Investigating cell behaviour in response to single ECM proteins provides a 
simplified model system. As the ECM in vivo is made up of multiple ECM 
proteins this could be considered as too simplified and to more faithfully mimic the 
in vivo environment, interactions with mulfiple ECM proteins is required. 
ECM secretions can be used to control cell differentiation, ES cells cultured under 
keratinocyte inductive conditions on glass do not form kerafinocytes and those 
cultured on gelatin rarely differentiate into keratinocytes. Keratinocyte 
differentiation can be increased when ES cells are cultured on surfaces with ECM 
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secretions from primary cell cultures. ECM secretions from different cell types 
result in different levels of ES cell differentiation 
ECM extracts can be produced consisting of multiple ECM proteins, for example, 
Matrigel™ is an ECM extract that is derived from Engelbreth-Holm-Swarm (ESH) 
murine sarcomas Matrigel™ can be used in vitro to mimic the in vivo 
environment. When ES cells are grown on Matrigel™ in vitro, they form 
polarised columnar epithelial-like structures, similar to those formed by ES cells in 
vivo, whereas, without Matrigel™ these structures are not observed 
Matrigel™ is made up of a combination of both ECM proteins and grovrth factors 
(Table 1.1). An alternative to Matrigel™ is Matrigel™ reduced growth factors 
(RGF), this has a similar ECM protein composition to Matrigel™ but has a 
reduced concentration of growth factors (Table 1.1). Matrigel^'^ is liquid at 4''C 
and forms a gel as the temperature is increased to 37"C and can subsequently be 
denatured at higher temperatures This provides a 3D matrix that wi l l present 
ECM molecules to cells along with encapsulated growth factors. An alternative 
basement membrane extract to Matrigel^^ is Cultrex basement membrane extract 
(BME)® (produced by Trevigen), this is derived from the same source and is 
claimed to contain laminin, collagen FV, entactin and heparan sulphate 
proteoglycan. Although Cultrex BME® is acknowledged as being similar to 
Matrigel™ '^ ^ there is little published information on Cultrex BME® 
(http://www.trevigen.com/) as at 5 November 2008. 
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Parameter 
Matrigel™ 
Percentage/concentration 
Matrigel ™ R G F 
Percentage/concentration 
E C M 
P R O T E I N S 
Laminin 56% 6 1 % 
Collagen IV 31% 30% 
Entactin 8% 7% 
G R O W T H 
F A C T O R S 
bFGF 0-0.1 pg/ml 0-0.1 pg/ml 
EOF 0.5-1.3 ng/ml <0.5 ng/ml 
IGF-1 15.6 ng/ml 5 ng/ml 
PDGF 12 pg/ml <5 pg/ml 
NGF <0.2 ng/ml <0.2 ng/ml 
TGF-p 2.3 ng/ml 1.7 ng/ml 
Table 1.1 The main constituents of Matrigel™ and Matrigel™ RGF. Matriger*^ is made up of a 
variety of E C M proteins and growth factors. Table shows approximate mean quantities for each 
component. Matrigel^'^ contains the following growth factors: basic fibroblast growth factor 
(bFGF); epidermal growth factor (EGF); insulin-like growth factor-1 (lGF-1); platelet-derived 
growth factor (PDGF); nerve growth factor (NGF); and transforming growth factor beta (TGF-P). 
Note: The total percentage of E C M proteins does not total 100% due to some unknown 
constituents and batch to batch variability. Data correct as of 26.2.08, from; 
http://www.bdbiosciences.com/discoverv_labware/products/displav_Droduct.phD?kevlD=230 
It is known that the culture of cells on surfaces coated with individual ECM 
proteins is not as effective as their culture on surfaces coated with multiple ECM 
components. MSCs induced to differentiate, when cultured on collagen I , laminin 
or fibronectin behave similarly. In contrast, when MSCs are induced to 
differentiate on surfaces presenting multiple ECM components (Matrigel™) their 
differentiation is enhanced, with a greater percentage of cells differentiating and a 
greater neiu-ite branching 
It is possible to obtain basement membrane extracts from cells. PYS-2 cells can be 
cultured in vitro and subsequently lysed, leaving their ECM attached to a surface. 
The ECM produced by PYS-2 cells consists of laminin, collagen IV and heparan 
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sulphate proteoglycan When investigating the proliferation of MSCs, the ECM 
prepared from PYS-2 cells performed better than, laminin or collagen IV when 
adsorbed to a surface. This is not surprising as the ECM from PYS-2 cells wi l l 
contain a mixture of molecules and not just one single molecule. However, when 
compared to Matriger*^, which does contain multiple molecules the ECM 
prepared form PYS-2 cells performed better at increasing proliferation, the authors 
suggested that either some activity was lost from Matrigel™ during isolation or 
that an intact structure is needed However, as the ECMs were prepared from 
different sources it is also possible that there were some differences in the 
composition of the two ECMs. 
When attempting to mimic cell behaviour in vitro, it is important to consider the in 
situ environment in which cells are normally found. When cells are grown in vitro 
with factors such as ECM proteins that they do not normally come into contact 
with, their development is abnomial for example, when keratinocytes are grown 
with collagen IV, found in the epidermal basement membrane (BM) their 
development is more representative of normal keratinocyte development. In 
contrast, when cells are grown with ECM proteins not found in the B M such as 
fibronectin or collagen I their behaviour is abnormal '^^ 
1.5.4 The identification ofpeptides motifs within ECM proteins 
The idea that cell attachment to proteins does not require the whole molecule to 
elicit an effect started with the observation that proteolytic fragments of fibronectin 
are active in promoting cell attachment "I From the primary sequence of 
fibronectin '^^ there have been small peptides identified that competitively inhibit 
cell attachment to fibronectin of which, the most studied are RGDS and 
PHSRN " ^ The cell receptor for RGD was identified by coupling RGD from 
fibronectin Sepharose and passing detergent extracts from huma placenta or 
cultured cells over the column, bound molecules were then eluted using soluble 
RGD The identification of the fibronectin receptor was first published in 1983 
The receptor identified was later ftiUy defined as the aSpi integrin. 
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Clarification that the effects of ECM proteins are mediated by peptides is gained 
fi'om inhibition experiments. Surfaces coated with laminin increase the attachment 
of small cell lung cancer cells in a dose dependant marmer. Preincubation of the 
cells with cyclic YIGSR peptide decreases the percentage of cells that attach to 
laminin coated surfaces, this too is in a dose dependant manner This indicates 
that the peptide YIGSR can inhibit the attachment of cells to laminin and therefore 
the effects o f laminin must be mediated thorough the peptide YIGSR. 
Peptide motifs are fi:equently studied individually, however proteins have 
numerous peptide motifs. Direct evidence that proteins have multiple motifs 
comes fi"om experiments where PC 12 cells cultured on laminin are only partly 
inhibited for neurite outgrowth by anti-PA22-2 (a peptide containing the laminin 
sequence I K V A V ) whereas cells cultured on PA22-2 immobilised surfaces are 
completely inhibited by anti-PA22-2 thus there must be other binding sites in 
laminin Laminin has three motifs that have been greatly investigated, YIGSR, 
I K V A V and RGD. However even these are an over simplification, for example, a 
series of peptides of laminin-1 have been synthesised 23 o f which have been found 
to be bioactive 
RGD and PHSRN motifs, found in fibronectin, are two peptides which have been 
thoroughly investigated. When presented together these peptides are known to 
have a synergistic effect. When in their natural presentation in fibronectin there is 
a spacer between the two motifs which means they are not presented together, this 
spacer has been found to be important in the efficacy of the motifs. The presence 
of a spacer unit increases the adhesion of HUVEC cells, when the spacer is 
removed or the length of this spacer is increased these changes result in a decrease 
in cell attachment. The hydrophilic/hydrophobic properties of the spacer unit are 
also important, a neutral spacer unit has been shown to result in increased cell 
attachment when compared to hydrophilic or hydrophobic spacers 
The most ful ly investigated motifs are those from laminin and fibronectin, fewer 
studies have investigated the effects of collagen motifs. Collagen is frequently 
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investigated for its ability to increase cell attachment. In the a-chain of collagen I 
there is a domain that induces cell attachment which is made up of 15 amino acids 
and is designated P-15, the GTPGPQGIAGQRGVV motif is the motif in this 
domain which confers the observed effects. The immobilisafion of P-15 has been 
found to increase cell attachment and viability of a variety of different cell types. 
The immobilisation of P-15 increases cell attachment of fibroblasts Fibroblasts 
grovm on an anorganic bone mineral material without the adsorpfion of P-15 show 
a greater reduction in cell viability following serum withdrawal than fibroblasts 
grown on an anorganic bone material with adsorption of P-15 Particles coated 
with P-15 and embedded in a hydrogel have been shown to increase cell 
attachment and the viability of osteoblastic cells The collagen IV peptide 
MNYYSNS is rarely investigated. This peptide is found in the N C I domain of the 
aSchain, one study has shown that when added as a soluble pepfide it significanfiy 
inhibits both the attachment and migration of melanoma cells 
7.5.5 The advantages of using peptides from extracellular matrix proteins to 
control cell behaviour 
Although proteins wi l l adsorb spontaneously onto a surface there are many 
limitations: the surface coating process is difficult to control; adsorption may lead 
to the protein becoming denatured resulting in reduced fianctionality; the 
orientation; and density of the protein are difficult to control leading to batch 
inconsistency and reduced reproducibility. The method of incorporation; such as 
adsorpfion, covalently binding or blending at the time of surface manufacture, can 
affect the amount of protein presented by the surface and in turn, these result in 
different responses of cells cultured on the surfaces Covalent attachment of 
protein by chemical coupling also results in substantial loss of protein activity 
owing to chemical modification of critical residues, denaturation and random 
orientation and inaccessibility Current methods result in surfaces that are 
highly defecfive in their presentation of molecules. There are patches where no 
molecules have attached and the surface is exposed to interactions with cells. 
Molecular deformafion is observed resuking in molecules becoming 
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attached to the surface. However, they exhibit decreased effects due to a 
conformational change reducing the availability of the binding sites In 
addition, aggregation leads to multiple layers of molecules, having two effects: it 
reduces the numbers of molecules available to attach to the surface hence reducing 
the activity of the surface; and it can result in lower levels not being accessible 
There is evidence to suggest the underlying material affects cellular behaviour, for 
instance CNS neurons grown on laminin coated platinum do not form glial cell 
types following 3 days culture, whereas cells grown on laminin coated tantalum do 
form glial cell types It was not demonstrated whether the effects observed 
were due to differences in adsorption of laminin or interactions of cells with the 
underlying surface however it is likely that both of these factors wi l l contribute to 
the observed effects. 
The conformation and exposure of active motifs by adhesive proteins can be 
controlled by other non-adhesive proteins on a surface. Fibronectin at a low 
concentration alone produces a low level of breast carcinoma cell attachment but 
when surfaces are coated with fibronectin and a protein that does not increase 
adhesion, osteonectin, adhesion to the surface is significantly increased. The 
presence of osteonectin on a surface in combination exposes more of the 
fibronectin RGD motifs thus increasing cell attachment 
Methodologies have been developed in an attempt try and produce surfaces in a 
more defined manner, for example, the immobilisation of whole proteins such as 
fibronectin to functionalised gold surfaces has been studied to produce a 
monolayer without molecular aggregation taking place An ideal system would 
produce surfaces that are frilly intact with no areas of unreacted molecules to 
ensure that all reactions observed are due to the molecules attached to the surface 
and not interaction between cells and the uncoated surface. A l l the molecules 
should retain their active conformation and be presented in the correct orientation 
for their active domains to be accessible by cells. Molecular aggregation should be 
avoided on the surface so that all the attached molecules are active. 
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1.5.6 Presentation of peptides affects their effectiveness 
Although presentation of peptide motifs does offer advantages over whole protein 
molecules, there are many considerations that must be made to ensure optimal 
activity o f the mot i f Concentration has been showTi to be important when 
investigating cell attachment; as the concentration of immobilised YISGR peptide 
is increased an increase in cell attachment is seen Motifs have certain residues 
that are essential for their activity, for example, replacement of the R residue in 
PHSRN results in a significant decrease its cell attachment activity " ^ Replacing 
I from EKVAV results in decreased cell attachment and neurite outgrowth of PC 12 
cells Furthermore, modification of the laminin motif YIGSR has been shown 
to affect its ability to increase PC 12 cell adhesion, i f Y is removed (or modified) or 
R changed this decreases the cell attachment of PC 12 cells however, this had no 
detractive effect on the peptide's ability to promote neurite outgrowth Some 
motifs, such as RGD, are found in many different molecules, for example RGDS is 
found in fibronectin whereas RGD is found in laminin, it has been shown that the 
S residue is not essential for the motifs function Although, one group 
showed that adding S to RGD increases its effect in controlling cell attachment 
The conformation of the motif has been shown to have no effect on its efficacy. 
The al l -L- and all- D - conformations of the laminin peptide motif I K V A V have 
similar effects on PC 12 cells attachment and neurite outgrowth The charge 
of the motif can affects its activity as addition of a NH2 group to the end of the 
YIGSR ""^  or RGD ^'^ peptides increases the activity of the peptide through 
removal of the peptides negative charge. The flanking sequences of a peptide are 
not vital to the activity of the peptide as when the motif I K V A V is inserted into 
equivalent regions of mouse a2 (ANSIKVSVGGGG) or drosophila a-chain 
(ANSIKVGVNFKP) (note there is a slight residue change but this has not effect as 
I is the critical residue) a similar response of PC 12 cells to cell attachment and 
neurite outgrowth is noted "^^ 
The concentration of the peptide has an effect on the surface behaviour, increasing 
the concentration of the RGD peptide facilitates adhesion of cells " ' . It is possible 
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to synthesise peptides with repeating units, for example YIGSR can be synthesised 
in a single peptide or with 16 repeating units. Surfaces presenting repeating units 
of YIGSR have greater cell attachment than surfaces presenting single YIGSR 
units 
The primary structure of the motif is important in maintaining its activity, for 
example, a reverse sequence would be AASIKVAVSADR vs. RDASVAVKISAA. 
When compared the reverse sequence does not increase cell attachment whereas 
the forward sequence does '"^ In agreement with this Graf et al. (1987) showed 
that reversing the RGD sequence results in reduced activity Conflicting reports 
have been made for whether peptides show greater functionality presented in a 
linear or cyclic form. Studies have shown that different cell types prefer different 
presentation methods, for example smooth muscle cells have a greater cell 
attachment when RGDS is presented in a cyclic fashion conversely 3T3 fibroblast 
adhesion is greater when RGDS is presented linearly. Additionally, it was found 
that spreading of 3T3 fibroblast was similar for both linear and cyclic motifs 
When RGDS is presented as a soluble linear peptide, it inhibits cell attachment to 
fibronectin and vitronectin. In comparison, when presented in a cyclic peptide, 
RGDS has an increased ability to inhibit cell attachment to vitronectin whereas it 
has a decreased ability to inhibit cell attachment to fibronectin 
There exist many contradicting reports regarding which conformation of peptide 
results in the greatest effect, demonstrating that peptide presentation is cell type 
specific and also fianctionally specific. Furthermore, it emphasises the need for the 
presentation of peptides in a defined and controllable manner. 
1.5.7 Current methods for peptide presentation 
There are numerous methods by which peptide motifs can be immobilised onto a 
surface ^^ "^  including; direct adsorption of protein from solution modifying the 
molecular characteristics of the surface using complex chemistry and active 
site directed immobilisation However, these approaches have their 
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limitations: the surface coating process is difficult to control; adsorption may lead 
to the protein becoming denatured resulting in reduced functionality; the 
orientation and density of the protein are difficult to control leading to batch 
inconsistency and reduced reproducibility. Covalent attachment of protein by 
chemical coupling also results in substantial loss of protein activity owing to 
chemical modification of critical residues, denaturation and random orientation and 
inaccessibility Current methods result in surfaces that are highly defective in 
their presentation of molecules. There are patches where no molecules have 
attached and the surface is exposed to interactions with cells. Molecular 
deformation is observed resulting in molecules becoming attached to the 
surface however they exhibit decreased effects due to a conformational change 
reducing the availability of the binding sites In addition, aggregation leads to 
multiple layers of molecules with the lower levels not being accessible by the 
cultured cells Molecules can also become attached to the surface in the 
incorrect orientation resulting in the active peptide not being accessible at the 
extremity of the surface. Molecular aggregation can result in two or more 
molecules joining together, this has two effects, firstly it reduces the numbers of 
molecules available to attach to the surface hence reducing the activity of the 
surface, and secondly it can result in the active domain of the molecules becoming 
hidden and therefore inactivating the molecule. An ideal system would produce 
surfaces that are f i i l ly intact with no areas of unreacted molecules so that all 
reactions observed are due to the molecules attached to the surface and not 
interaction between cells and the uncoated surface. A l l the molecules should retain 
their active conformation and be presented in the correct orientation for their acfive 
domains to be accessible by cells. Molecular aggregation should be avoided on the 
surface so that all the attached molecules are active (Figure 1.9). 
-53 
Incorrect 
presentation 
Unreacted 
patch 
Molecular 
deformation 
/ 
Molecular 
aggregation 
/ 
CURRENT MOLECULAR PRESENTATION 
IMPROVED MOLECULAR PRESENTATION 
Figure 1.9 The defects in surfaces prepared using current technologies. There are a number of 
possible shortcomings of current methods for the attachment of molecules to surfaces (upper 
diagram). Unreacled patches, molecular deformation, incorrect presentation and molecular 
aggregation are all possible reasons for surfaces with low activity being produced. An improved 
molecular presentation (lower diagram) would be where the layer is intact and all of the molecules 
presenting in a defined orientation with their activity being maintained. 
1.5.8 Self assembled monolayers - a more defined process 
Self assembled monolayers (SAMs) are organic surfaces that form spontaneously 
from the adsorption of molecules either from gas or liquid phase to a metallic 
surface. SAMs are similar to biological membranes and present molecules as a 
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membrane would to other cells. They can be formed from molecules, such as 
alkanethiols. The reaction is spontaneous as the absorption of the molecules 
lowers the free energy of the metal substrate. SAMs have the general structure of a 
spacer linked to the metallic surface via a ligand with a molecule of interest 
attached to the surface. The spacer prevents non specific reactions of the cells with 
the base surface. SAMs can be formed on a number of different metals, including 
copper, silver, mercury and palladium. However as gold is by far the most 
extensively studied and most existing technologies are compatible with gold this is 
at present the preferred metal substrate for the formation of SAMs 
1.5.9 The Orla approach 
In this study, we have adapted an existing technology that enables the stable self-
assembly o f proteins on surfaces to develop a novel tool for applications in cell 
culture (Figure l.IO). The technology employs engineered variants of the N -
terminal transmembrane (TM) domain from the Escherichia coli outer membrane 
protein, OmpA The motifs from ECM proteins are engineered into the flexible 
outer loops of OmpA. The protein attaches to the cell culture surface via a single 
cysteine residue thereby forming an oriented monolayer. Gaps between protein 
molecules are filled in using thiolipids or thioalkanes so that only the surface loops 
and the motifs of interest are exposed. This method of protein immobilisation 
results in stable, oriented monolayers that display only the motifs of interest in a 
flinctional conformation and alleviates many of the problems associated with 
adsorption and chemical methods 
P-barrel proteins are very stable structures and here the bacteria Escherichia coli 
(E.coli) outer membrane protein A (OmpA) forms the base of this technology. 
OmpA is a highly stable P-barrel protein that has a 16-stranded conformation that 
is resistant to: protease; urea; guanidine hydrochloride; sodium dodecyl sulphate 
(SDS); and heat denaturation. The high stability of this protein makes it ideal to 
act as a scaffold. OmpA has long variable extracellular loops, ideal for 
engineering and short periplasmic turns that are suitable for interaction with a gold 
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surface. OmpA can be modified and purified with the insertion of a cysteine 
residue (E183C) at the f i f th periplasmic turn, in a similar manner to other mutants 
It is this introduced cysteine residue that allows attachment to the gold 
surface via sulphur gold bond Correct insertion is judged by the ability to form 
trimers and its insolubility at low detergent concentrations. Self assembly onto the 
gold surface is achieved by samples of freshly reduced detergent-solubilised 
trimeric OmpA-E183C. Synthetic thiolipids containing a sulphur bearing head 
group and a phospholipid are then added sequentially to fill in the gaps between 
OmpA molecules and build up the bilayer. The inf i l l molecule properties 
influence the final property of the SAM, with hydrophobic molecules preventing 
cell attachment and hydrophilic ones promoting attachment it is possible to 
present two peptide motifs within one OmpA molecule. Fibronectin has two well 
studied domains, PHSRN and RODS, which are known to act synergistically. The 
spacing between these two molecules is known to be a key factor in their efficacy, 
this can be mimicked by the addition of a spacer This distance is also 
mimicked by the presentation of these two motifs in the OmpA molecule Orla 35 
(Table 1.2). 
-56 
B 
C ^ 
OH OH OM QM OH OH OH OH OH OH OH OH 
s s s s s s s s s s s t 
Figure 1.10 Schematic showing assembly of Orla surfaces. Surfaces are assembled in the 
following manner A) Glass coverslips are first cleaned to remove any residues. B) Coverslips are 
coated with titanium to allow the attachment of gold. C) Gold is spluttered onto the surface. D) 
The surface is passivated by P-mercaptoethanol to facilitate the attachment of OmpA. E) OmpA is 
allowed to self assemble on the surface in a controlled fashion due to the modified cysteine residue 
(red). F) Infill molecules are allowed to self assemble on the surface and fill the gaps between 
OmpA molecules to form an intact monolayer. 
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1.6 Stem ceil therapy using the E C M 
ES cells provide an unlimited source of cells and hence could potentially be used 
to produce an unlimited supply of skin. Experiments using murine ES cells 
demonstrate that the combination of surface coating, soluble molecules and culture 
conditions are key in the differentiation of ES cells into skin. Using surfaces 
coated with ECM secreted by primary human normal fibroblasts, with the addition 
of ascorbic acid, ES cells can be induced to differentiate into keratinoctyes. With 
the correct culture conditions of a liquid air interface, these ES cell derived 
keratinocytes can from a highly organised structure resembling skin. Although 
there would remain some undifferentiated, unorganised regions and hence, more 
knowledge is needed i f this is to be used to produce skin for engraftment 
It is possible for the cornea to become damaged due to diseases such as Stevens-
Johnson syndrome or severe microbial infection furthermore it is possible to 
damage the cornea by chemical or thermal bums resulting in the loss of corneal 
and limbal epithelial cells. This could cause loss of visual acuity and as such a 
method of removing damaged cells and replacing with new ones would be 
favourable. 
The corneal epithelium is maintained by a population of stem cells, termed limbal 
stem cells (LSC), located in the basal layer of the limbal epithelium. It follows 
that i f the factors contained within this niche were recreated in vitro this would 
form a favourable environment for the production of corneal epithelial cells. The 
basement membrane of the limbal epithelium is composed of collagen, laminin and 
fibronectin furthermore it is known that during wounding the content of 
fibronectin within the ECM increases It has been demonstrated that murine 
ESC can be cultured on collagen IV coated surfaces to direct them towards corneal 
epithelial-like cells. Upon transplantation onto a damaged cornea the transplanted 
cells assume a corneal epithelial cell-like morphology. 
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In addition it is known that cells from the ocular surface produce a myriad of 
cytokines that control cell behaviour By combining factors produced by limbal 
fibroblasts and coating surfaces with collagen IV it has been demonstrated that 
human ESC can be differentiated to form corneal epithelial-like cells 
1.7 Current understanding shown within the literature 
Currently there are a large number of proposed uses of stem cells for the cure of 
diseases. However, in the literature there is a significant lack of understanding of 
how stem cell behaviour is affected and controlled. Transplantation of stem cells 
into immunocompromised animals is widely used as a model system to study cell 
potency. In addition to the study of cell potency, the teratoma model provides a 
method to study stem cell behaviour with multiple factors acting together to direct 
and control stem cell fate. 
In the literature there have been numerous different locations investigated for the 
transplantation of stem cells to study stem cell behaviour, however one site that 
has not been fully investigated is the liver. This site has a known regenerative 
capacity that would be predicted to provide an ideal environment for stem cell 
grovv1;h. This would provide an alternative environment for the control of stem cell 
behaviour. From in vivo studies, factors controlling stem cell behaviour are 
predicted, such as the ECM. 
Expanding upon in vivo studies it is possible co-inject cells with ECM components 
to study how this affects their behaviour. The most extensively smdied ECM 
component for transplantation is Matrigel^^^. Matrigel™ has been studied for a 
number of different applications. However, few studies have applied it to the 
teratoma model. Matrigel™ is a complex mixture of ECM components made up 
of both ECM proteins and growth factors. To date, no studies have investigated 
how the individual ECM proteins that make up Matrigel^'^ affect stem cell 
behaviour in the teratoma model. By studying these individual components this 
wi l l allow a better understanding of how the ECM affects stem cell behaviour in 
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vivo. Having demonstrated that the ECM affects cell behaviour it is possible to 
investigate the effects of peptide motifs on cells. 
In the literature, there are many examples of methods to present peptides to control 
cells. What is lacking is the study of how peptide motifs when presented in a 
defined and reproducible manner affect cell behaviour. By studying cell behaviour 
in the response to the ECM this will allow a greater understanding of how to 
control stem cell behaviour. 
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Surface name Motif Source 
OmpA - -
Orla 1 RODS Fibronectin 
Orla 11 I K V A V Laminin 
Orla 30 VFDNFVKL Tenascin C 
Orla 31 GTPGPQGIAGQRGVV Collagen I 
Orla 32 MNYYSNS Collagen IV 
Orla 34 PHSRN Fibronectin 
Orla 35 PHSRN+RGD Fibronectin 
Orla 36 YIGSR Laminin 
Orla 37 YIGSR+IKVAV Laminin 
MOSl Collagen I 
Collagen FV 
GTPGPQGIAGQRGVV 
MNYYSNS 
M0S2 Fibronectin 
Laminin 
RODS 
YIGSR 
M0S3 Fibronectin 
Collagen 1 
Collagen IV 
RODS 
GTPGPQGIAGQRGVV 
MNYYSNS 
M0S4 Fibronectin 
Collagen I 
Laminin 
RODS 
GTPGPQGIAGQRGVV 
YIGSR 
M0S5 Fibronectin 
Collagen I 
Collagen IV 
Fibronectin 
Laminin 
RODS 
GTPGPQGIAGQRGVV 
MNYYSNS 
PHSRN 
YIGSR 
Table 1.2 Biomimetic surfaces tested. Table shows nomenclature of biomimetic surface, motifs 
presented and source of motifs. Where + is shown this denotes two motifs are presented in a single 
OmpA molecule. Mixed Orla Surfaces (MOS) are composed of multiple OmpA molecules each 
presenting one single motif 
-61 
C H A P T E R 2 - M O D I F Y I N G T H E IN VIVO ENVIRONMENT 
T O M O D U L A T E T E R A T O M A D E V E L O P M E N T 
2.1 Introduction 
The study of stem cell behaviour is important as stem cells are believed to hold the 
answer to both curing multiple diseases and gaining a greater understanding of the 
mechanisms that control development. Stem cell behaviour can be studied both in 
vitro and in vivo. In vitro study provides a simplified system where all of the 
environmental factors affecting cell behaviour can be controlled. In comparison, 
the in vivo environment is highly complex and less controllable where multiple 
factors such as: the ECM; physical forces; soluble molecules; 3D shape; and cell-
cell interactions all act simultaneously to control stem cell behaviour. Although in 
vivo study is less controllable than in vitro studies it provides a method to 
investigate stem cell behaviour in an environment that is not artificial and 
representative of their natural environment. 
To investigate stem cell behaviour, undifferentiated EC stem cells and ES cells can 
be transplanted into immunocompromised animals. Following transplantation, 
spontaneous differentiation occurs and a mass of unorganised differentiated cell 
types are formed - a teratoma. The main application of teratoma formation is to 
demonstrate the potential of the transplanted cells. This is achieved by 
transplanting stem cells into an immunocompromised animal (usually a mouse), 
allowing a teratoma to form then subsequently studying the composition of the 
teratoma and cell types contained within 25.35,66,243-246 Q^^Q^ tj^at this method is 
widely used to validate stem cell potency relatively little is known about how these 
unique structures develop and what controls their formation. 
Although teratoma formation and analysis is seen as the gold standard to assess 
potency, inconsistencies exist in the method by which this assay is conducted. 
Previous studies have demonstrated that the anatomical location in which cells are 
transplanted affects their behaviour The anatomical location in which stem 
cells have been transplanted varies and can include: muscle "''^  '^'^ ; testis 
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kidney capsule or subcutaneous ^^ '^ ^ One factor that could influence 
the transplanted cells and affect their behaviour is the physical environment, for 
example, cells transplanted into the muscle wi l l be subjected to continual 
stretching and contractions whereas cells transplanted into other sites such as the 
testis w i l l not be subjected to such forces. In vitro, stretching of cells is used to 
produce muscle tissue from stem cells and it is likely that the physical condition 
of the muscle wi l l affect the developmental potential and differentiation of the 
transplanted stem cells. 
Routinely, all of the above mentioned anatomical sites are used for the 
transplantation of stem cells. An alternative transplantation site for teratoma 
formation that has not been investigated is the liver. This provides an environment 
that is: not subject to physical strain unlike the muscle; has a high blood supply 
unlike the skin; and is rich in nutrients. The liver is known to be a highly 
regenerative organ and therefore is likely to contain the correct factors for the 
expansion of the transplanted cell population. Studying this location wi l l allow 
factors to be proposed that can control cell behaviour. 
In vitro, extracellular matrix proteins have been shown to affect stem cell 
behaviour, laminin, collagen IV and fibronectin have all been shown to be 
important in EC stem cell differentiation and the levels of secretion have been 
found to change during differentiation ™. Within different anatomical locations a 
major component of the environment is the ECM, which contains: collagens; 
fibronectins; and laminins. Collagen is a major part of the ECM within the liver 
making up 80%"^' The liver is also known to be rich in the glycoproteins, 
fibronectin and laminin "^^ Collagen I is also important in the skin as, 70-80% of 
the dry weight of the dennis is collagen 1 Fibronectin is also found in the 
dermis of the skin "^^ Hence, '\n vivo, interactions of cells with the ECM could be 
key in the control of cellular behaviour. 
To investigate how the ECM affects cell behaviour and teratoma development in 
vivo, stem cells can be co-injected with ECM components into 
immunocompromised animals to modulate teratoma formation. To date, few 
studies have been conducted using co-transplantation of ECM molecules and stem 
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cells; however, this technique has been used for tumour cells. One studied factor 
that has been used with tumour cells is an ECM extract - Matrigel™. MatrigeF"^ 
is a mixture of collagen IV, laminin, heparan sulphate, proteoglycan, entactin, 
nidogen and various growth factors (Table 1.2) that form a solid gel at 37°C and 
therefore when injected into a body a gel wi l l form Co-transplantation of 
prostatic, breast and ovarian carcinoma cells with Matrigel™ has been shown to 
significantly increase the rate of tumour formation of these cells which do not 
readily form tumours when Matrigel^'^ is not present Furthermore the 
effects of Matrigel can in part be reduced with the co-injection of laminin peptide 
YIGSR thus implementing laminin as a key component 
In addition to MatrigeF'^, collagen I has also been co-injected to aid tumour 
growth '^'^ •^ ^^ ^ the effects observed are not as pronounced as with Matrigel™ and 
the effects are not observed in all cells. Matrigel™ is a complex mixture of 
multiple molecules and it would be expected that individual ECM proteins such as 
collagen I wi l l not be as effective as multiple ECM proteins. When Matrigel™ is 
co-injected an increase in tumour size is observed. Potential factors contributing to 
the increased tumour size could be due to the observation of a decreased necrosis 
and increased vascularisation of tumours. Matrigel™ contains a wide number o f 
growth factors, with the removal of these growth factors beneficial effects are still 
observed on tumour formation, thus indicating that the ECM components do effect 
tumour development 
In a similar manner to that implemented with tumour cells, stem cells could be co-
transplanted with various ECM molecules to influence cell fate and modulate 
teratoma development. It would be expected that Matrigel™ would be a potent 
factor in increasing the success rate of teratoma formation. As MatrigeF"^ is a 
mixture of different ECM proteins it provides a method for studying how complex 
interactions between multiple different factors influence teratoma growth in vivo. 
This experimental paradigm is highly complex and simplification of this system 
wi l l allow for a greater interpretation of the interactions between stem cells and 
ECM components. Matriger"^^ consists of both growth factors and ECM proteins; 
there are alternative versions of Matrigel™ available, such as a version with 
reduced levels of growth factors (EOF, lGF-1, PDGF and TGF-beta). Co-
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transplantation of Matrigel""^ with reduced growth factors with stem cells wi l l 
allow specific analysis of how the ECM affects stem cells in the absence of any 
effects caused by the growth factors present. MatrigeF'^ with reduced growth 
factors is a mixture of collagen, laminin and entactin and is presenting multiple 
different ECM proteins to the transplanted cells. To further simplify this system, 
stem cells can be co-transplanted with individual ECM proteins. In addition to 
collagen FV and laminin found in Matrigel™, other proteins that have been shown 
to influence cell behaviour in vitro include collagen I and fibronectin. 
To fiirther simplify this system, ECM mimics can be used. Extracel™-X is an 
ECM mimic composed of three components, thiol-modified hyaluronan (a 
constituent of the ECM), thiol-modified gelatin (hydrolysed collagen) and a thiol-
reactive cross linker (polyethylene glycol diacrylate, PEGDA). Unlike Matrigel™, 
gelation is not achieved by a change in temperature but by time, dependent upon 
the relative quantities of cross linker added. The gel that is produced has a high 
water content of 97-98% giving a high permeability for oxygen and water soluble 
metabolites. In vitro cells are able to attach and gels are biocompatible in vivo. 
The biodegradability of the hydrogel can be controlled with the relative amounts of 
its constituents. Cells can be seeded into the hydrogels and injected 
subcutaneously for in vivo growth Extracel^'^-X has been used to investigate 
the growth of pancreatic adenocarcinoma cells transplanted into mice. Compared 
to cells transplanted without Extracel™-X, an increase in the time in which 
tumours are formed is observed. Extracel™-X increases the rate of tumour 
progression and subsequently the final tumour mass Extracel™-X has also 
been demonstrated to increase the rate of tumour formation and size of cancer cells 
transplanted into mice ^ ' ' V 
In addition to natural ECM mimics, synthetic materials have been developed to 
mimic the in vivo environment. PuraMatrix™ is a synthetic fiber made of 8-16 
RAD peptide units that mimic ROD, the mutation of G to A has previously been 
demonstrated to not affect its activity Due to the repeating hydrophilic and 
hydrophobic units the peptides self-assemble into P-sheets and then into fibers 
with a diameter of 7-lOnm. PuraMatrix^"^ forms a gel at 37°C, the resultant 
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hydrogel has a low peptide concentration (0.5-1%) and mimics the gels formed by 
collagen. 
It has been noted that the success rate of teratoma formation can vary. Some 
studies have shown that failure of graft formation can be attributed to 
compromised viability of the transplanted cells however the age of the host does 
not influence the teratoma Other studies have found that the efficiency of 
teratoma formation can be influenced by the site into which the cells are 
transplanted. Intramuscular transplantation had a success rate of 12.5% and 
testicular transplantation had a success rate of 60%. Also, modulating the local 
environment with the co-transplantation of the extracellular matrix component 
Matrigel™ has a dramatic increase in the rate of teratoma formation '^ '^ . 
HYPOTHESIS 
The anatomical site into which stem cells are transplanted are known to influence 
teratoma behaviour. Due to the known regenerative capacity of the liver, it is 
predicted that transplantation of EC stem cells and ES cells intrahepatically wi l l 
produce large teratomas. As the ECM is known to be a key component of the in 
vivo environment, co-transplantation with different ECM components can be used 
to modulate teratoma development. Previously, Matrigel™ has been shown to 
increase the success rate of tumour formation, it is predicted that a similar trend 
w i l l be observed for EC stem cells. Furthermore, co-transplantation with 
individual ECM proteins found in Matrigel™, such as collagen FV and laminin 
should influence teratoma success rate and behaviour similar to Matrigel™, 
although, the effects may be less pronounced. As well as ECM proteins found in 
Matrigel^'^, collagen I and fibronectin are tested for their abilities to influence 
teratoma behaviour. It would be expected that collagen I would influence the 
success rate of teratoma fonnation similar to collagen IV, however the effects on 
their development would be varied due to the different signaling mechanisms. 
Matrigel™ contains several growth factors using an alternative version with 
reduced growth factors, it would be expected that a reduction in teratoma grow1;h 
rate would be observed. Two ECM mimics are used, Extracel^'^-X and 
PuraMatrix™. Extracel™-X contains collagen and it would be expected that its 
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effects on teratoma behaviour would be similar to collagen I or collagen IV. 
PuraMatrix™ contains RAD peptides that mimic the RGD motif found in 
collagen, fibronectin and laminin and would be expected to behave similar to these 
proteins, however as it is only presenting the peptide and not the whole protein, a 
reduction in the effects seen should be observed. It is predicted that the success 
rate of teratoma formation wil l be modulated depending upon the ECM component 
with which EC stem cells are co-transplanted. It would be expected that factors 
such as Matrigel™, collagen I and collagen IV, that form gels would increase 
teratoma success rate by encapsulating the cells and maintaining their viability. 
A I M 
Gain a greater understanding of teratoma development by presenting stem cells 
with a novel microenvironment to modulate the growth and development of the 
transplanted cells. In addition, co-transplantation of stem cells with ECM 
molecules wi l l provide information on how the ECM regulates teratoma 
development. 
OBJECTIVES 
1. Transplant stem cells into the liver and subcutaneously to modulate cell growth 
and development using different microenvironments. 
2. Co-transplant stem cells with ECM components to increase the success rate of 
teratoma formation and influence the cell types within. 
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2.2 Materials and Methods 
Cell culture 
The human EC stem line TERA2.cl.SP12 was maintained in D M E M (Lonza), 10% 
Foetal bovine serum (Invitrogen), 2 mM L-glutamine (Lonza), 20 units/mL of 
penicillin and 20 jxg/mL streptomyci^"^^ Cultures were passaged as required 
using acid cleaned glass beads. The hESC line, hES-NCLl were grown and 
maintained in medium containing knockout-DMEM (Invitrogen), 100 \iM P-
mercaptoethanol (Sigma), 1 mM L-glutamine (Invitrogen), 100 m M nonessential 
amino acids; 10% serum replacement (Invitrogen), 1% penicillin-streptomycin 
(Invitrogen); and 4 ng/ml basic fibroblast growth factor (Invitrogen) 
Intrahepatic and subcutaneous cell transplantation 
A l l procedures involving mice were conducted in accordance with guidelines and 
permission granted by the Institution and the Home Office (UK). Approximately 
5x10^ cells were resuspended to a final volume of 100 Using a 25G x 5/8" 
needle, cells were injected either beneath the skin (subcutaneous) or into the liver 
(intrahepatic) of adult male nude (nu/nu) mice. Each animal received one graft of 
either hESC or EC stem cells into one of the two locations. To validate the 
findings, this procedure was repeated 3-5 times in each site for each stem cell type. 
Mice were sacrificed after 3-12 weeks and a post-mortem examination was 
performed during which teratoma tissues were surgically removed. 
Co-transplantation of ECM components with EC cells 
The ECM components were prepared as follows: collagen I (Sigma) was dissolved 
in O.IM acetic acid, chlorofomi sterilised and diluted to a concentration of Img/ml 
(double the final concentration required) then balanced to pH7.0 using sodium 
hydroxide; collagen IV (Sigma) was dissolved in 0.25% acetic acid, chloroform 
sterilised and diluted to a concentration of ling/ml (double the final concentration 
required) then balanced to pH7.0 using sodium hydroxide; fibronectin was used as 
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supplied (Img/ml); laniinin was used as supplied (Img/ml); and Matrigel™ was 
used as supplied (lot concentration, ~9.8mg/ml). EC stem cells were trypsinised, 
resuspended in media, centrifuged and washed twice with PBS to remove any 
residual media. The cell number was determined and the required number were 
resuspended in half the final injection volume. The cell suspension was mixed 
with an equal volume of ECM component and loaded into a syringe with a 25G x 
5/8" needle. Approximately 5x10^ cells were injected subcutaneously into adult 
male Nude (nu/nu) mice. Each animal received bilateral grafts of EC stem cells 
suspended in PBS and EC stem cells suspended in an ECM component. To 
validate the findings, this procedure was repeated 6 times for each ECM 
component. Injection of ECM components without any EC stem cells was carried 
out twice for each ECM component. Mice were sacrificed after 6-13 weeks and a 
post-mortem examination performed during which teratoma tissues were surgically 
removed. 
Co-transplantation of ECM components and synthetic matrices with EC cells 
Cultrex BME (AMS Biotechnology #3432-005-02, RGF #3433-005-02) was 
thawed from storage (-SO'^ C) on ice at 4"C and a cell solution in PBS was added to 
dilute the stock concentrations of 17.3mg/ml and 14.2mg/ml to lOmg/ml. Cells 
were added to this solution and transplanted as previously described. 
Extracel^'^-X (Glycosan biosystems) was prepared as described by the 
manufacturer. Glycosil™, Gelin-S™ and Extralink™ vials were removed from 
storage (-20°C) and thawed at 37°C for 30 minutes. DG water was removed from 
storage (-20°C) and thawed at 37"C for 15 minutes. Under aseptic conditions 
2.0ml of DG water was added to both Glycosil™ and Gelin-S™ vials, these were 
mixed at 37°C for 30 minutes. 1.0ml of DG water was then added to the 
Extralink™ vial and inverted to dissolve. Equal volumes of Glycosil™ and Gelin-
S™ were mixed, lOmillion cells were added to this solution (25^1 cells:250^1 
Glycosil™, Gelin-S^'^ solution). To form the hydrogel, 250|al of cells suspended 
in Glycosil™ and Gelin-S™ was added to 1.0ml of Extralink™. From this 
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solution, 100|al of cells suspended in hydrogel were taken and loaded into a 
syringe and transplantation was carried out as previously described. 
PuraMatrix™ (BD biosciences) was removed from storage (4°C) and sonicated to 
decrease its viscosity for 30 minutes in a water bath. Cells were harvested, 
centrifugated at 800 RPM for 2 minutes and resuspended in 100|al of filter 
sterilised 10% sucrose solution. Cells were then centrifugated at 800 RPM for 2 
minutes, cell number was ascertained using a haemocytometer and this step 
repeated to produce a cell suspension of 2million cells in 100|il of 10% sucrose 
solution. 100|al of PuraMatrix™ was added to the cell solution, gentle pipetting 
was used to mix the two solutions. To initiate gelation, 200|il of PBS Ix was 
added to the cells/PuraMatrix™ suspension. Syringes were loaded with 100|al of 
this solution using a 20G needle, switched to a 30G needle and transplantation was 
carried out as previously described. 
Tissue processing 
Specimens were preserved in Bouin's fixative (70% (v/v) saturated picric acid 
(Sigma); 25%. (v/v) formaldehyde (37%/40%, Sigma); and 5% (v/v) glacial acetic 
acid (Sigma)) at room temperature overnight or in 4% parafonnaldehyde (4% PFA 
(Sigma) in phosphate buffered saline (PBS, Sigma)) overnight at 4°C. Fixed 
tissues were dehydrated through a series of progressively concentrated alcohol 
washes of 70%, 80%, 90% and 95% for two hours each and 100% dry alcohol for 
24 hours. Samples were cleared in Histoclear for 24 hours, incubated at 60°C in 
Histoclear with wax (1:1); samples were incubated at 60°C in wax for 48 hours and 
embedded. Samples were sectioned to 6)im and mounted onto electrostatically 
charged slides. A l l samples were de-waxed and rehydrated for histology and 
immunocytochemical analysis. 
Histology 
Tissues fixed in Bouin's fixative were stained with either Haematoxylin and Eosin 
(H&E) or Weigert's Haematoxylin (Weigert's) using routine methods. 
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Haematoxylin and Eosin 
Samples were de-waxed in Histoclear for 6 minutes and rehydrated using, 100%, 
95% and 70% alcohol for 2 minutes each and washed in dH20 for 2 minutes. 
Nuclear staining was achieved using Mayer's Haemalum (RALamb) for 6 minutes, 
which was washed in dH20 and blued using alkaline alcohol (3ml ammonia in 
100ml 70% alcohol) for 15 seconds. Samples were washed in dH20, dehydrated in 
70%) and 95% alcohols for 1 minute each and cellular staining was achieved using 
Eosin (RALamb) for 10 seconds, sections were finally wash in 95% alcohol and 
100% alcohol for 25 seconds each, Histoclear for 4 minutes and mount in DPX. 
Weigert 's Haematoxylin 
Samples were de-waxed in Histoclear for 6 minutes and rehydrated using, 100%), 
95% and 70% alcohol for 2 minutes each and wash for 2 minutes in dH20. 
Cartilage was stained with alcian blue ( I g alcian blue, 3ml glacial acetic acid, 
100ml dH20, stirred overnight) for 6 minutes and washed in dH20. Cellular 
staining was achieved using Weigert's Haematoxylin ( I g Haematoxylin in 100ml 
100% alcohol mixed 1:1 with 4ml 30% FeCb + 1ml concentrated HCl + 95ml 
dH20) for 20 minutes, sections were washed in 50% alcohol and dipped in \ % acid 
alcohol (1ml concentrated HCl + 99ml 70% alcohol) and then sections were taken 
to water using 70%) alcohol for 1 minute and dH20, bone was stained using 
Ponceau S (10ml 1% Ponceau S ( I g Ponceau S in 100ml dH20) + 1.2ml glacial 
acetic acid + 90ml saturated aqueous picric acid) for 10 seconds, sections were 
washed in 95% alcohol for 10 seconds and 100%) alcohol for 1 minute, Histoclear 
4 minutes, mounted in DPX. 
Immunohistochemistry (fluorescence) 
Tissues fixed in PFA, de-waxed and taken to water as previously described for 
haematoxylin and eosin staining and then processed for antigen retrieval by 
microwaving (800W) tissues in lOmM citrate buffer (stock solution: 19.2g 
anhydrous citric acid in 1000ml dH20 (O.IM) pH6, Sigma) for 3x 2 minutes. 
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Sections were left standing in warm citrate buffer for 20 minutes and subsequently 
washed 3x 10 minutes in PBS. Sections were permeablilsed for 15 minutes ( 1 % 
Triton X-100 (Fisher) PBS solution) and blocked for 15 minutes {5% normal goat 
serum (NGS, Invitrogen), 0.1% Triton X-100, PBS). Sections were incubated with 
the following primary antibodies: Stage-specific embryonic antigen-3 (SSEA3), 
1:4, (gift from Peter Andrews); pan epithelial keratin, 1:200, (Chemicon 
International; http://www.chemicon.com); Nestin, 1:200, (Chemicon); 
Neurofilament 200kD (NF200), 1:200 (Sigma); and TRA-1-60, 1:4, (gift from 
Peter Andrews) in PBS containing 1% bovine serum albumin (Sigma), 0.2% 
Triton-X-100 (Sigma) and 5% normal goat serum (NGS, Sigma) over night at 4°C 
prior to washing 3x 2 minutes in PBS and incubation with fluorescence-conjugated 
secondary antibodies (For SSEA3 and TRA-1-60: mouse IgM, 1:200 (Sigma); for 
Nestin and Pan Epithelial keratin: mouse IgG, 1:200 (Sigma); For NF200: rabbit 
IgG, 1:400 (Sigma)) for 1 hour at room temperature. Immuno-stained tissue 
sections were subsequently washed 3x 10 minutes in PBS, mounted using 
Vectashield® (Vector Labs), examined by fluorescence microscopy and digital 
images were taken. 
Immunohistochemistry (peroxidase) 
Sections were cleared, rehydrated and antigen retrieval carried out as previously 
described for fluorescence immunohistochemistry. Endogenous Avidin/Biotin 
activity was blocked using a blocking kit (Vector Labs) and permeabilisation and 
blocking carried out as described for fluorescence immunohistochemistry. 
Sections were incubated with the following primary antibodies; Ki67 (1:200 
(Abeam)), human nuclear antigen (1:25 (Chemicon)) and CDX2 (1:50 
(Novocastra)). Negative controls were carried out with the omission of the 
primary antibody. To detect the primary antibodies, a universal ABC detection kit 
was used (Vector labs). Sections were incubated for 30 minutes with a 
biotinylated secondary antibody and washed for 5 minutes in PBS. To detect the 
secondary antibody, sections were incubated for 30 minutes with Vectastain® Elite 
ABC reagent (Vector Labs) and then washed for 5 minutes in PBS. To visualise 
the location of the primary antibody, sections were incubated in a purple coloured 
Vector VIP peroxidase substrate (Vector Labs). Sections were briefly counter 
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stained using Mayer's Haemalum for 10 seconds and blued for 10 seconds using 
4% alkaline alcohol (4% ammonia (Fisher) in 70% alcohol). Sections were 
dehydrated through a series of alcohols, cleared using Histoclear and mounted 
using DPX (RA Lamb). 
Imaging 
A l l images were taken on a Nikon Diaphoto 300 with a digital camera using Nikon 
A C T l image capture software. 
Measurements of images 
Measurements were determined using ImageJ software (National Institute for 
Health; http://rsb.info.nih.gov/ii/). 
Low magnification images 
Low magnification images were produced by capturing multiple images at 4x 
magnification and subsequently stitching these images together by hand in Adobe 
Photoshop. Cross sections images are compared showing the greatest cross 
sectional diameter of teratomas, and adjusted to account for teratoma length. 
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2.3 Results 
Comparison of tumours formed from different anatomical locations 
2.3.1 Embryonal carcinoma intrahepatic transplantation produces large 
teratomas in comparison to subcutaneous transplantation 
Transplantation of EC cells into the liver resulted in teratomas dramatically 
different in structure to those seen following transplantation beneath the skin. 
Transplantation into the liver resulted in rapid growing teratoma masses that were 
terminated 3-4 weeks post transplantation. In comparison, subcutaneous 
transplantation resulted in much slower growing teratomas, which could be 
maintained for 10-12 weeks. Subcutaneous teratomas were solid in composition 
with no cystic regions. Intrahepatic teratomas were cystic with areas of solid 
material similar to subcutaneous teratomas. Cystic regions were surrounded by 
simple epithelial cells. Subcutaneous teratomas had an estimated volume of -40-
50mm"' and intrahepatic teratomas were estimated to be five to eight times larger 
with an estimated volume of ~225-360mml The mass of solid material for 
intrahepatic teratomas was estimated to be -70-80% thus indicating that the cystic 
regions are not solely accountable for the increase in tumour size (Figure 2.1). 
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Figure 2.1 Morphological comparison of fiEC stem cell subcutaneous and intrahepatic 
teratomas. Low magnification images show middle sections of teratomas. Larger intrahepatic 
teratomas are shown on the left, whereas, smaller subcutaneous teratomas are shown on the right. 
Fluid filled cavities (fc) were observed in intrahepatic teratomas. Histological staining: 
Haematoxylin and eosin, all images are shown at the same magnification. Scale bar: 1 mm. 
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2.3.2 Embryonal carcinoma transplanted intrahepatically produces immature 
teratomas 
To identify the cell types present within the intrahepatic teratoma, 
immunohistochemical analysis was carried out. Teratomas produced by hEC stem 
cells are known to consist of undifferentiated elements and differentiated 
components. The undifferentiated elements within a teratoma produced by hEC 
stem cells are known to be reactive to SSEA-3 for this reason this antibody was 
used to assess the undifferentiated elements of the teratoma. Teratomas from hEC 
stem cells are also known to contain neural progenitor cells, the class V I 
intermediate filament antibody nestin, that recognises neural stem/progenitor cells 
was used to assess the' neural progenitor cell population. Epithelial cells are 
abundant in teratomas produced by hEC cells, to assess this, an antibody to pan 
keratin that recognises a broad range of human keratins was used. To assess the 
presence of more differentiated neural cells, the neurofilament antibody NF200 
was use to detect these. 
Intrahepatic teratomas consisted of both undifferentiated and differentiated 
elements. Intrahepatic teratomas were found to have expression of the pluripotent 
stem cell marker SSEA-3 and the differentiated cell markers, nestin and epithelial 
keratin, indicating that both immature and mature differentiated tissues are present. 
Subcutaneous teratomas were found to be more differentiated with fewer 
undifferentiated cell types and were found to have no expression of SSEA-3 and 
the expression of nestin, keratin and NF200 were all greater than for intrahepatic 
teratomas, indicating a more differentiated teratoma. The location of the nestin 
expression was different in each of the two teratomas, with nuclear localisation in 
the subcutaneous teratoma and cytoplasmic expression in the intrahepatic teratoma. 
The cytoplasmic staining was reminiscent of undifferentiated pluripotent stem cells 
and multilineage progenitor cells in vitro ^^ '^  (Figure 2.2). 
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IH xenograft SC xenograft 
Figure 2.2 Immunohistochemical analysis of the composition of teratomas grown in 
intrahepatic or subcutaneous locations. Embryonal carcinoma stem cells were grafted and 
maintained intrahepatically (IH) for 3-4 weeks (A, C, E, G) or subcutaneously (SC) for 10-12 
weeks (B, D, F, H). Samples were immunologically stained for: SSEA-3 (A, B); Nestin (C, D); 
Epithelial keratin (E, F); or NF200 (G, H). Brightfield haematoxylin and cosin stained images are 
shown with their corresponding fluorescence counterpart. Al l images are shown at the same 
magnification. Scale bar: (A-F) 100|im. 
2.3.3 Human embryonic stem cells transplanted intrahepatic produces large cystic 
tumours 
Transplantation of ES cells into the liver of SCID mice, produces large tumours 
within 3-4 weeks, several of these tumours grew so rapidly that they resulted in 
dramatically reduced health of the animal and termination of the experiment. 
Histological examination showed that the teratoma contained no solid material and 
was solely composed of fluid filled cavities, further examination through the whole 
of the tumour showed this to be the case throughout (Figure 2.3). Cystic regions 
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were not surrounded by any identifiable epithelial. The estimated volume of the 
tumour was ~510mm^. 
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Figure 2.3 Intrahepatic transplantation of ES cells produces large cystic teratomas. Teratomas 
were found to be composed of fluid filled cavities (fc) with no evidence of any solid or 
differentiated material. Images show serial sections 600|am apart. Histological staining; 
haematoxylin and eosin. Scale Bar: 2mm. 
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2.3.4 Transplantation of embryonic stem cells subcutaneously produces teratomas 
composed of both solid and fluid filled cavities 
Upon examination of teratomas produced by hES cells, it was found that these 
teratomas consisted mainly of solid material made up o f neural (n); cartilage (c); 
epithelial (EpK); and bone (arrows) cells (Figure 2.4). In addition there were 
numerous fluid filled cavities (Figure 2.4, fc). The fluid filled cavities were 
surrounded by both simple epithelial cells and epithelial cells reminiscent of the 
gut. The size of the teratoma was dramatically smaller than the tumour produced 
following intrahepatic transplantation; the estimated teratoma volume was -100-
I25mm^ 
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Figure 2.4 Transplantation of hES cells subcutaneously produced solid teratomas with small 
cystic regions. Histological examination throughout the whole teratoma demonstrated that the 
majority of the teratoma is solid material. Evidence of both differentiated elements including 
neural tissue (n), cartilage (c) and epithelial keratin (EpK) as well as fluid filled cavities (fc) was 
observed. Histological staining; Haematoxylin and Eosin. Images show serial sections 600nm 
apart. Scale Bar: 2mm. 
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2.3.5 Subcutaneoii.s ti ansplanlalion of ernbiyonic stem cells produces teratomas 
composed of cell types from all three germ layers 
In order to have a comparison for intrahepatic transplantation of hES, these cells 
were transplanted subcutaneously and their differentiation potential was 
investigated. In agreement with previous work, hES cells transplanted 
subcutaneously resulted in teratomas composed of cell types from all three germ 
layers. The teratomas produced were heterogeneous and histological analysis 
showed that they were pku ipolcnt and composed of cell tyj^es from all three germ 
layers: bone, cartilage (mesoderm); neural epithelial (ectoderm); gut (endoderm); 
and primitive kidney (mesoderm) (Figure 2.5). 
Figure 2.5 Subcutaneous transplantation ofES cells produces fully differentiated teratomas. A) 
Low power examination demonstrated the heterogeneous nature of the teratoma with cartilage (c), 
bone (b) neural tissue (n) and epithelial keratin (EpK). B) Primifive kidney glomeruli (gm) and 
associated tubules (t). C) Neural epithelium was observed forming neural tube-like structures. D) 
Bone (b) and cartilage (c). E) Cartilage (c). F) A gut like structure was also observed with a 
folded epithelia and lumen (g) and associated muscle layer (m). G) Epithelial keratin. H) 
Epithelium with goblet cell, insert shows a goblet cell secreting mucus. Histological staining; A, B, 
E Weigert's Haematoxylin, C. D, F, G Haematoxylin and Eosin. Scale Bars: A=400|im; B, C, F, 
G=100nm; D, E=200nm; H=20nm insert 20nm 
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2.3.6 Immmohistochemical analysis confirms that subcutaneous transplantation 
of embryonic stem cells produces teratomas composed of cell types from all three 
germ layers 
Immunohistochemical analysis was performed to verify that teratomas produced 
by the transplantation of ES cells are composed of cell types from all three germ 
layers. Positive staining for the caudal-related homeobox transcription factor 
antibody (CDX2) confirmed the presence of cells derived from endoderm (Figure 
2.6, A) . Cell types positive for smooth muscle actin confirms presence of 
mesoderm derived cells (Figure 2.6, B). Nestin expression demonstrates that cells 
of an ectodermal origin are also present (Figure 2.6, C). Taken together, these 
results demonstrate that teratomas derived from hES cells are pluripotent and 
composed of cell types from all three germ layers. 
Figure 2.6 Immunohistochemical confirmation of the presence of cell types from all three germ 
layers. Teratomas were positive from antibodies to cell types from all three germ layers. A) 
Positive expression for the endodermal marker CDX2. B) Positive expression for the mesoderm 
marker smooth muscle actin (SMA). C) Positive expression for the ectoderm marker nestin. 
Positive staining is shown in purple with negative regions shown in blue. Al l images were taken at 
the same magnification scale bar; lOOnm. 
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How the ECM affects teratoma development 
One factor that could contribute to the different results obtained following 
transplantation into alternative environments is the composition of the ECM. Co-
transplantation of stem cells into a single environment with different ECM 
components could provide evidence of whether the ECM plays an important role 
in teratoma formation. 
2.3.7 Co-transplantation of embryonal carcinoma cells with different extracellular 
matrix components increases the success rate of teratoma formation 
Subcutaneous transplantation of hEC stem cells with the following solutions was 
carried out: PBS (control); collagen 1; collagen IV; fibronectin; laminin; and 
Matrigel™. The success rate of teratoma formation was different depending upon 
the ECM component used. No teratoma fonnation was observed when cells were 
transplanted with either collagen IV or fibronectin. Teratoma formation was 
observed when cells were transplanted with PBS (control), collagen I , laminin and 
MatrigeF"^ (Table 2.1). No tumours fonned for any ECM component transplanted 
without cells. 
E C M component Tumour formation rate 
Control (PBS) 4% (1/24) 
Collagen I 33% (2/6) 
Collagen IV 0% (0/6) 
Fibronectin 0% (0/6) 
Laminin 33% (2/6) 
Matrigcl 100% (6/6) 
Table 2.1 The success rale of teratoma formation of hEC stem cells co-transplanted with various 
ECM components. Numbers in brackcis show the number of successful teratomas and the total 
number of animal in which u anspkiiilalions were carried out. 
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2.3.8 Co-transplantalion of embiyonal carcinoma cells with different extracellular 
matrix components affects the growth rate of teratomas 
Teratoma progression was followed by weekly measurements of the mean 
teratoma diameter using calipers. Cells transplanted with Matrigel™ readily 
formed teratomas within one week post transplantation and their growth was rapid 
with the experiment being temiinated six weeks post transplantation. Cells 
transplanted with collagen 1 and PBS (control) fonned teratomas more slowly (first 
palpable five weeks post transplantation) than with Matrigel™ (first palpable one 
week post transplantation). Collagen I teratomas grew at a slower rate than the 
control. Cells co-transplanted with laminin first showed signs of teratoma growth 
six weeks post transplantation, whilst their progression was quicker than collagen I 
teratomas it was not as rapid as the control teratoma (Figure 2.7 A). Following 
termination of the experiments, histological analysis was carried out. Teratomas 
produced with the co-injeclion of Matrigel™ appeared to have a similar cross 
sectional diameter similar to cells transplanted when suspended in PBS, however, 
the teratoma produced from co-transplantation with Matrigel™ had only been 
allowed to develop for six weeks, whereas, the control teratoma had been allowed 
to develop for thirteen weeks (over twice the time allowed for Matrigel™ co-
transplantation development). Teratomas produced with the co-injection of 
laminin, showed a reduction in cross sectional diameter, when compared to control 
teratomas. Those transplanted with collagen I showed a flirther reduction (Figure 
2.7, B). 
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Figure 2.7 The growth of teratomas depends upon the co-transplanted ECM component. A) 
Graphical representation of teratoma growth rate for EC stem cells co-transplanted with PBS 
(control), collagen 1, laminin and Matrigel'". Points represent average values for all successfiil 
teratomas in each group. B) Low power images showing cross sections of teratomas at their widest 
cross sectional length. Note, cross sectional areas were adjusted to account for teratoma length and 
areas were reduced for teratomas of shorter length to give a true representation of teratoma size. 
All samples are shown at the same magnification. Scale = 1mm, histological staining, 
haematoxylin and eosin. 
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2.3.9 Teratomas produced by EC stem cells co-transplanted with extracellular 
matrix components are solid in composition 
It was previously demonstrated that teratomas can consist of both soHd and cystic 
cavities fi l led with f luid (Sections 2.3.3 and 2.3.4). Upon examination of serial 
sections throughout the teratomas formed, no cystic areas were observed for any o f 
the teratomas and all tumours appeared as a solid mass throughout (Figure 2.8, 
shows a teratoma formed by co-transplantation of EC stem cells with Matrigel™ 
and is representative of all teratomas formed). 
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Figure 2.8 Examination of serial sections throughout a teratoma formed by co-transplantation 
of EC cells with Matrigel™. Sections demonstrate that the teratoma is solid throughout the whole 
of the material. Histological staining; Haematoxylin and Eosin. Sections are 2mm apart; all 
images are shown at the same magnification, Scale Bar: 1 mm. 
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2.3.10 The extracellular matrix affects the cell types present within the teratoma 
When EC stem cells were suspended in PBS without any additional ECM and 
transplanted subcutaneously, teratoma development was consistent with that 
previously reported and as described herein (Section 2.3.1). Both differentiated 
cell types of glandular structures composed of cavities surrounded by epithelial-
like cells (Figure 2.9, A ) and neural rosettes (Figure 2.9, B) were observed. In 
addition, cell types with an undifferentiated morphology similar to that of 
pluripotent hEC cells were seen (Figure 2.9, C). Immunohistochemical analysis 
revealed that within the teratoma there existed populations o f Ki67 positive cells, 
thus demonstrating cells within the teratomas were proliferative (Figure 2.9, D). 
\ 
?, S k i 
Figure 2.9 Histological examination of teratomas produced by EC cells co-transplanted with no 
additional ECM. Cells types indicative of EC teratomas were observed. A) Glandular structures 
(g). B) Neural rosettes (arrows). C) Embryonal carcinoma cells. D) Proliferative Ki67 positive 
cells (dark red). Histological staining: A-C Haematoxylin and Eosin. Immuno-staining: D Ki67. 
Scale Bars: A lOOum, B-D 50nm. 
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2.3.11 Co-transplantation with collagen I decreases the differentiation potential 
of embryonal carcinoma stem cells 
Similar to control teratomas, co-transplantation of EC stem cells with collagen I 
produced a solid teratoma with both embryonal carcinoma cells and proliferative 
elements. The collagen I teratoma was the smallest of all the teratomas produced. 
However, differentiation appeared to be suppressed and no glandular structures or 
neural elements were observed (Figure 2.10, A, B). Similar to control teratomas, 
cells with morphology similar to undifferentiated hEC stem cells were seen (Figure 
2.10, C). Also similar to control teratomas, Ki67 positive cells were seen, 
demonstrating that cells within the teratoma were proliferating (Figure 2.10, D). 
Figure 2.10 Histological examination of teratomas produced by EC cells co-transplanted with 
collagen I. Teratomas were solid in composition with few alternative cell types. A, B) The tumour 
appeared solid throughout. C) Embryonal carcinoma cells. D) Proliferative Ki67 positive cells 
(dark red). Histological staining: A-C Haematoxylin and Eosin. Immuno-staining: D Ki67. Scale 
bars; A 200nm, B lOOum, C, D 50^m. 
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2.3.12 Co-transplantation with laminin increases the differentiation potential of 
embryonal carcinoma stem cells 
Co-transplantation of EC stem cells with laminin appeared to increase the 
developmental potential of EC stem cells. As observed in control teratomas, 
glandular structures (Figure 2 .11 , A) , neural rosettes (Figure 2.11, B), pluripotent 
EC stem cells (Figure 2.11, C) and Ki67 positive proliferating cells (Figure 2.11, 
D) were all present, hi addition, in one of the two teratomas produced, several 
nodules of cartilage were found, suggesting that mesodermal differentiation of 
TERA2.C1-SP12 cells is possible (Figure 2.11). 
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Figure 2.11 Histological examination of teratomas produced by EC cells co-transplanted with 
laminin. Teratomas were solid in composition with numerous cell types. A) Glandular structures 
(g). B) Neural tissue. C) Embryonal carcinoma cells. D) Proliferative Ki67 positive cells (dark 
red). E) Cartilage nodule (c). Histological staining: A-C Haematoxylin and Eosin, E Weigert's 
Haematoxylin. Immuno-staining: D Ki67. Scale Bars: A 200|im, B-E 50nm. 
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2.3. J 3 Co-transplantation with Matrigel™ had no apparent effect on the 
differentiation potential of embryonal carcinoma stem cells 
Co-transplantation o f EC cells with Matrigel™ produced teratomas similar in cell 
composition to control teratomas. Differentiated elements of glandular structures 
(Figure 2.12, A ) and neural rosettes (Figure 2.12, B) were present. Also 
undifferentiated cell types with morphology similar to pluripotent EC stem cells 
were present (Figure 2.12, C). Immunohistochemical analysis further confirmed 
that teratomas produced with the co-transplantation of hEC stem cells and 
Matrige^'^ were similar to control teratomas by demonstrating that populations of 
proliferative cells existed (Figure 2.12, D). 
Figure 2.12 Histological examination of teratomas produced by EC cells co-transplanted with 
Matrigel™. Teratomas were solid in composition with cell types similar to control teratomas. A) 
Glandular structures (g). B) Neural rosette (n). C) Embryonal carcinoma cells. D) Proliferative 
Ki67 positive cells (dark red). Histological staining: A-C Haematoxylin and Eosin. Immimo-
staining: D Ki67. Scale bars; A 200nm, B-D 50nm. 
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2.3.14 Immunohistochemical analysis of teratomas produced by co-
transplantation of EC stem cells and extracellular matrix proteins 
To gain a specific identification of the teratoma constituents, 
immunohistochemical analysis was performed. An antibody to pan keratin that 
recognises a broad range of human keratins demonstrated that keratinised 
epithelial is present in all teratomas. The class V I intermediate filament antibody 
nestin that recognises neural stem/progenitor cells demonstrated that neural 
progenitor cells were present in all teratomas. The neurofilament antibody NF200 
was detected in both control teratomas and those produced from co-injection with 
Matrigel™, however, no expression was observed in teratomas produced from the 
co-transplantation of EC stem cells with collagen I or laminin. The 
undifferentiated EC stem cell marker TRA-1-60 was present in all teratomas; 
however, the levels of expression were highest in control and Matrigel™ teratomas 
(Figure 2.13). 
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Control (PBS) Collagen Laminin Matrigel 
Figure 2.13 Immunohistochemical analysis of teratomas produced by co-transplantation with 
ECM components. Teratomas were assessed for their reactivity to antibodies for differentiated 
elements (keratin and NF200), neural progenitor cells (nestin) and undifferentiated EC stem cells 
(TRA-1-60). All images as shown at the same magnification, scale = lOOfim. 
2.3.15 Co-transplantation of embryonal carcinoma cells with different 
extracellular matrix components affects the success rate of teratoma formation 
Subcutaneous transplantation of EC stem cells with the following solutions was 
carried out: PuraMatrix™, Extracel™, Matrigel™, Cultrex BME and Cultrex 
BME RGF. The success rate of teratoma formation was different depending upon 
the component used. No teratoma formation was observed when cells were 
transplanted with either PuraMatrix™ or Extracel™. Teratoma formation was 
observed when cells were transplanted with Matrigel™, Cultrex BME and Cultrex 
BME RGF (Table 2.2). 
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E C M component Success rate 
Extracel'^ 0% (0/3) 
PuraMatrix"^ 0% (0/3) 
Matrigel 100% (3/3) 
Cultrex BME 100% (3/3) 
Cultrex BME RGF 100% (3/3) 
Table 2.2 The success rate of teratoma formation for various ECM components. Numbers in 
brackets show the number of successful teratomas and the total number of animals in which 
transplantations were carried out. 
2.3.16 Co-transplantation of embryonal carcinoma cells with different 
extracellular matrix components affects the growth rate of teratomas 
Teratoma progression was followed by weekly measurements of the mean 
teratoma diameter. Cells transplanted with Matrigel^'^, Cultrex BME and Cultrex 
BME RGF all readily formed teratomas within three weeks post transplantation 
and their growth was rapid with the experiment being terminated eight weeks post 
transplantation. Growth rates were similar for Matrigel™, Cultrex BME and 
Cultrex BME RGF (Figure 2.14, A). Histological analysis demonstrates that cross 
sectional diameters of all teratomas produced were similar (Figure 2.14, B). 
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Figure 2.14 The growth of teratomas is not dependent upon growth factors. A) Graphical 
representation of teratoma growth rate. Points represent average values for 3 teratomas in each 
group. B) Low power images showing sections of teratomas at their widest cross sectional length. 
Note, all samples are shown at the same magnification. Scale = 1mm, histological staining, 
haematoxylin and eosin. 
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2.3.17 Teratomas produced by EC stem cells co-transplanted with extracellular 
matrix components are solid in composition 
It was demonstrated previously that teratomas can consist of both solid and cystic 
cavities filled with fluid (Sections 2.3.3 and 2.3.4). It has also been shown that EC 
stem cells co-transplanted subcutaneously with collagen I , laminin or Matrigel™ 
all resulted in teratomas, which were solid in composition (Sections 2.3.8 and 
2.3.9). Upon examination of serial cross sections throughout the teratomas formed 
by co-transplantation with Cultrex BME and Cultrex BME RGF, no cystic areas 
were observed and all tumours appeared as a solid mass throughout (Figure 2.15, 
shows a teratoma formed by co-transplantation of EC stem cells with Cultrex BME 
RGF and is representative of all teratomas formed). 
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Figure 2.15 Examination of sections throughout a teratoma formed by co-transplantation of EC 
cells with Cultrex BME RGF. Serial sections demonstrate that the teratoma is solid throughout the 
whole of the material. Histological staining; Haematoxylin and Eosin. Scale Bar: 1 mm. 
2.3.18 Co-transplantation of EC stem cells with Cultrex BME has no effect on the 
differentiation potential of embryonal carcinoma stem cells when compared to 
controls 
Co-transplantation of EC stem cells with Cultrex BME produced teratomas similar 
to control teratomas and those produced by the co-transplantation of Matrigel™ 
(Section 2.3.13). Differentiated cell types typical of teratomas produced by EC 
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stem cells were present. Both neural (Figure 2.16, A) and epithelial (Figure 2.16, 
B) differentiated cells were present, in addition, undifferentiated cell types were 
also present (Figure 2.16, C). 
Figure 2.16 Histological examination of teratomas produced by EC stem cells co-transplanted 
with Cultrex BME. Teratomas were solid in composition with cell types similar to control 
teratomas. A) Neural cells. B) Epithelial cells. C) Embryonal carcinoma cells. Histological 
staining: A-C Haematoxylin and Eosin. Scale bars; A-C lOO i^m 
2.3.19 Co-transplantation of EC stem cells with Cultrex BME RGF has no effect 
on the differentiation potential of embryonal carcinoma stem cells 
Co-transplantation of EC cells with Cultrex BME produced teratomas similar to 
control teratomas and those produced by the co-transplantation of Matriger'^ 
(Section 2.3.13). Differentiated cell types typical of teratomas produced by EC 
stem cells were present. Both neural cells (Figure 2.17, A) and epithelial cells with 
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mucus secreting goblet cells (Figure 2.17, B) were present, and, in addition, 
undifferentiated cell types were also present (Figure 2.17, C). 
Figure 2.17 Histological examination of teratomas produced by EC stem cells co-transplanted 
with Cultrex BME RGF. Teratomas were solid in composition with cell types similar to control 
teratomas. A) Neural cells. B) Epithelial cells with goblets cells (arrow). C) Embryonal carcinoma 
cells. Histological staining: A-C Haematoxylin and Eosin. Scale bars; A lOOum, B 50nm, C 
lOOtim. 
2.3.20 Immimohistochemical analysis of teratomas produced by co-
transplantation of EC stem cells with Ciiltrex BME or Cultrex BME RGF 
To gain specific identification of the cell types present within the teratomas, 
immunohistochemical analysis was performed. Similar to teratomas produced by 
the co-transplantation of EC stem cells with Matrigel™ (Section 2.3.13), teratomas 
produced with Cultrex BME and Cultrex BME RGF were reactive to pan keratin, 
nestin, NF200 and TRA-1-60 (Figure 2.18). 
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Figure 2.18 Immunohistochemical analysis of teratomas produced by co-transplantation with 
Cultrex BME and Cultrex BME RGF. Teratomas were assessed for their reactivity to antibodies 
for differentiated elements (keratin and NF200), neural progenitor cells (nestin) and 
undifferentiated cells (TRA-1-60). All images as shown at the same magnification, scale = lOOum. 
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2.3.21 Teratomas are composed of human cell types 
It is important to demonstrate that the structures observed originate from the 
transplanted cells, this can be achieved using an antibody to human nuclear antigen 
To demonstrate teratoma formation was due to the transplanted cells an 
antibody reactive to human cell types was employed. Staining revealed that all 
cell types within the graft were positive for human nuclear antigen thus 
demonstrating that the origin of the teratoma was from the human transplanted 
cells and not the host mouse cells. Furthermore staining with anti epithelial keratin 
(a cytoskeletal marker) demonstrates the specificity of the anti human nuclear 
antigen for the nucleus of cells. No significant levels of background staining were 
observed (Figure 2.19). To demonstrate antibody speficifity staining was 
conducted on a section where the edge of the teratoma was present. The edge of 
the teratoma is surrounded by host skin tissue, negative staining of this host skin 
demonstrated minimal cross reactivity with the host tissue. 
Nueleaf.Al^l^^ elial Keratin 
Edger' ' " ' ^ ^ ^ ^ ^ ^ V ' ' : Negative control 
Figure 2.19 Confirmation that teratoma origin is human. Staining for human nuclear antigen 
produced positive staining located at the nucleus of the cells. Images show antibody nuclear 
localisation of human nuclear antigen and cytoplasmic localisation of epithelial keratin. All images 
were taken at the same magnification. Positive areas of staining are shown in brown. Scale Bar: 
50nm. 
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Summary of results 
The effects of anatomical site on teratoma development 
Subcutaneous Liver 
Decreased size Increased size 
Increased differentiation Decreased differentiation 
The effects of ECM components on teratoma development 
E C M component Effect on proliferation Effect on differentiation 
Collagen I Decrease Decrease 
Collagen IV No teratoma formed 
Fibronectin No teratoma formed 
Laminin Decrease Increase 
Matrigel"" Increase No change 
Cultrex BME Increase No change 
Cultrex BME RGF Increase No change 
Table 2.3 Summary tables. Tables summarise the findings of this section. 
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2.4 Discussion 
In this study it is demonstrated that the environment into which human pluripotent 
stem cells are grafted radically affects their ability to proliferate and differentiate. 
When transplanted intrahepatically cells proliferate rapidly and result in immature 
teratomas. When transplanted subcutaneously cells grow slower and result in 
more differentiated teratomas. The observed result that stem cells transplanted 
into the liver produce larger teratomas has since been recognised and validated by 
an independent group Transplantation of hES cells intrahepatically did not 
result in a teratoma but resulted in a large rapid growing tumour. In comparison, 
solid teratomas composed of all three germ layers were produced when cells were 
transplanted subcutaneously. Co-transplantation of hEC stem cells with 
Matrigel™, collagen I and laminin increased the success rate of teratoma 
formation. It was shown that the growth rate of teratomas can be modulated by the 
ECM component with which hEC stem cells are co-transplanted: Matrigel™ 
increased the growth rate whereas; collagen I and laminin decreased the growth 
rate. Using histological and immunohistological analysis, it was found that 
Matrigel^^ has no effect on the composition of the teratoma, whereas, it appeared 
that collagen I decreased the different cell types present and laminin increased the 
cell types present. To validate the hypothesis that the ECM is the key in 
controlling cell behaviour, an alternative version of Matrigel™ was used with 
reduced levels of growth factor. Teratomas produced with the reduced growth 
factor ECM extract behaved similarly to those produced with growth factors, 
demonstrating that the ECM is the main component controlling cell behaviour. 
The highly complex in vivo environment complicates the clarification of the 
precise factors eliciting the different teratoma production in the two transplantation 
sites, although some explanations for the observed differences can be proposed. 
The type of location differs between the two transplantation sites. The liver is a 
highly active metabolic organ with a large supply of blood, which may be more 
conducive for cell growth than the subcutaneous environment. The locations also 
differ in their potential for cell expansion, the liver is a large malleable organ 
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enclosed within the body providing room to allow transplanted cells to expand 
whereas, cells transplanted beneath the skin are restricted in the dermal layer 
where the connective tissues wi l l limit cell expansion. 
The mechanical differences between the liver and skin may account for the 
differences in differentiation and proliferation that were observed. Mechanical 
load upon the cells plays a role in controlling their differentiation. When a 10% 
cyclic strain is applied to human ES cells grown on a deformable elastic substrate 
an increase in the undifferentiated stem cell marker SSEA-4 and the pluripotency 
marker Oct4 is observed It is possible that when transplanted into alternative 
locations the cells are subject to variations in the mechanical environment. One of 
the potential mechanisms for the transduction of mechanical signals in EC cells is 
the process whereby cell adhesion increases protein kinase C (PKC) and mediates 
tyrosine phosphorylation of pp'"'''^'^ a cytoplasmic tyrosine kinase. Studies 
have localised this at the sites of focal adhesions. When cells are treated with a 
tyrosine kinase inhibitor there is a decrease in cell adhesion with a corresponding 
decrease in the formation of stress fibers suggesting that pp'^^'''^'^ control cell 
attachment through involvement in the formation of stress fibers 269 
It is difficult to conclusively determine whether the mechanical load experienced 
between these two alternative anatomical locations accounts for the differences 
seen as no study has investigated the mechanical properties of murine skin and 
liver in situ. One study where these two were measured under the same conditions 
was conducted on porcine skin and liver. Although the liver would appear to be 
more malleable than skin under the conditions investigated by Constantinides et al 
the opposite was observed and the skin demonstrated a Youngs modulas of 222kPa 
whereas liver demonstrated a Young's modulas of 760kPa The stiffness of the 
liver is known to change in response to health '^^ likewise the elastic recoil of skin 
is known to decrease following dehydration and hence the amount of hydration 
can affect the stiffness of the skin. Hence the health of the animals used in 
investigations herein could greatly vary from those used by other investigators. 
The lack of information of the youngs modulas of murine skin and liver makes it 
hard to conclusively determine whether the mechanical differences between these 
two locations can account for the differences observed. 
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The experiments were conducted using immunocompromised animals. It is 
possible that a low level of immunity still remained within the animals which 
could result in the recognition and destruction of the foreign injected cells. The 
liver is a known immune privileged site and is unlikely to have any level of 
immunity, therefore, cells transplanted intrahepatically are not likely to be 
destroyed by the immune system. The skin is not an immune privileged site and 
cells transplanted subcutaneously could be recognised and destroyed by any 
residual immunity. Therefore, it may be that fewer cells are successfully 
transplanted subcutaneously compared to intrahepatically, which would result the 
formation of a smaller teratoma. 
The liver is an organ with substantial regenerative capacities and the capability to 
f i i l ly regenerate following the removal of up to 65-70% of the liver Upon 
injury of the liver several molecules are upregulated, including stem cell factor 
(SCF) SCF is located in the liver where it is bound to the membrane in its 
inactive form, upon liver damage it becomes cleaved by cell surface enzymes and 
released from the membrane upon which it becomes active. In the active form 
SCF acts as a mitogen to repair cellular damage and acts upon hepatocytes to 
increase their proliferation and repair the liver. SCF has been immobilised to 
surfaces to enhance proliferation Upon injection of stem cells intrahepatically 
this damage could cause SCF to become active and act upon the transplanted stem 
cells, this would account for the larger teratoma produced. When cells are 
transplanted subcutaneously there is no such increase in molecules that wi l l 
influence cell proliferation. I f the transplanted cells in the liver are being 
promoted to proliferate this would account for the higher level of immature cells 
when compared to those produced following subcutaneous transplantation. 
Following tumour metastasis different organs wi l l form tumours more readily than 
others, there are several factors which account for these differing tumour formation 
rates including: tumour cell adhesion to organ cells; survival; and proliferation 
279,280 poliowing the tail vein injection of the murine EC stem cell line F9 the 
majority of mmours are formed in the liver with relatively few in the lungs It 
has been proposed that the ECM of the liver provides favourable interactions with 
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the transplanted cells which promote tumour formation. Extraction of ECM from 
liver, lungs and kidney and subsequent adsorption onto culture surfaces provide a 
method for investigating how EC stem cells interact with the ECM from these 
organs. It was demonstrated that compared to ECM extracted from lung and 
kidneys the ECM from liver provides a more favourable surface for cell adhesion 
and increased proliferation of EC stem cells. Further investigations isolated the 
component that increased EC stem cell proliferation within the ECM These 
studies were conducted either in vitro or by injecting into the tail vein, which is 
dissimilar to the investigations conducted herein. However, they demonstrate the 
liver ECM has the potential to both increase cell attachment and stimulate 
proliferation. I f the liver is capable of increasing cell attachment, it follows that 
transplantation into the liver wi l l allow greater cell attachment of cells and also 
stimulate proliferation in comparison to transplantation into the skin. These 
observations are inline with those observed here and validate the observation made 
that the ECM is a key factor in teratoma formation. 
Consistent with previous studies, Matrigel™ increased the success rate of teratoma 
formation Collagen I also increased the rate of teratoma fonnation but to a 
lesser extent than the increase seen with Matrigel™ 203,258 success rate of 
tumour formation could be due to: increased cell survival prior to and during 
transplantation; increased stimulation of transplanted cells; or a combination of 
both. Cell survival could be increased by gel formation of the ECM component 
reducing shear forces experienced by the cells upon exit from the needle during 
injection. However, gel formation was not a common factor in teratoma fonuation 
as teratomas were also produced when injected with laminin, which does not form 
a gel, and teratomas were not produced when cells were co-transplanted with 
collagen IV, which forms a gel readily. Matrigel™ is a mixture of ECM proteins 
and growth factors, when the growth factors are removed Matrigel™ continues to 
be effective No group has conclusively demonstrated the method by which 
Matrigel™ increases the rate of tumour formation and comparison of Matrigel™ 
to synthetic 3D gels could provide some way of solving the complex mechanisms 
of this system. 
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In order for cells to function correctly they must attach and interact with 
surrounding cells. One method by which cells interact with surrounding cells is 
the formation of focal contacts. One of the first observations that showed the 
existence of focal contacts was by Ambrose in 1961 Surface contact 
microscopy can be used to visualise parts of cells that are attached to surfaces. 
Using this technique, it was apparent that cells do not attach to a surface using the 
whole of their surface and discrete focal contacts are made. Interference reflection 
microscopy is similar to surface contact microscopy in that it shows the areas 
closer to the surface. Interference reflection microscopy was used to confirm these 
results and similar to the observations of Ambrose, cells were found to adhere to 
surfaces at discrete focal contacts Integrins binding is one mechanism of cell-
cell interactions. Integrins mediate their effects via a whole host of adaptor 
proteins. The first protein to bind is tensin, tyrosine kinase FAK also binds early 
following integrin clustering. Ligand binding to the clustered integrins results in 
the recruitment of cytoskeletal components such as vinculin, talkin and a-actinin. 
Ligand binding and tension induce phosphorylation mediated by members of the 
Src protein kinase family (c-Src, Csk and Fyn) leading to activation of multiple 
molecules including: Rho-like GTPase; phospholipase-Cy (PLCy); and the ERK 
and JNK signaling cascades. The ability of cells to survive and proliferate in the 
absence of anchorage has strong correlations with tumourgenicity. Anchorage 
independence growth is a key step in becoming tumourgenic . When cells that 
normally grow under adhesive conditions lose their contacts they can undergo 
anoikis. As shown herein, removal of EC stem cells from their culture surface can 
induce cell death, EC stem cells removed from their culture surface and suspended 
in a gel provides necessary contacts to promote cell survival. Therefore 
suspension of EC stem cells in a gel such as Matrigel™ could promote cell 
survival and therefore increase the number of viable cells being delivered to the 
transplantation site, thus accounting for the increase in teratoma size. 
This data suggests that Matrigel™ increases hEC stem cell proliferation whereas 
collagen I and laminin decrease hEC stem cell proliferation. Matrigel™ is known 
to contain a large array of growth factors, including: bFGF; EGF; IGF-1; PDGF; 
NGF; and TGF-beta ' ^ l It has been demonstrated that bFGF and EGF 
increase proliferation of EC cells whereas, IGF-1 has no effect on EC proliferation 
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However, co-transplantation of hEC stem cells with a Matrigel™ equivalent 
Cultrex BME and Cultrex BME RGF shows that growth factors are not essential in 
increasing the success rate of teratoma formation and also does not affect the 
composition of the teratomas produced. 
Differentiation was also affected: laminin increased the developmental potential; 
and collagen I decreased the developmental potential. It has been demonstrated 
that the secretion of collagen IV, laminin and fibronectin change as EC cells 
differentiate Embryonal carcinoma cells lines are not alike but vary in their 
capacity for differentiation and growth •'^ Cartilage formation in vivo has been 
observed from the EC cells GCT27X-I and NSR CI 35 prior to this study 
TERA2.cl.SPI2 cells have not been demonstrated to form cartilage in vivo. This 
study presents the first evidence that TERA2.cl.SP12 can differentiate into 
cartilage. However, only one experiment has been conducted to investigate the 
effects of ECM components when co-transplanted with stem cells, Matrigel™ was 
found to increase the success rate of teratoma formation, no effects on 
differentiation were noted 
The observation of the formation of collagen nodules from EC cells co-
transplanted with laminin is of particular interest. The formation of collagen 
nodules from NTERA2 (the parent line of Tera2.cl-SP12 cells) in vivo has not 
been reported. There has been one reported example of collagen nodule formation 
in vivo from a sub-line of NTERA2 ^^ '^ . It has been reported that the local 
environment can influence collagen fomiation by ES cells. Transplantation of ES 
cells into the knee increases the relative percentage of collagen formed by the cells 
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Teratoma formation can be used to classify the potency of stem cells however, this 
approach is limited. Care should be taken when interpreting cell potency using the 
teratoma model as the factors required to guide development of a cell may not be 
present in a certain location. Transplantation into an alternative site could provide 
the necessary factors and show a more complex differentiation capacity. Detailed 
examination of stem cell behaviour in response to these ECM components is 
required to ftilly understand the observations made in vivo. 
109 
COMPARISON OF RESULTS GAINED TO HYPOTHESIS UNDER 
INVESTIGATION 
It was hypothesised that the anatomical site into which stem cells are transplanted 
would influence teratoma behaviour and that due to the known regenerative 
capacity of the liver, it was predicted that transplantation of EC stem cells and ES 
cells intrahepatically wi l l produce large teratomas. Large teratomas were indeed 
produced; however, there was no identifiable teratoma material when hES cells 
were transplanted. 
Matrigel™ has been shown to increase the success rate of tumour formation, a 
similar trend was observed for hEC stem cells. It was hypothesised that individual 
components, from this cocktail of ECM components, when co-transplanted with 
hEC stem cells, would influence teratoma success rate and behaviour similar to 
Matrigel™. Collagen IV and laminin are components of Matrigel™, however, 
only laminin was found to increase the success rate of teratoma formation. It was 
hypothesised that with the removal of growth factors from Matrigel™ would affect 
the behaviour of transplanted cells; however no difference was observed, 
demonstrating that the ECM is a major factor controlling the cells. Neither of the 
two ECM mimics used: Extracel-X™ and PuraMatrix™ had an effect on teratoma 
success rate and teratoma formation was not observed. Previously, using 
condrocytes, when PuraMatrix™ is compared to two natural scaffolds, a 
telopeptide collagen I and alginate (from seaweed), it does not increase 
proliferation as well as the natural scaffold, furthermore, histological analysis 
showed that the gels formed by PuraMatrix™ were more sparsely laden with cells. 
The Young's modulus of the PuraMatrix^"*^ gel was lower than those formed by the 
natural molecules demonstrating that the gel is weaker A weak gel formed and 
no increase in the rate of proliferation could explain why there is no effect on 
teratoma formation. 
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C H A P T E R 3 - E V A L U A T I N G B I O M I M E T I C S U R F A C E S F O R 
C E L L C U L T U R E AND T H E C O N T R O L O F C E L L U L A R 
B E H A V I O U R 
3.1 Introduction 
Laboratory cultured cells are widely used in the field of biomedical science and 
provide scientists with model systems to investigate cell activity. The process of 
cell culture involves the removal of cells from their natural {in vivo) location and 
their subsequent growth in an artificial (in vitro) environment. Optimisation of the 
culture environment is critical to enable cells to grow, fijnction and survive in a 
realistic and representative manner. There are many parameters that must be 
considered in this process including the constituents of the media, growth 
supplements, and the surface upon which cells grow. Often, it is necessary to 
tailor the culture environment for optimal growth survival and differentiation of a 
particular cell type. Some cell types do not attach to standard tissue culture plastic 
or glass unless it is coated with an appropriate growth promoting molecule that 
more accurately represents the environment their native counterparts' experience. 
Within tissues, cells are in contact with other cells and the ECM, both of which 
play an important role in controlling cell behaviour. Interactions between cells and 
ECM components are important in many biological processes such as cell growth 
and development ^''"-^^ These interactions can be recreated in vitro by coating 
surfaces with ECM molecules In general, cells utilise integrins, a family of 
transmembrane glycoproteins, to attach to specific cell binding sites that are 
displayed by ECM proteins such as collagen, fibronectin and laminin. The 
integrins are able to link the cell cytoskeleton to a material surface via these 
proteins which are present on the surface. The adsorption or immobilisation of 
specific ECM proteins can therefore be used to enhance cell attachment. In order 
to mimic the in vivo environment, purified components of the ECM are frequently 
used in the laboratory to coat cell culture plastic or glass to enhance cell adhesion 
17 
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Previous work has demonstrated that immobilisation of whole ECM proteins, such 
as fibronectin, results in conformational changes in the molecule Alteration 
of the molecular conformation can result in decreased ECM activity by reducing 
the availability o f functional domains to the cell In some instances of coating 
surfaces with whole ECM proteins, multiple layers of molecules are produced 
instead of a single monolayer This can result in some molecules being hidden 
by those above and it can become difficult to determine the actual amount of ECM 
protein available to interact with the cultured cells. The biological effects elicited 
by key components of the ECM can be attributed to certain short peptide motifs 
within the whole molecule 2'"^"^^^. it is possible to present these motifs to imitate 
the behaviour elicited by the whole molecule. Peptides can be immobilised to 
surfaces in a controllable manner with a defined conformation and hence it is 
sometimes advantageous to present the functional peptide motif(s) as opposed to 
the whole ECM molecule. Many factors contribute to the effective presentation of 
peptide motifs within biomimetic surfaces: including density of the molecules 
the nature of the substrate supporting the biomimetic surface the distance 
presented motifs are from the surface 'o^- '^"'^ ''^ . conformation of the 
presented molecules on the surface Accordingly, the method by which 
ECM peptide motifs are presented by the biomimetic surface is extremely 
important. 
There are numerous methods by which such peptide motifs can be immobilised 
onto a surface "^'^  including, direct adsorption of protein from solution or by 
modifying the molecular characteristics of the surface using complex chemistry 
However, these approaches have their limitations: the surface coating process is 
difficult to control; adsorption may lead to denaturation of the protein resulting in 
reduced fiinctionality; the orientation and density of the protein are difficult to 
control leading to batch inconsistency; and reduced reproducibility. Covalent 
attachment of protein by chemical coupling also results in substantial loss of 
protein activity owing to chemical modification of critical residues; denaturation, 
random orientation and inaccessibility These limitations are problematic in 
cell culture and consequently, there is demand for improved surfaces for in vitro 
cell growth that possess known composition and more accurately represent a 
biologically relevant environment. Such surfaces must be manufactured in a 
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controlled fashion to reduce batch variability and increase the consistency and 
robustness of the cells cultured on such surfaces. 
A proposed improvement upon current technologies for presenting peptides to 
cells is that developed by Orla Protein Technologies The technology employs 
engineered variants of the N-terminal transmembrane (TM) domain from the 
Escherichia coli outer membrane protein, OmpA motifs from ECM proteins 
are engineered into the flexible outer loops OmpA and the protein is attached to 
the surface via a single cysteine residue thereby forming an oriented monolayer. 
Gaps between protein molecules are filled in using thiolipids or thioalkanes so that 
only the surface loops and the motifs of interest are exposed (figure 1.10). This 
method of protein immobilisation results in stable and oriented monolayers that 
display only the motifs of interest in a functional conformation which alleviates 
many of the problems associated with adsorption and chemical methods 
To evaluate the effectiveness of this technology the adherence of the neuron-like 
rat pheocytochroma cell line, PC 12, on OmpA surfaces presenting peptide motifs 
from ECM proteins is investigated. PC 12 cells are known to attach poorly to 
uncoated glass and in order for the cells to attach and grow as an adherent 
monolayer the culture surface must be coated with ECM proteins To 
demonstrate that motifs are presented in a functional manner, the ability of ECM 
protein motifs derived from, collagen, fibronectin and laminin are presented by 
OmpA molecules and the rescue of PC 12 cell attachment is determined. 
Comparisons to control surfaces presenting no motifs are made and surfaces which 
increase cell attachment demonstrate that the motifs are presented in a manner 
which cells can recognise. 
In addition to cell attachment, PC 12 cells are a widely used model system to study 
neurite behaviour as they are known to produce neurites in response to NGF 
PC 12 cells have been used to investigate effects on: neurite length; neurites per 
cell; and branches per neurite It is known that the culture of PC 12 cells on 
surfaces coated with different ECM proteins affect their neurite behaviour. 
Preparations of collagen I gels can be made for the culture of PC 12 cells. These 
gels can be modified with the addition of other proteins, such as laminin or 
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fibronectin. In comparison to the unmodified collagen I gel, there is little effect on 
PC 12 neurite length when laminin is added, however upon the addition of 
fibronectin a reduction occurs thus demonstrating that ECM proteins can 
influence PC 12 neurite behaviour. PC 12 neurite outgrowth is investigated in 
response to biomimetic surfaces presenting motifs from collagen I , collagen IV, 
laminin and fibronectin. This allows investigation of how these motifs affects 
neurite behaviour and also provides further validation that the motifs investigated 
are presented in a fiinctional manner which cells can recognise. 
The differentiation of cells in tissues is affected by a complex combination of 
different factors within their local environment including: soluble molecules; local 
geometry; and interactions with the ECM. In combination these factors form a 
niche that allows correct cellular development and tissue function^*'^. Direct 
evidence that local micro-environments determine the development of certain cell 
types has been demonstrated when neural progenitor cells transplanted into the 
subventricular zone, rostral migratory stream, hippocampus or striatum undergo 
neurogenesis in a similar fashion to endogenous cells for example, cells in the 
subventricular zone of the brain grow in contact with ECM proteins, collagen I and 
laminin Combined with the correct culture media, immobilisation of the ECM 
proteins, entactin, collagen, and laminin, onto the culture surface partially recreates 
in vivo growth conditions and allows the differentiation of murine embryonic stem 
cells into cells characteristic of the subventricular zone '. 
NSPCs are of great interest as they are considered a potential source of cells for 
clinical applications, notwithstanding, little work has been conducted to investigate 
these cells fully. Several smdies have investigated the effect of ECM components 
on neural cells However, fewer examples have been demonstrated of how 
peptides can be used to control these cells. Multiple motifs from laminin (RGD, 
YIGSR) and bone marrow homing proteins have been used to control neuronal 
cells Using rat neural stem cells it has been demonstrated that the peptide 
RGD produces similar levels of neuronal and glial differentiation to PLO/laminin, 
conversely the laminin peptide I K V A V was found to have no effect. Upon mixing 
the active RGD and the inactive I K V A V motif the greater the proportion of 
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inactive I K V A V the lesser the effect the surfaces have on glial and neuronal 
differentiation 
Although the presentation of individual motifs provides a simplified system for the 
study of cell behaviour, this could be considered far too simplified and the 
presentation of multiple motifs on a single surface more faithfully represents the in 
vivo environment. Several groups have studied the effects of presenting multiple 
motifs on a single surface and both intuitive and counterintuitive effects have been 
noted ^'^'^'^ 
Through presenting specific ECM peptides either individually or in combination, 
we can identify those domains that play an important role in the differentiation of 
cultured neural tissues. This approach can be used to assist in the development of 
defined culture conditions for the generation o f specific cell types for use in 
research and tissue engineering. 
HYPOTHESIS UNDER INVESTIGATION 
The main hypothesis that is under investigation is that the presentation of motifs 
from ECM proteins via biomimetic surfaces wi l l influence cell behaviour. It is 
hypothesised that not all motifs wi l l be effective in influencing all cell types and 
some motifs may not be presented in an orientafion to which cells can recognise 
and bind. As it is known that surfaces coated with the ECM proteins collagen I , 
collagen IV, fibronectin and laminin all increase cell attachment of PC 12 cells it is 
hypothesised that the presentation of these motifs wi l l increase cell attachment. 
Furthermore, as the ECM protein collagen I is more effective than the ECM 
protein fibronectin, it is expected that attachment to the corresponding peptide 
motifs wi l l have a similar effect. It is hypothesised that presentation of motifs via 
biomimetic surfaces wi l l also influence neurite outgrowth, however it is predicted 
that the most effective motifs wi l l be those that wi l l be able to influence PC 12 cell 
attachment. The most effective motifs wi l l then be assayed for their potential to 
control neural stem/progenitor cells and surfaces composed of mixed motifs wi l l 
be used to increase their effect. It is hypothesised that presentation of multiple 
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motifs from different ECM proteins wi l l have an increased effect when compared 
to individual motifs. 
A I M 
To evaluate the presentation of motifs by OmpA biomimetic surfaces to identify 
motifs that are presented in a functional manner to cells and demonstrate that these 
surfaces can be used to control neuronal attachment and differentiation. 
OBJECTIVES 
1. Evaluate whether biomimetic surfaces can control the attachment of 
cultured cells 
2. Evaluate whether this technology can control differentiation of neuronal 
cells 
3.2 Materials and methods 
Cell culture 
PC 12 cells 
Cultures of PC 12 cells were purchased from American Type Culture Collection 
(ATCC; http://www.lgcpromochem-atcc.com) and were maintained according to a 
previously described method Cell stocks were grown on cell culture 
plasticware (VWR; http://uk.vwr.com) pre-coated for 24 hours at 37°C with a 
0.1% solution of collagen IV from human placenta (Sigma-Aldrich; 
http://www.sigmaaldrich.com) in 0.1 M glacial acetic acid (Sigma-Aldrich). PC 12 
cells were grown in RPMl 1640 media (Cambrex; http://www.cambrex.com) 
supplemented with: 10% heat-inactivated foetal bovine serum (Invitrogen; 
http://www.invitrogen.com); 2mM L-glutamine (Cambrex); 20 units/mL of 
penicillin and 20 [ig/mL streptomycin (Cambrex). Cultures were maintained at 
37°C in a humidified 5% COj incubator, the medium was changed three times a 
week. The cells were passaged as required using trypsin-EDTA solution as 
standard (Cambrex). 
Neuroblastic cells 
SH-SY5Y cells (ATCC) were maintained using RPMl 1640 (Cambrex) 
supplemented with: 15% heat-inactivated foetal bovine serum (Invitrogen); 2mM 
L-glutamine (Cambrex); 20 units/mL of penicillin and 20 [ig/mL streptomycin 
(Cambrex). Cultures were maintained at 37°C in a humidified 5% CO2 incubator, 
the medium was changed three times a week. The cells were passaged as required 
using trypsin-EDTA solution as standard (Cambrex). 
Murine fibroblast cells 
Murine fibroblast cells (ATCC) were maintained using DMEM (Sigma) 
supplemented with: 10% heat-inactivated foetal bovine serum (Invitrogen); 2mM 
L-glutamine (Cambrex); 20 units/mL of penicillin and 20 |Lig/mL streptomycin 
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(Cambrex). Cultures were maintained at 37°C in a humidified 5% CO2 incubator, 
the medium was changed three times a week. The cells were passaged as required 
using trypsin-EDTA solution as standard (Cambrex). 
Osteoblast-like cells 
Cultures o f MG63 (ATCC) were maintained using D M E M (Sigma) supplemented 
with: 10% heat-inactivated foetal bovine serum (Invitrogen); 2mM L-glutamine 
(Cambrex); 20 units/mL of penicillin and 20 |ig/mL streptomycin (Cambrex). 
Cultures were maintained at 37°C in a humidified 5% CO2 incubator, the medium 
was changed three times a week. The cells were passaged as required using 
trypsin-EDTA solution as standard (Cambrex). 
Coating glass coverslips with purified ECMproteins 
Borosilicate glass coverslips (VWR) were first sterilised by immersion in 70% 
ethanol for 15 minutes and then washed twice with sterile PBS (Cambrex). 
Coverslips were coated with solutions of the following at concentrations ranging 
from Ing/ml to Img/ml: collagen I (Sigma-Aldrich) diluted in 0.1 M glacial acetic 
acid; collagen IV (as previously described above); f i 
bronectin (Sigma-Aldrich) diluted in sterile ddH20; or laminin (Sigma-Aldrich) 
diluted in sterile PBS (Cambrex). Coverslips were immersed in the coating 
solution for 24 hours, collagen and laminin coatings at 37°C and fibronectin 
coating at room temperature. Coverslips were immersed in the coating solution for 
24 hours. Surfaces were then washed twice with PBS to remove any traces of un-
adsorbed molecules and placed in fresh multi-well culture plates. 
Protein engineering 
The peptide motifs in ECM components most likely to enhance cell attachment 
were identified from literature (see Table 1). Oligonucleotides designed to encode 
the relevant motifs were synthesised (Sigma Genosys; 
http://www.sigmaaldrich.com/Brands/Sigma_Genosys.html). Annealed 
oligonucleotides were ligated into the gene encoding the modified OmpA T M 
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domain scaffold such that the motif was within an outer loop of OmpA. Four 
different plasmids were constructed with motifs as shown in Table 1. The parental 
modified OmpA was used as a negative control. The DNA sequence of each 
construct was verified before use. A l l constructs thus possess a 6xHis tag and a 
cysteine residue at the N-temiinus. 
Expression, purification and refolding 
Exponential phase cultures of E. coli BL21 (Novagen; 
http://www.merckbiosciences.co.uk;) containing expression plasmid were induced 
with isopropyl-p-D-thiogalactopjTanoside and shaken for six hours at 37°C. After 
harvest and lysis, the insoluble fraction was enriched and solubilised in the binding 
buffer (8M Urea, 20 mM imidazole, 0.5 M NaCI, 20 m M sodium phosphate 
pH7.4). The OmpA based proteins were purified by Ni-affmity using an A K T A 
Prime system (GE Healthcare; http://www.gehealthcare.com/worldwide.html) with 
a step elution at 250 m M imidazole. The fractions containing the desired proteins 
were further purified on a QFF anion exchange column (GE Healthcare) in 30 m M 
ethanolamine buffer at pH9.5 with elution in the same buffer plus 80mM NaCl. 
The proteins were shown to be >98% homogenous as judged by gel 
electrophoresis (data not shown). The proteins were refolded by a very slow 
dilution (1/40) into the refold buffer (50 mM Tris HCl, 0.1 mM EDTA, 1% n-octyl 
glucopyranoside, 1 m M dithiothreitol pH8.0). Correct refolding was indicated by 
band shift on SDS polyacrylamide gel electrophoresis and correct formation of 
the P-barrel structure confirmed by circular dichroism spectroscopy (data not 
shown). 
Preparation of culture surfaces 
The protein-thioalkane monolayer was manufactured essentially as described 
Figure 1. Borosilicate glass coverslips (VWR) were cleaned, sputter coated with a 
lOnm layer of titanium followed by a 25nm layer of gold and cleaned in 1% 
Hellmanex® (Hellma; http://www.hellma.co.uk). The surfaces were passivated by 
incubation with 1% (v/v in ddHiO) 2-mercaptoethanol (Fisher; 
http://www.fisher.co.uk) and washed with ddH20. OmpA proteins were diluted to 
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2 \ig mL"' in refold buffer. Hexadecanethiol (HDT, Sigma) was diluted to 0.15 mg 
mL"' in ethanol. Protein was applied to the surface in three 1 hour incubations 
with 1% SDS and ddH20 washes between each protein application. After the last 
protein application the gaps between the immobilised protein molecules were in-
filled by overnight incubation with HDT solution followed by washes with ethanol 
followed by 1% SDS (Sigma) and finally ddHjO. The coverslips with fully 
assembled surfaces were dried under nitrogen gas and stored at 4°C with desiccant 
until required. Control surfaces with only HDT or untreated gold were also 
prepared and stored. Prior to use, the coverslips were sterilised by immersion in 
3ml 70% ethanol for 15 minutes followed by two washes with 5ml sterile 
phosphate buffered saline (PBS, Cambrex). 
Cell attachment assay 
PC 12 cells growing on cell culture plastic were removed by trypsination to 
produce a single cell suspension and the number of cells was determined using a 
haemocytometer. Cells were subsequently seeded at a density of 300,000 cells/well 
in a 6-weIl culture plate (VWR) containing alternative growth surfaces. Cells were 
maintained at 37°C in a humidified, 5% CO2 incubator for 24 hours. Cultures were 
washed once with 2ml PBS and fixed using 4% paraformaldehyde (Sigma-
Aldrich) in PBS for 30 minutes, washed twice with PBS and mounted using 4',6-
diamidino-2-phenylindole (DAPI, Invitrogen) in Vectashield® (Vector 
Laboratories; http://www.vectorlabs.com). Cells were visualised using a Nikon 
Diaphoto 300 fluorescence microscope and digital images recorded using a Nikon 
Digital Camera DXM1200. Nine random fields of view were sampled using the 
lOx objective lens for each surface tested. Experiments were repeated in triplicate. 
PCI 2 cell differentiation 
In preparation for differentiation, a single cell suspension of PCI2 cells was 
achieved by trypsinisation followed by two media washes to remove any trypsin 
and the number o f cells determined using a haemocytometer. Cells were seeded at 
a density of 300,000 cells/well in a 6-well culture plate (VWR) containing 
alternative growth surfaces. Cells were maintained at 37°C in a humidified, 5% 
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C02 incubator for 24 hours. The medium was replaced with 50ng/ml nerve growth 
factor (NGF, Sigma-Aldrich) containing media and the cells were differentiated for 
ten days with medium changes every three days. Immunocytochemical analysis 
was carried out as detailed below. Experiments were repeated at least three times. 
Images were captured of 20 randomly selected single differentiated PC 12 cells per 
condition. Cells were examined and the number of neurites per cell body; the 
length of the longest neurite; and the number of neurite branches were determined 
and recorded. Neurite branching data was normalised to neurite length to take into 
account that longer neurites are more likely to have an increased number of 
branches 
Culture and differentiation of neural stem/precursor cells 
NSPCs were isolated from the subventricular zone of the lateral ventricles of adult 
eGFP transgenic male Wistar rat forebrains, as described previously 
Subependymal tissue was harvested from 8-12 week old rats and subjected to 
papain dissociation (Papain Dissociation System; Worthington Biochemical 
Corporation, Lakewood, NJ, USA; http://www.worthington-biochem.com). The 
resultant cell suspension was centrifuged and the pelleted cells were subjected to a 
discontinuous density gradient to remove cell debris. Dissociated cells were re-
suspended in complete medium (CM) containing Neurobasal™ media 
(Invitrogen); B27 neural supplement (Invitrogen); 2 m M L-glutamine (Sigma-
Aldrich); 100 )ag/ml penicillin-streptomycin (PenStrep; Sigma-Aldrich); 20 ng/ml 
epidermal growth factor (recombinant human EOF; Gibco-Invitrogen); 20 ng/ml 
basic fibroblast growth factor (recombinant human bFGF; Invitrogen); and 2 ng/ml 
heparin (Sigma-Aldrich) and incubated at 37°C in a humidified incubator with 5% 
CO2. GFP-positive neurospheres appeared in 2-3 weeks, after which cells were 
passaged every week. 
Neurospheres were mechanically dissociated to produce a single cell suspension 
and the number o f cells was determined using a haemocytometer. Cells were 
subsequently seeded at a density of 400,000 cells/well in a 6-well culture plate 
containing alternative growth surfaces. Cells were maintained at 37°C in a 
humidified 5% CO2 incubator for 24 hours in CM. The medium was replaced with 
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differentiation medium containing: Neurobasal™ media; B27 neural supplement; 2 
mM L-glutamine; 100 |j.g/ml penicillin-streptomycin; and \ % foetal bovine serum 
(FBS, Invitrogen); cells were differentiated for 4 days. Immunocytochemical 
analyses were carried out (see below), cells were visualised using a fluorescence 
microscope and digital images recorded. A l l experiments were repeated in 
triplicate. Images were captured of nine random fields of view per condition. 
Neuronal differentiation was assessed by the number of p i l l positive cells 
observed per field of view. 
Statistical analysis 
The distribution of data was tested using the Kolmogorov-Smirfnov test. For data 
that were not nomially distributed, subsequent post-hoc analysis was carried out as 
described by Zar Data that was normally distributed was analysed using 
ANOVA. p<0.05 (*), p<0.0] (**) and p<0.001 (***) were used to indicate levels 
of statistical significance. 
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3.3 Results 
Controlling attachment using biomimetic surfaces 
3.3.1 Attachment ofmidtiple cell types on infill biomimetic surfaces 
Different cell types require different culture conditions therefore it is important to 
use numerous cell types to gain a correct understanding of how these biomimetic 
surfaces control cell behaviour. Biomimetic surfaces are composed of two aspects 
that can control cell attachment: peptide motifs and inf i l l molecules. To gain a 
greater understanding of cell responses to these biomimetic surfaces, cell 
behaviour of different cell lines was evaluated on biomimetic surfaces presenting 
infi l l molecules without any peptide motifs present. Surfaces were prepared 
presenting the following molecules: mercaptoundecanoic acid (MUDA) which is 
hydrophilic (due to the terminal carboxylic acid group); hexadecane thiol (HDT) 
which is hydrophobic (due to the terminal methyl group); and a thiolipid (DPPE) 
which is a lipid membrane mimic. In all tested cell types, surfaces presenting 
HDT were found to inhibit cell attachment when compared to gold coated surfaces. 
In some cell types M U D A was found to increase cell attachment when compared 
to uncoated surfaces however, in two cases the level of cell attachment to MUDA 
presenting surfaces was equal to or lower than the attachment to uncoated surfaces. 
In three of the four cell types examined DPPE was found to have an intermediate 
effect on cell attachment resulting in a level between the negative effect produced 
by HDT and the positive effect produced by M U D A (Figure 3.1). 
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Figure 3.1 Different cell types respond differently to similar surfaces. Attachment was compared 
following 24 hours culture o f various cell lines. The surfaces tested were: glass coverslips (glass); 
gold plated coverslips (gold); HDT inf i l l coverslips (HDT); DPPE inf i l l coverslips (DPPE); and 
M U D A inf i l l coverslips ( M U D A ) . For each o f three independent experiments, nine random fields 
of view were examined (a total o f 27 fields of view), bars represent mean values +SEM. A l l data 
was compared to gold *p<0.05. **p<0.01. ***p<0.001 
Following seven days cell culture, coverage appeared similar on M U D A , DPPE 
and uncoated surfaces for all cell types tested. Osteoblastic cells were shown to 
overcome the inhibitory effect of HDT and their attachment to these surfaces 
increased (Figure 3.2). Neuroblastic cells were partially able to attach to HDT 
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surfaces however PC 12 cells and murine fibroblast cells were not able to attach to 
HDT regions and only able to attach to uncoated regions (Figure 3.3). 
Glass Plastic 
DPPE 
Figure 3.2 Cell attachment, growth and proliferation of human osteoblasts following seven days 
culture. Phase images show representative fields of view o f human osteoblasts fol lowing seven 
days culture in proliferative medium. Scale bar 200nm. 
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MUDA 
Figure 3.3 Cell attachment, growth and proliferation of murine fibroblasts following seven days 
culture. Phase images show representative fields o f view o f murine fibroblasts following seven 
days culture in proliferative medium. HDT-edge shows attachment to uncoated regions (left) and 
little attachment to HDT coated regions (right). Scale bar 200)im. 
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3.3.2 Comparison of PC 12 cell attachment to biomimetic and control surfaces 
From previously published work PC 12 cells are documented as a model system for 
studying cell attachment The attachment of PC 12 cells to inf i l l surfaces was 
compared to a routine culture of adsorbed collagen IV. When comparing cell 
attachment to control levels it is clear that any differences which do arise are 
minimal (Figure 3.4). 
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Figure 3.4 Adsorption of collagen IV to glass surfaces greatly enhances cell attachment of PCI 2 
cells. After 24 hours cell attachment of PC 12 cells to the following surfaces was compared; glass, 
gold, HDT, DPPE, M U D A and adsorbed collagen IV. Nine fields o f view were examined. Data 
represents mean values +SEM of three independent experiments. A l l data was compared to 
glass*** p<0.001 
3.3.3 Alternative ECM protein surfaces for PCI 2 cell attachment 
Although PC 12 cells are routinely cultured on collagen IV coated surfaces, 
alternative ECM proteins such as collagen I , fibronectin and laminin can be 
adsorbed onto surfaces to support the attachment of PC 12 cells. However, the 
optimal concentration can only be determined by experimentation. Surfaces were 
prepared with differing protein concentrations; cell attachment was proportional to 
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rising concentrations of adsorbed ECM protein up to an optimal level after which 
no fiirther increase in cell attachment was observed. Effective concentrations for 
optimal cell attachment were determined for collagen I (250)ig/ml), collagen IV 
(8}ig/ml), fibronectin (50|ig/ml) and laminin (10|ig/ml). In all cases (except 
collagen I) once the optimal concentration for cell attachment was reached a slight 
decrease in attachment was then observed with any further increase in 
concentration. This could be due to molecular aggregation taking place at these 
high concentrations thus reducing the effective concentration of protein (Figure 
3.5). 
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Figure 3.5 Increasing initial concentration of protein used to adsorb to surfaces increases PC 12 
cell attachment. As the concentration o f protein is increased a corresponding increase in cell 
attachment fol lowing 24 hours culture is observed. However increases in protein concentrations 
above the optimal results in a detrimental effect on cell attachment. Data represents mean values of 
nine fields o f view per surface ±SEM. Note different scales of .v-axes demonstrate the effectiveness 
of the ECM protein tested. 
3.3.4 Attachment of PC12 cells to alternative control surfaces at optimal 
concentration 
The greatest level of PC 12 cell attachment was observed on collagen FV coated 
surfaces. Laminin coated surfaces supported cell attachment in a similar manner to 
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collagen IV, with a high level of cell attachment and an even distribution o f cells. 
On the contrary, surfaces coated with collagen I and fibronectin supported the 
attachment of fewer cells and their distribution was noted to be more clumped, 
demonstrating that cell-cell interactions are more favourable than cell-surface 
interactions (Figure 3.6). 
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Figure 3.6 PCI2 cell attachment to surfaces coated with adsorbed protein. (A) Bar chart 
showing the differential adhesion o f PCI 2 cells following 24 hours culture to alternative surfaces at 
optimal coating concentrations including: uncoated glass; glass coated with adsorbed ECM 
proteins: collagen 1 (250ng/ml); collagen I V (Sug/ml); fibronectin (50ng/ml); and laminin 
(lOng/ml). Data represents mean number o f cells per field o f view (nine randomly selected fields 
were examined per surface) for three independent experiments (+SEM). (B) Fluorescence 
micrographs o f cultures grown on either glass surfaces coated with adsorbed protein. DAPI 
staining revealed large numbers o f cells attached to surfaces coated with adsorbed proteins; 
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collagen I , collagen I V , fibronectin and laminin whilst there was little i f any evidence of cells 
adhering to glass. Scale bar: lOOnm. ***p<0.001 
3.3.5 Presentation of ECM motifs expressed in OmpA enhance cell attachment of 
PC 12 cells 
Surfaces were prepared presenting single motifs from the ECM proteins collagen I , 
collagen IV, fibronectin and laminin (Orla 1, 11, 31, 32, 34, 36, ROD, I K V A V , 
GTPGPQGIAGQRGVV, MNYYSNS, PHSRN, YIGSR respectively, Table 1.2) 
and the tenascin C mofif (Orla 30, Table 1.2). As ECM proteins have multiple 
active domains, two surfaces were prepared, presenting two motifs simultaneously 
to more faithfully recapitulate the in vivo environment (Orla 35 and 37, fibronectin 
and laminin respectively, Table 1.2). Surfaces were infilled with HDT to minimise 
non-specific cell attachment and therefore any increase in attachment level would 
be of a direct consequence of the presented motifs. 
The level of cell attachment to culture surfaces consisting of the OmpA scaffold 
with or without the insertion of various ECM molecule motifs was examined 
(Figure 1.10). Only a low level of attachment (17 cells) per field of view was 
observed on surfaces containing only OmpA infilled with HDT on gold (OmpA-
control). Cell attachment was increased by the presence of OmpA with no motif(s) 
presented when compared to HDT alone. This is due to two factors: assembly of 
OmpA prior to HDT assembly resulted in a lower concentration of HDT present on 
the surface; and the outer loops of OmpA provide a roughened surface providing a 
topographic advantage over the flat surface presented by HDT. The inclusion of 
sequences from the functional domains of the ECM proteins, collagen I , collagen 
IV, fibronectin or laminin into OmpA significantly enhanced the attachment of 
PC 12 cells compared to OmpA-control surfaces. When PCI2 cells were cultured 
on adsorbed ECM proteins differences in cell spreading was observed, in 
agreement with this, cell spreading is greater on some biomimetic surfaces than on 
others. However, the trend was not analogous for each molecule/motif: cell 
spreading on surfaces coated with laminin or collagen IV proteins produced an 
even distribution of cells. In agreement the collagen IV biomimetic surface 
showed the least amount of clumping, conversely the laminin biomimetic surface 
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was not observed to produce an even cell distribution. Not all surfaces had a 
positive effect on cell attachment; no increase was seen from Orla 1, 30 or 11. 
When motifs were combined in a single OmpA molecule the level of attachment 
observed was similar to that of the least effect motif Orla 36 presented singularly 
increased cell attachment and Orla 11 did not increase cell attachment, when the 
two motifs were combined in a single OmpA molecule (Orla 37). Furthermore, 
when presented to PC 12 cells the attachment of the combined surface was similar 
to the least effective motif I K V A V (Orla 11). A similar trend was observed for 
Orla 1 combined with Orla 34 - Orla 35 (Figure 3.7). 
PC 12 cells are able to bind to; Orla 31, 32, 34, 36. This demonstrates that these 
motifs are presented in a functional manner. 
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Figure 3.7 Presentation of motifs from ECM molecules increases PC 12 cell attachment 
following 24 hours culture. Surfaces displaying ECM motifs presented by the OmpA molecule 
enhance the attachment o f cultured cells. A) Bar chart showing mean number o f cells per field o f 
view o f PCI2 cells to surfaces coated with self assembled OmpA or OmpA-ECM moti f protein. 
The protein surfaces were all completed by infi l l ing with HDT. Data represents mean number o f 
cells per field o f view (nine randomly selected fields were examined per surface) for three 
independent experiments (+SEM). Values for each motif condition were normalised to the number 
of cells attached to surfaces coated with OmpA without a motif insertion. B) Fluorescence 
micrographs of cultures grown on surfaces consisting of either OmpA without any ECM motif 
insertion or OmpA carrying a motif f rom the ECM protein, collagen 1. collagen I V , fibronectin or 
laminin. Scale bar: lOOnm. *p<0.05. **p<0.005 
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3.3.6 Comparison of biomimetic surfaces to protein adsorbed surfaces 
To compare biomimetic surfaces to protein adsorbed surfaces, the level of cell 
attachment on surfaces of known amounts of adsorbed ECM proteins can be 
compare to the number of cells attached to biomimetic surfaces. This allows an 
equivalent concentration of biomimetic surfaces to be deduced. Each ECM 
domain tested had levels of cell attachment equivalent to the following 
concentrations of their corresponding adsorbed protein: collagen 1 129|ig/ml; 
collagen IV O.l^g/ml; fibronectin 18|ig/ml; and laminin 2.0^g/ml (Figure 3.8). 
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Figure 3.8 Comparison of the mean number of cell attachment following 24 hours culture 
between Orla peptide surfaces to that of protein coated surfaces. Points represent protein coated 
surfaces at various concentrations (±SEM), arrowed line illustrates mean cell attachment level of 
biomimetic surfaces and approximate protein concentration equivalent. 
Upon calculation of the relative attachment to biomimetic surfaces as a percentage 
of protein coated surfaces (Table 3.1) the order of effectiveness of biomimetic 
surfaces is Orla 34 (fibronectin) > Orla 31 (collagen I) > Orla 36 (laminin) > Orla 
32 (collagen IV) . It is important to consider the level of attachment relative to 
adsorbed protein as the biomimetic surface Orla 31 results in one of the lowest 
significant results however when taking the attachment of PC 12 cells to adsorbed 
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collagen I protein, this biomimetic surface produces the second greatest level of 
cell attachment. 
Attachment to Attachment to protein 
Surface biomimetic surface adsorbed surface Percentage (%) 
(^g/ml) (^g/ml) 
Collagen 1 60 250 24 
Collagen IV 0.1 8 1.3 
Fibronectin 18 50 36 
Laminin 1.5 10 15 
Table 3.1 Table gives information of the level of cell attachment to biomimetic surfaces and the 
maximal cell attachment level to surfaces with adsorbed protein. Final column shows the 
attachment o f cells on biomimetic surfaces as a percentage of the maximal level of ailachmenl o f 
cells to protein adsorbed surfaces. 
Controlling neurite behaviour using biomimetic surfaces 
3.3.7 Neurite outgrowth of PCI2 cells cultured on control surfaces 
ECM proteins have previously been shown to affect PC 12 cell growth and neural 
differentiation "' ' '•225.29.-!,304 pj.gyiQys studies have investigated multiple aspects of 
neurite behaviour from PC 12 cells and these include: neurite length; number of 
neurites per cell; and the number of branches per neurite. 
Using a similar paradigm, neurite behaviour of PC 12 cells cultured on various 
adsorbed ECM proteins was investigated. Based on previous observations 
(Section 3.3.6) surfaces were prepared of the ECM proteins collagen I , collagen 
IV, fibronectin and laminin of varying concentrations from 1600|ig/ml to 
0.0\\ig/ml. The following concentrations resulted in optimal cell coverage 
following ten days NGF induced differentiation: collagen I (800|ig/ml); collagen 
IV (0.5|ag/ml); fibronectin (35ng/ml); and laminin (5|ag/ml). A similar trend to 
that previously observed was seen, collagen and laminin provided the best 
- 134-
substrates for cell coverage, whereas collagen I and fibronectin supported fewer 
cells and their coverage appeared clumpy (Figure 3.9). 
Surfaces of decreasing concentrations were studied and surfaces where sufficient 
single cells were visible were analysed for neurite outgrowth. The following 
concentrations of ECM proteins were used: collagen 1 (800)ig/ml); collagen IV 
(0.25|Lig/ml); fibronectin (17.5|ig/ml); and laniinin (2.5|ig/ml). Comparisons 
between cells grown on coated and uncoated surfaces gave the changes described 
below in comparison to control surfaces. Cells grown on uncoated surfaces had a 
mean neurite length of 129.4|am ±7.4fim. When normalised to cells cultured on 
uncoated surfaces it was found that cells grown on collagen I decreased the mean 
neurite length by -25.2|am ±9.8|am whereas for all the other tested substrates the 
following increases in mean neurite length were observed: collagen IV 35.1)a.m 
±9.5fim; fibronectin 51.9|im ±11.5|am; and laminin 15.1|am ±8.3|im. Cells grown 
on uncoated surfaces had a mean number of 2.50 ±0.07 neurites per cell. Culture 
of cells on surfaces coated with ECM proteins increased the number of neurites per 
cell: collagen I 0.25 ±0.10; collagen IV 0.95 ±0.09; fibronectin 0.55 ± 0.08; and 
laminin 0.17 ±0.09. When analysing branching, cells grown on uncoated surfaces 
had 1.70 (±0.19) branches per mm of neurite. Culture of cells on fibronectin 
decreased the branching on neurites by -0.60 (±0.20) branches per mm. Culture of 
cells on all other ECM proteins tested resulted in an increase in neurite branching 
per mm: collagen 1 4.4 (±0.58); collagen IV 3.8 (±0.45); and laminin 2.1 (±0.47). 
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Figure 3.9 ECM proteins provide adequate surfaces for the differentiation of PC 12 cells. 
Images show representative fields o f view of PC 12 cells cultured for 10 days under NGF induced 
differentiation conditions. A l l images were taken at the same magnification, scale bar = lOOjim. 
3.3.8 Neurite outgrowth of PC 12 cells cultured on biomimetic surfaces 
Having demonstrated that PC 12 cells respond differently to different adsorbed 
ECM proteins, biomimetic surfaces presenting motifs from these ECM proteins 
was investigated. Motifs from collagen I , collagen IV, fibronectin and laminin 
were all found to increase mean neurite length. Both of the fibronectin motifs and 
the laminin YIGSR motif produced a significant increase in neurite length, 
however the laminin motif I K V A V had no effect on neurite length (Figure 3.10 A) . 
The most effective motif in promoting neurite growth was Orla 31 (Figure 3.10 D, 
Orla 31). When investigating the influence on the number of neurites per cell of 
various biomimetic surfaces, many of the surfaces appeared to increase the number 
of neurites per cell, only one surface produced a significant increase (Orla 32) 
(Figure 3.10 B, D Orla 32). Two surfaces produced a significant increase in 
neurite branching: Orla 31 and Orla 36 (Figure 3.10 C). PC 12 cells cultured on 
Orla 36 biomimetic surfaces appear highly branched (Figure 3.10 D, Orla 36). 
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Consistent with previous studies, the tenascin C motif had no significant effect on 
any of the aspects tested for neuronal behaviour. 
In agreement with PC12 adhesion data (Section 3.3.7), when two motifs were 
presented by a single OmpA molecule these surfaces had an effect similar to that 
of the motif, which when presented alone gave the lesser response. Orla 36 was 
found to significantly increase neurite branching whereas, Orla 11 did not 
significantly increase neurite branching. When these two motifs were presented in 
a single protein (Orla 37) the level of neurite branching was similar to that of Orla 
11 alone and the significant increase from Orla 36 was no longer observed. Both 
Orla 1 and Orla 34 had positive effects on the mean neurite length, however, when 
combined in a single OmpA molecule no significant increase in mean neurite 
length was observed suggesting that the presentation of both motifs simultaneously 
has a detrimental effect on their correct presentation. 
PC 12 cells responded to: Orla 1; Orla 31; Orla 32; Orla 34; and Orla 36. This 
demonstrates that these motifs are presented in a ftinctional manner. 
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Figure 3.10 Regulation of neurite formation in response to alternative ECM motifs. Results 
were recorded from cultures o f PC 12 cells grown for 10 days under NGF differentiation conditions 
on different biomimetic surfaces. A) The mean neurite length. B) The mean number o f neurites per 
cell. C) The mean nimiber o f branches/mm of neurite. Values were normalised to those o f cells 
grown on control (OmpA) surfaces. Negative values represent a decrease when compared to 
control levels. Data represents mean values o f 20 randomly selected single cells per surface for 
three repeats (+SEM). D) Fluorescence micrographs showing prime examples o f cultures grown on 
alternative biomimetic substrates: OmpA-control; Oria 31 ; Oria 32; and Oria 36. Cells were 
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stained with the nuclear marker D A P I (blue) and the neuronal marker pi l l - tubulin (red). Scale 
bars: OmpA-control and Orla 31: lOOum; Orla 32 and Orla 36: 25|im. *p<0.05. **p<0.005 
Controlling neuronal differentiation using biomimetic surfaces 
3.3.9 Coating surfaces with alternative ECM proteins modulates cell attachment 
Surfaces were prepared by adsorbing laminin (following poly-d-lysine, PDL 
adsorption), fibronectin, collagen I and collagen IV. NSPCs neurospheres were 
dissociated and allowed to adhere. Following 24 hours proliferation, the media 
was changed to differentiation media and cells were cultured for a further four 
days. The confluency of the cultures appeared different, cells grown on PDL-
laminin or fibronectin appeared clumpy favouring cell-cell interactions instead of 
cell-surface interaction, whereas cells on collagen I or collagen IV were more 
homogeneously spread and a greater number of single cells were apparent. The 
number of neuronal cells present was investigated by positive staining with p i l l 
tubulin NSPCs grown on PDL-laminin or fibronectin appeared less differentiated 
whereas those grown on collagen I or collagen IV appeared more differentiated 
with a more extensive network of neurites (Figure 3.11 A). To quantitatively 
compare cell number on the different surfaces the mean cell number for each field 
of view was calculated, this revealed that there were no differences in cell number 
between PDL-laminin and fibronectin. In contrast collagen I and collagen IV 
resulted in significantly fewer cells than PDL-laminin and fibronectin although 
there was no difference between collagen I and collagen IV (Figure 3.11 B). 
Further analysis of neural cell types proved that cultures of cells on PDL-laminin 
or fibronectin had significantly fewer neuronal cells when compared to cultures 
grown on collagen I or collagen IV (Figure 3.11 C). 
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Figure 3.11 Analysis of NSPCs grown for 4 days under differentiation conditions on alternative 
surfaces with adsorbed ECM proteins. A ) Fluorescence images show p i l l positive cells (red) and 
nuclei (blue). Representative images are shown. Scale bar: lOOnm. B) Bar chart shows the 
quantitative analysis o f cell number on alternative growth surfaces o f nine randomly selected fields. 
Bars show mean values +SEM, n=3. C) Quantitative analysis o f p i l l positive cells on alternative 
protein adsorbed surfaces. Data represents the mean percentage o f p i l l positive cells per field o f 
view for nine randomly selected fields as a percentage o f the total population per field o f view for 
each repeat. Bars show mean values+SEM, n=3. ***p<O.OOJ 
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3.3.10 Presentation of motifs from ECM proteins by biomimetic surfaces 
modulates NSPC attachment and the number of neuronal cells 
Previous studies using PC 12 cells have demonstrated that Orla 31, Orla 32, Orla 34 
and Orla 36 are all effective when presented in our system, in a correct and 
accessible orientation. Therefore, these motifs were selected for further 
investigation. The motif RODS (Orla 1) when presented by our system was only 
found to result in a positive effect in one of the assays. However, previous studies 
have shown RODS has a positive effect on neural cells ^^^-"'^  and hence was 
included in further investigations. NSPCs were allowed to adhere for 24 hours and 
subsequently differentiated for a further four days. Cultures of NSPCs on 
biomimetic surfaces all appeared similar in cell attachment, except for cells 
cultured on Orla 32 where fewer cells attached (Figure 3.12 A). Quantitative 
analysis clearly demonstrates the differences in cell number: Orla 32 significantly 
reduces cell number when compared to OmpA without any inserted motif (Figure 
3.12 B). Analysis of the percentage of p i l l positive cells revealed that only Orla 1 
significantly enhanced the percentage of neuronal cells (Figure 3.12 C). One 
possible explanation for this difference is that the higher cell confluency results in 
reduced differentiation; a 3-fold difference in cell attachment was noted whereas a 
1.5-fold difference in differentiation was observed. Surfaces composed solely of 
M U D A produced a 5-fold increase in cell number however no increase in 
differentiation was observed. 
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Figure 3.12 Influence of alternative ECM motifs on cell number and NSPC differentiation. A ) 
Fluorescence images of NSPC cultures grown for 4 days under differentiation conditions on 
biomimetic substrates presenting multiple motifs, cells were stained with the nuclear marker, DAPI 
(blue), whilst neurons were labeled with pl l l - tubulin (red). Scale bar: 100|im. B) The mean 
number o f cells per field o f view was compared to the number on biomimetic substrates. C) The 
niunber o f pi l l - tubulin positive cells were recorded on substrates presenting multiple ECM motifs 
compared to control (OmpA) surfaces. Values represent the number o f cells different to control 
(OmpA) levels (zero line) and were compared statistically to the control (OmpA) surfaces. The 
data represents mean values o f 20 randomly selected single cells per surface for three repeats 
(+SEM). ***p<0.001 
3.3.11 Presentation of mixed peptides to more faithfully recapitulate the in vivo 
environment 
The ECM comprises of multiple different molecules, each presenting different 
peptide motifs. In order to mimic this, surfaces were produced which consisted of 
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multiple peptides - Mixed Orla Surfaces (MOS) (for information regarding the 
composition of MOS see Table 1.2). Observation of the cultures showed there 
were no clear differences in cell number between the different surfaces (Figure 
3.13 A) . Quantitative analysis confirmed thai there were no significant differences 
in cell number between the different surfaces examined (Figure 3.13 B). Further 
analysis was conducted and the effect on neuronal differentiation assessed. M0S2 
was the only surface to produce significant increases in neuronal differentiation 
when compared to OmpA (control). M0S2 contains Orla 1, and this result is 
consistent with previous studies, which showed Orla 1 to be the best motif for 
increasing neuronal differentiation. 
The surface that had the smallest effect on neuronal differentiation was M O S l , the 
only surface that does not contain Orla 1 (Figure 3.13 C). As additional motifs are 
added to a surface, the relative coverage of each motif is decreased, for instance, 
M0S2 has two motifs and the coverage of RODS is 50%, M0S3 has three motifs 
and the coverage of RODS is 33%, MOSS has five motifs thereby reducing the 
coverage of RODS to just 20%. There is no difference between the presentation of 
RODS alone (100% coverage) and M0S2 (50% RODS coverage). 
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Figure 3.13 Influence of surfaces presenting multiple ECM motifs on cell number and 
neuroprogenitor differentiation. A) Fluorescence images o f NSPC cultures grown for 4 days 
under differentiation conditions on biomimetic substrates presenting multiple motifs, cells were 
stained with the nuclear marker, D A P l (blue), whilst neurons were labelled with pi l l - tubulin (red). 
Scale bar: 100|j,m. B) The mean number o f cells per field o f view was compared to the number on 
biomimetic substrates. C) The mean percentage o f pll l- tubulin positive cells was recorded on 
substrates presenting multiple ECM motifs and compared to control (OmpA) surfaces. Values 
represent the number o f cells different to control (OmpA) levels (zero line) and were compared 
statistically to the control (OmpA) surfaces. Data represent mean values o f 20 randomly selected 
single cells per surface for three repeats (+SEM). ***p<O.OOJ 
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Summary of results 
Certain motifs were found to be inactive in the assays tested. The laminin motif 
I K V A V and the tenascin C motif did not show any significant increase in cell 
attachment or neurite behaviour. Surfaces where two motifs were combined 
within one molecule proved inactive. Of all the motifs tested for influences on 
neuronal differentiation, RODS was the only motif that produced a significant 
increase when compared to control levels. When mixed motif surfaces were 
produced RODS was found to be a key component and without this motif present 
in sufficient quantities little increase above control (OmpA) levels were observed 
(Table 3.2). 
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Surface 
name 
Motif Source Adhesion Neurite 
behaviour 
Neuronal 
differentiation 
Orla 1 RGDS Fibronectin - Y Y 
Orla 11 I K V A V Laminin - - NT 
Orla 30 V F D N F V K L Tenascin C - - NT 
Orla 31 G T P G P Q G I A G Q R G W Collagen I Y Y -
Orla 32 MNYYSNS Collagen IV Y Y -
Orla 34 PHSRN Fibronectin Y Y -
Orla 35 PHSRN+RGD Fibronectin - - NT 
Orla 36 YIGSR Laminin Y Y -
Orla 37 Y I G S R + I K V A V Laminin - - NT 
M O S l 
Collagen 1 
Collagen I V 
GTPGPQGIAGQRGVV 
MNYYSNS 
NT NT -
M0S2 
Fibronectin 
Laminin 
RGDS 
YIGSR 
NT NT Y 
M0S3 
Fibronectin 
Collagen I 
Collagen IV 
RGDS 
GTPGPQGIAGQRGVV 
MNYYSNS 
NT NT -
M0S4 
Fibronectin 
Collagen 1 
Laniinin 
RGDS 
GTPGPQGIAGQRGVV 
YIGSR 
NT NT -
MOSS 
Fibronectin 
Collagen I 
Collagen IV 
Fibronectin 
Laminin 
RGDS 
GTPGPQGIAGQRGVV 
MNYYSNS 
PHSRN 
YIGSR 
NT NT -
Table 3.2 Summary of results. Table shows, motif/s presented by surfaces, origin o f motif/s and 
whether they showed an increase in the test variable when compared to control (OmpA) surfaces 
for the three independent assays. (Y) indicates that a positive effect was observed, (-) that no 
positive effect was observed and (NT) indicates that these motifs were not tested in that particular 
assay. 
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3.4 Discussion 
The technology discussed here, developed by Orla Protein Technologies, has been 
assessed as a platform for the control of cell attachment, neurite outgrowth and 
neuronal differentiation. Surfaces composed of inf i l l molecules without any 
peptide motifs could be used to control the attachment of multiple cell types, 
although the effects were cell type dependant. It was shown that motifs from 
collagen 1, collagen IV, fibronectin and laminin were able to enhance the cell 
attachment of PC 12 cells to a surface. These motifs were then demonstrated to 
control various aspects of neurite outgrowth from PC 12 cells. The motifs that 
were found to have a positive effect on PC 12 attachment and neurite outgrowth 
were then assayed for their effects on NSPCs. When investigating attachment; a 
peptide from collagen IV was found to significantly reduce the level of attachment, 
whereas the fibronectin peptide RODS significantly increased the percentage of 
PIII positive cells. Surfaces were prepared where multiple motifs were presented 
on a single surface and this resulted in some expected and in some unexpected 
results. 
Previous studies, supported herein, have provided evidence that topographic 
features of a surface can influence cell attachment and growth Cell attachment 
is enhanced when OmpA molecules presenting no motifs are added to a surface, 
however, when compared to HDT alone it is seen that for significant increases in 
cell attachment the presentation of ECM motifs is essential. 
Cell spreading is also affected by the surface upon which cells are cultured. 
Surfaces where cell coverage is clumpy show that the cells prefer cell-cell 
interactions in comparison to cell-surface interactions. PC 12 cells attached to 
glass surfaces coated with adsorbed fibronectin protein develop as aggregations of 
cells whereas cells grown on collagen IV protein coated surfaces were more 
uniformly distributed. Cells cultured on surfaces using OmpA to present the 
fibronectin domain formed clumps whereas collagen motifs resulted in a more 
even cell distribution. 
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In contrast to the data from experiments coating glass with solubilised whole 
proteins, surfaces that displayed the fibronectin motif, PHSRN, enabled the 
greatest level of cell attachment. Each surface was manufactured in such a way 
that the concentration of OmpA molecules presenting the different ECM domains 
was approximately equivalent. When considering the level of attachment to 
adsorbed proteins, the collagen I motif (Orla 31) resulted in the greatest level of 
cell attachment compared to the whole molecule. However, when compared to the 
level of attachment to adsorbed proteins, the collagen I motif provides the highest 
level of attachment. 
Studies have demonstrated that the laminin motif RGD ^'^ and the 
fibronectin motif RODS are highly effective in promoting cell adhesion. In 
contrast to previous work, the RGDS motif was not effective in our system when 
presented to PC 12 cells using a HDT infi l l background. There may be some 
reluctance for groups to publish negative results however, one group has shown 
that, in their system, RGDS does not increase cell attachment whereas YIGSR 
and KQAGDV do increase cell attachment '^^ Many factors affect the efficacy of 
immobilised peptides on surfaces, including: the distance between the peptide and 
the substratum the immediate environment surrounding the functional 
domain and the orientation and configuration of the motif and its secondary 
structure These factors can affect the accessibility of the active part of the 
peptide to the cell, the activity of the peptide and the topography of the surface. 
Surfaces were produced by which multiple motifs were presented by a single 
OmpA molecule, these were found to be ineffective in the assays tested. Several 
surfaces presenting a single motif were similarly found to be ineffective in 
enhancing cell attachment. Surfaces that were not effective in enhancing PC 12 
attachment were excluded from ftirther analysis. 
Cell differentiation is influenced by cues within their environment, notably the 
interaction with adjacent cells, soluble signals and the ECM. Within developing 
tissue, cells differentiate as a combined response to multiple signalling events. 
This is especially relevant to the ECM which is often composed of mixtures of 
different molecules that sun-ound cells and tissues and are important in 
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determining cell growth, state of differentiation and cell migration It is 
difficult to elucidate and investigate the exact role of individual ECM molecules in 
a standardised and reproducible manner. The presentation of peptide motifs helps 
to determine the exact factor influencing cell behaviour. 
PCI2 cells are also known for their ability to produce neurites in response to NGF 
and are used as a model system to study neuritogenesis Previous studies have 
investigated the effects of whole proteins on PC 12 neurogenesis and, upon 
comparison; similarities can be drawn with the data presented herein. Care should 
be taken when interpreting this data as, the whole protein w i l l contain numerous 
motifs whereas only single motifs are presented herein. 
Presentation of motifs from laminin, fibronectin, collagen I and collagen IV by 
OmpA molecules increased neurite length in comparison to control surfaces. This 
is consistent with previous reports whereby the exposure of PCI2 cells to ECM 
molecules resulted in enhanced neurite outgrowth Similarly, as previously 
noted, no significant differences were detected between the lengths of neurites 
grown on collagen I or laminin However, the data for fibronectin is not 
completely consistent with those of Paralkar et al. who showed that collagen IV 
and laminin produced similar levels of neurite outgrowth more effectively than 
fibronectin. 
Laminin has been demonstrated to increase the percentage of PCI2 cells producing 
neurites When comparing laminin and fibronectin, laminin increased the 
percentage o f cells with neurites whereas fibronectin had no effect over that of the 
control Collagen I has previously been shown to significantly increase the 
numbers of neurites formed by PC 12 cells compared to numbers induced in 
cultures grown on laminin Whilst the collagen I motif did increase the mean 
number of neurites originating from the cell body, this was not a significant 
change. On the other hand exposure to collagen IV significantly increases the 
number of processes formed per cell. There are inconsistencies between published 
studies and the data reported herein, potentially due to the variation in the methods 
used to evaluate the effect of ECM proteins on cell growth. The Nakajima group 
were unable to obtain attachment of their cells to collagen I or collagen IV coated 
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surfaces, whereas, cell attachment of NSPCs was obtained on these surfaces. 
These contradictory findings could be due to the different cell types however, their 
procedure for collagen coating differed from that recommended by the 
manufacturer. When coating was carried out as described by Nakajima no 
attachment of NSPCs was observed whereas with the recommended coating 
procedure attachment of NSPCs was possible. There is a need to standardise this 
process and the presentation of fianctional ECM peptide domains in a controlled 
and consistent manner, using well engineered synthetic surfaces, wi l l significantly 
improve reproducibility. 
The local influence of substrate molecules in determining distinctive growth 
patterns has been recognised To further investigate neuritogenesis, the 
number of branches per neurite formed was recorded. Peptide motifs for both 
collagen I and laminin induced significant levels of branching per neurite, 
inparticular, neurites grown on the laminin YIGSR motif appeared highly 
branched. Investigation of neurite branching has previously shown that laminin 
increases branching in comparison to fibronectin which is consistent with the 
data reported herein whereby neurites growing on surfaces presenting the laminin 
motif YIGSR produced significantly more branches compared to cells cultured on 
surfaces expressing motifs RODS or PHSRN associated with fibronectin. 
The behaviour of different cells on a surface have been attributed to the expression 
of integrins. PC 12 cells are known to attach poorly to fibronectin coated surfaces, 
upon comparison to cell lines that show a good level of attachment to fibronectin 
the differences were attributed to different expression levels of the a-integrin 
PC 12 cells are known to express a l , 6, 3, v and weakly a5 
The integrin heterodimers a i p i and a3pi are known to be the PC 12 receptors of 
laminin. Their binding has been localized to two different regions on the laminin 
molecule, with a l p l binding at the El-4 region and the a3(3I binding at the E l 
domain. In contrast, a i p i is the main integrin of PC 12 cells that binds to collagen 
I or collagen IV 
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These results demonstrate that surfaces presenting peptide motifs can influence 
neuritogenesis. Interactions between the peptide motifs investigated herein and the 
cell are known to be mediated by integrins and these results show integrins to be 
important in neuritogenesis. A process related to neuritogenesis is the formation of 
new synapses (synaptogenesis). Integrin signalling is also important in the process 
of controlling synaptogenesis and is controlled by cell-cell interaction between 
astrocytes and hippocampal neurons. One proposed mechanism for 
synaptogenesis is that phosphorylation of myristoylated alanine-rich C kinase 
substrate (MARCKS) leads to actin rearrangement, spinogenesis and finally 
synaptogenesis. This is mediated via up regulation of phospholipase A2 (PLA2) 
leading to an increase in the release of arachidonic acid. Arachidonic acid is 
required for the translocation of PKC(£) from the cytosol to the plasmamembrane, 
where it then induces the phosphorylation of MARCKS. Using the integrin 
blocker echistatin a reduction is phosphorylation of MARCKS is observed, 
implementing integrin binding as a mechanism to control synaptogenesis 
The work herein demonstrates that peptide motifs from collagen, fibronectin and 
laminin can be used to promote neuritogenesis. These results have implications in 
the wider literature for the application of this technology in increasing 
neuritogenesis in vivo. Peptides can be immobilised into scaffolds for 
transplantation in vivo to aid cell transplantation. Incorporation of scaffolds with 
immobilised ROD has been shown to increase the number of cells within a 
scaffold in vivo and ROD has also been immobilised onto scaffolds to promote 
repair following spinal cord injury There are many studies using I K V A V 
and YIGSR to promote neuritogenesis on scaffolds for transplantation into 
areas of damage. However, what has not been investigated is how the alternative 
peptides tested herein affect neuritogenesis in vivo for example, it has not been 
investigated how the collagen I peptide GTPGPQGIAGQRGVV could promote 
neuritogenesis in vivo. These results suggest that alternative motifs should be 
tested other than the currently investigated motifs. 
Cell fate and the direction of cell differentiation are regulated by multiple factors 
including the interaction between cells and their surrounding ECM It has been 
investigated whether certain active ECM peptide domains influenced the 
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differentiation of adult NSPCs to induce the formation of p i l l tubulin-positive 
cells, indicative of neuronal differentiation. 
The effect o f ECM proteins specifically on neuronal differentiation by neural stem 
cells (derived from the striatum of foetal rats) has been previously reported An 
array approach was used whereby either whole ECM molecules or artificial ECM 
proteins were tethered to a synthetic substrate in the presence and absence of 
known growth factors. It was demonstrated that growth factors were more 
predominant determinants for the specification of neural stem cells than matrix 
components, although the effects of growth factors were often influenced by the 
type of co-immobilised ECM. Li the absence of growth factors, ECM proteins for 
laminin and fibronectin induced neuronal differentiation Even though a 
different type of neuroprogenitor cell was used in this study, the motif for 
fibronectin (RGDS) had a significant effect on the formation of neurons. Collagen 
I has been previously recognised as a key component to enhance neuronal 
differentiation when used as a gel for three dimensional cell growth When 
presented by OmpA molecules the collagen I motif did not have a significant 
influence on neuronal differentiation. 
Of the motifs tested, only collagen IV resulted in a decreased number of pIII 
tubulin-positive cells formed by adult NSPCs. This is in contrast to the behaviour 
of foetal cortical neurons whose differentiation is promoted in the presence of 
collagen IV Such results draw attention to the differences between the model 
systems where the response of developing neurons to ECM proteins may differ as 
a consequence of their tissue origin. There are inconsistencies in the manner in 
which ECM proteins are represented in different studies, notably the use of either 
the whole ECM molecule adsorbed onto a solid substrate (with different studies 
using alternative concentrations) or the presentation of the functional ECM peptide 
domain alone. The conformation of adsorbed whole molecules is likely to be 
variable and different to that where the active peptide motif is presented in a 
uniform and controlled manner as reported here. This in turn is likely to influence 
the interaction of the cells with the substrate and consequently the differentiation 
response. 
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Proteins of the ECM can possess several different functional domains; therefore, it 
can be difficult to determine which domain is important for a certain function 
within a particular cell growth system. This is complicated further when several 
domains are functioning simultaneously and presentation is in such a way that the 
molecular conformation of such molecules is varied. In vivo, cells interact with the 
ECM composed of multiple co-localised proteins. Given the complexity of these 
interactions, there are significant advantages to studying the fiinction of ECM 
proteins and their active domains both individually and in various combinations. 
To evaluate the combined function of different ECM peptide domains, biomimetic 
surfaces were produced which were composed of a mixture of different motifs 
presented in a uniform fashion (Figure 1.10). When presented as a single peptide 
motif, collagen I and collagen IV produced opposite differentiation results 
however these responses were approximately equal in magnitude. In combination 
these functional domain effects appeared to cancel out resulting in no change 
compared to control levels. 
Earlier work studying rat neural stem cells demonstrated that it is possible to 
produce surfaces expressing the RGD peptide that appear to induce similar levels 
of neuronal differentiation to PLO/laminin surfaces Moreover, the laminin 
peptide I K V A V was found to have no effect on neuronal development. Upon 
bringing the two conditions together and creating a surface comprised of the active 
RGD and the inactive I K V A V motifs, the effect on neuronal differentiation was 
decreased in proportion to the dilution of the combined positive and negative 
effects The work described here is consistent with the observation that when 
ECM motifs that elicit approximately equal positive and negative effects on cell 
differentiation are combined, the cumulative effect amounts to no change relative 
to the control. 
When presented singularly, laminin (YIGSR) and fibronectin (RGDS) both 
induced neuronal differentiation. When the domains were co-presented this 
resulted in a surface that was similar to fibronectin (RGDS) alone. Contrary to 
previous results where PCI2 cells and motifs were presented in a single OmpA 
molecule, presentation of two motifs on a single surface did not have a detrimental 
effect compared to the more effective of the two motifs. 
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An increase in neuronal differentiation is observed when the RODS motif is 
presented at 100% (Orla 1) and 50% (M0S2); however, when the motif 
concentration is decreased below this level no effect is seen. Previous work has 
shown that the concentration of peptides immobilised to surfaces is critical in 
controlling cell fate as; insufficient peptide concentrations result in no elicited 
effects 
The addition of the fibronectin RODS motif to produce a surface in combination 
with the collagen I and collagen IV domains, resulted in an increase in neuronal 
differentiation, as would be expected. However, counterintuitive interactions were 
also observed. When three peptide motifs (Orla 1,31 and 36), that singularly all 
produced positive effects on cell differentiation, were combined on a single 
surface, the resulting effect, although positive, was not significantly different from 
the control surface. Furthermore, when five peptide motifs (Orla I , 31, 32, 34 and 
36) were expressed in combination, it appeared that the posifive effects of 
fibronectin (RODS), laminin and collagen I did not significantly counteract the 
negative influence of collagen IV. 
Studies of the differentiafion of murine embryonic stem cells have shown that the 
summative effects of combined ECM molecules did not consistently correlate with 
their activities when presented individually. Cultures of these cells on surfaces 
presenting collagen I , fibronectin or laminin resulted in an increase in 
differentiation However, when fibronectin was presented on a surface in 
combination with collagen I , a significant decrease in differentiation is observed 
313,314 
When Fittkau et al. studied cell adhesion to the peptides YIGSR, ROD and 
PHSRN, the greatest level of cell attachment was on ROD, then PHSRN, then 
YIGSR. When YIGSR was presented by a combined surface with RGD this 
increased cell attachment level whereas, co-presentation of RGD and PHSRN 
reduced cell attachment compared to levels on RGD alone, these results are 
surprising as, when presented alone PHSRN preformed better than YIGSR. This 
was consistent for two different cell types, however when investigating migration 
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with these cell types the results for mixed surfaces was not consistent with cell 
attachment data This highlights that not only are the responses of cells to 
combinations of peptides complex but that the responses are also subject to the 
behaviour being investigated. 
It would appear that in certain situations it is possible to create substrates 
composed of ECM proteins that influence cell differentiation in predictable ways 
however, there are other situations where the combination of alternative ECM 
molecules introduces additional complexity. 
As well as surfaces directing cell fate there are a number of possible explanations 
for the differences in the number of p i l l positive cells: surfaces could affect the 
selective attachment of one cell type; surfaces could favour selective death; or 
surfaces could favour selective propagation. These factors cannot be discounted as 
potential reasons for the observed effects. The percentage of p i l l positive cells 
was used to account for surfaces where reduced cell attachment was observed. 
The growth of cells outside the body requires the development of technologies to 
recreate the natural environment that cells experience in living tissues for optimal 
cell survival, growth and fiinction. Biomimetic substrates presenting the active 
peptide motifs of various ECM proteins can be used to regulate cell attachment, 
neurite behaviour and neural differentiation in vitro. The presentation of 
individual ECM peptide sequences enables direct assessment of their function 
whereas the production of surfaces containing more than one motif allows 
assessment of the combinatorial effects of different ECM peptides. The 
development of this technology wi l l lead to the creation of synthetic ECM 
substrates designed to interact with differentiating cells and wi l l be of direct 
relevance to tissue engineering and regenerative medicine. 
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COMPARISON OF RESULTS GAINED TO HYPOTHESIS UNDER 
INVESTIGATION 
The main hypothesis that was under investigation is that the presentation of motifs 
from ECM proteins via biomimetic surfaces wi l l influence cell behaviour. It was 
hypothesised that cell behaviour would have been similar to the ECM protein from 
which they were derived. However, other groups have found this is not the case. 
Cells that show similar attachment levels to the whole protein laminin do not 
necessarily show similar levels of attachment to the laminin peptide YIGSR. 
Chinese hamster ovary (CHO) cells and neuroblastoma x glioma cells (NG108-15) 
both show similar attachment levels to the laminin protein, however, when 
cultured on surfaces presenting the laminin peptide YTGSR, in comparison to CHO 
cells, NG108-15 cells show a reduced level of attachment of 59%. This level of 
attachment could not be increased by increasing the concentration of peptide used 
to coat the surfaces It was hypothesised that not all motifs wi l l be effective in 
influencing all cell types. This was observed herein, only four of the nine motifs 
tested had positive effects on PC 12 cell attachment. It was hypothesised that the 
most effective motifs for controlling PC 12 neurite behaviour would be those that 
were able to influence PC 12 cell attachment, this was not completely true as one 
motif that had no effect on cell attachment was able to influence neurite behaviour, 
this highlights the fact that cell adhesion and neurite behaviour are not controlled 
by the same mechanism and that one orientation/conformation of motif although it 
may not be correct for one function, it can still activate other pathways. It was 
hypothesised that presentation of multiple motifs from different ECM proteins wi l l 
have an increased effect when compared to individual motifs. This hypothesis was 
not supported as the presentation of two motifs that had a positive effect on a 
single surface did not result in an increase above the level from one of the motifs 
and furthermore, the presentation of three motifs that each resulted in positive 
effects resulted in a surface that did not greatly enhance the effect. 
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C H A P T E R 4 - HOW T H E E C M A F F E C T S E M B R Y O N A L C A R C I N O M A 
S T E M C E L L S IN V I T R O AND T H E I M P L I C A T I O N S IN T E R A T O M A 
D E V E L O P M E N T 
4.1 Introduction 
EC stem cells have been well studied as a model system for cellular behaviour. In 
vitro, EC stem cells can be induced to differentiate towards a neuronal phenotype 
with the addition of retinoic acid '^^ '^ . Within seven days a marked effect on their 
morphology is observed, this is accompanied with a decrease in proliferation 
This decrease in proliferation is confirmed as, in cultures of undifferentiated 
NTERA2 cells, -90% of the total population is positive for the proliferation 
marker Ki67, following seven days retinoic acid treatment this expression is 
reduced to ~50% of the total population 
There is an increasing amount of information suggesting that stem cell 
differentiation can be directed by interactions with the ECM. For example, the rate 
at which EC stem cells secrete ECM proteins changes during differentiation, which 
indicates the key role of the ECM in controlling development The culture of 
ES cells on surfaces coated with different ECM proteins demonstrates that their 
developmental potential can be modulated. Culture of ES cells on collagen I , 
fibronectin or laminin inhibits differentiation toward trophoectoderm. Whereas, 
when ES cells are cultured on collagen IV coated surfaces, differentiation toward 
the trophoectoderm is induced In addition to individual proteins, mixtures of 
proteins have been found to control development. For example, it has been 
reported that collagen I and laminin have no effect on differentiation whereas 
MatrigeF'^ markedly increases differentiation Further data suggesting that the 
ECM controls stem cell differentiation comes from experiments where an increase 
in the rate of neuronal differentiation has been observed when EC stem cells are 
cultured on laminin as opposed to fibronectin, collagen I or collagen IV coated 
surfaces ECM proteins have also been demonstrated to affect the induction of 
neural differentiation, with laminin increasing the levels of tyrosine hydroxylase 
'^'^  and collagen IV inducing neuronal differentiation '^ '^ .^ Taken together, this data 
suggests that the ECM can be used to control stem cell differentiation. 
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There is also evidence to suggest that under certain conditions, the ECM can 
inhibit differentiation and maintain a pluripotent phenotype. ES cells are routinely 
cultured on murine embryonic fibroblasts (MEFs) in order to maintain their 
pluripotency; the mechanism(s) by which this maintenance occurs is unknown. 
Studies suggest that the ECM has a key role in maintaining stem cell pluripotency. 
The ECM can be extracted from MEFs and used to support stem cell pluripotency 
This ECM extract consists of procollagen and fibronectin Matrigel™, an 
alternative ECM extract has also been demonstrated to maintain ES cell 
pluripotency The ECM proteins laminin and fibronectin when presented 
singularly have also been shown to maintain ES cell pluripotency. Cells cultured 
in the absence of fibronectin on a gelafin do not remain as undifferentiated cells, 
demonstrating that under these conditions the interactions with ECM proteins are 
having a greater effect than the 3D environment for maintaining pluripotency 
Proliferation is also affected by the ECM upon which the cells are cultured. 
Laminin coated surfaces increase the confluence of EC stem cells and hence 
proliferation Collagen TV, fibronectin and laminin coated surfaces have all 
been shown to increase the proliferation of EC stem cells when in the presence of 
mitogens Laminin and Matrigel™ "'^ have also been shown to increase 
proliferadon. 
In Chapter 2 the anatomical site in which cells were transplanted was found to 
influence cell behaviour •'^ '^  and the ECM was proposed as a potential factor 
influencing the observed effects. Further experimentation demonstrated that co-
transplantation of stem cells with ECM components influences cell behaviour and 
confirmed the ECM as a key factor in controlling stem cell behaviour. Although 
the co-transplantation of stem cells with ECM molecules provided evidence that 
the ECM modulates teratoma behaviour, in vivo experimentation is complex which 
makes analysis of the control mechanisms difficuU. Co-transplantation of ECM 
components appeared to have three clear effects on teratoma development: the 
success rate of tumour development; the size of the teratoma (proliferation of 
cells); and the differentiation of the transplanted cells. 
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The in vivo environment is highly complex and the culture of cells in vitro on 
surfaces coated with ECM components helps go part way to simplify this. Coating 
surfaces provides a method for studying the effects of whole ECM proteins on 
stem cell behaviour. Some ECM components, such as Matrigel^"^, are complex 
mixtures of multiple proteins and growth factors. Individual components, such as 
laminin can be taken from this mixture and presented alone, however, this is still 
complex as ECM proteins are composed of multiple motifs. To simplify this 
further, cells can be cultured on surfaces presenting individual ECM protein motifs 
to identify the exact motif having the observed effects. As previously discussed, 
coating surfaces with proteins can be limiting and it is important to consider how 
the active motif of the ECM protein is affecting cell behaviour. In Chapter 3 it was 
demonstrated that motifs can be presented to cells in a functional manner to control 
their behaviour by expanding on this it is possible to investigate how motifs 
influence stem cell behaviour. 
Transplantation of cells into the liver produced large teratomas composed of 
immature cells, whereas subcutaneous transplantation produced small highly 
differentiated teratomas. The following observations were made when EC cells 
were transplanted with ECM components: Matrigel™ increased teratoma success 
rate, teratoma size and had no effect on differentiation; collagen I decreased 
teratoma size and also decreased differentiation; and laminin decreased teratoma 
size and increased differentiation. When the cells were co-transplanted with 
collagen IV or fibronectin, teratoma fomiation did not occur. 
In vitro culture provides a model system by which it is possible to elucidate how 
the ECM proteins are affecting the cells. In this Chapter, the control of cell 
behaviour is monitored by analysis of gene expression assessed by the relative 
quantities of mRNA. Although the presence of mRNA does not demonstrate that a 
functional protein wi l l be produced this does indicate how a cell is behaving. The 
cell line Tera2.cl-SP12 is a model system for the invesfigation of differentiation 
induced by the addition o f retinoic acid. 
159 
The differentiation of EC stem cells following retinoic acid treatment is a complex 
process, microarrays have demonstrated that a large number of neural transcripts 
are upregulated Upon differentiation, EC stem cells are known to increase the 
expression of plll-tubulin and P0U5F1 expression decreases with almost 
complete reduction, following 7 days retinoic acid treatment Proliferation is 
known to decrease as the EC stem cells undergo differentiation In this section, 
the induction of differentiation in Tera2.cl-SP12 cells is investigated using the 
following markers: neuronal markers p i l l tubulin and tyrosine hydroxylase; a 
marker of pluripotency, P0U5F1 (Oct4); and a marker of proliferation, Ki67. 
HYPOTHESIS UNDER INVESTIGATION 
Large teratomas are produced when EC stem cells are co-transplanted with 
Matrigel™ whereas transplantation with collagen I or laminin results in a 
reduction in teratoma size compared to controls. When cells are cultured on 
surfaces coated with different ECM components in vitro, it is predicted that the 
level of the proliferative marker Ki67 should be increased on surfaces coated with 
Matrigel™ whereas a reduction in the expression of Ki67 should be observed on 
surfaces coated with collagen I or laminin. EC stem cells co-transplanted with 
collagen I appeared to show a reduction in their differentiation potential. This 
reduction in differentiation could be due to maintenance of the EC stem cell 
pluripotency. To test this, EC stem cells are cultured on surfaces with adsorbed 
ECM components and the expression of Oct4 is investigated. I f interactions of EC 
stem cells with collagen I prevents differentiation and maintains pluripotency, it 
would be expected that the relative levels of Oct4 wi l l be greater than cells 
cultured on other surfaces. To ftirther investigate the effects on differentiation, the 
gene expression levels of two neuronal markers are investigated, i f differentiation 
is decreased when cells are cultured on collagen I , there should be a reduction in 
the expression of these markers. Although no teratoma formation was observed 
when cells were co-transplanted with collagen IV or fibronectin, these are included 
in this assay for comparison. The peptide motifs from collagen I , collagen IV, 
fibronectin and laminin are investigated to demonstrate whether these are the 
principle effectors of controlling EC stem cell differentiation. It would be 
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predicted that the motifs wi l l have a similar effect to the whole proteins however 
the response should be reduced as only single peptides are presented, as opposed to 
multiple motifs in the whole protein. A l l of the motifs have previously been 
demonstrated to be presented in the correct fashion for the adhesion of PC 12 cells. 
However, it is likely that Tera2.cl.SP12 cells wi l l not have the same compliment of 
integrins and their response to the presented motifs wi l l not follow the same 
pattern as for PC 12 cells. 
A I M 
To culture EC cells on surfaces presenting various ECM proteins in order to 
elucidate how these control EC behaviour and hence provide possible explanations 
for the observations seen during teratoma experiments. 
OBJECTIVES 
1. Culture EC cells on various ECM proteins and assess their behaviour. 
2. Culture EC cells on surfaces presenting peptide motifs from ECM 
molecules and assess their behaviour. 
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4.2 Materials and methods 
Surface preparation 
Biomimetic surfaces were prepared as previously described (Section 3.2). 
Surfaces with adsorbed proteins were produced as previously described (Section 
3.2). Coating concentrations were used as recommended by the manufacturer and 
published data to ensure maximal coverage: collagen I (2mg/ml); collagen IV 
(2mg/ml); fibronectin (50mg/ml) ^ " ; laminin (20mg/ml) and Matrigel™ (1:3, 
stock:media without FCS, Penicillin/streptomycin or 1-glutamine, stock 
concentration ~9.8mg/ml). Adsorption of ECM components was carried out as 
previously described (Section 3.2). Biomimetic surfaces presenting motifs from 
collagen I (Orla 31), collagen IV (Orla 32), fibronectin (Orla 34) and laminin (Orla 
36) were manufactured and prepared for cell culture as previously described 
(Section 3.2). Experiments were repeated in triplicate. 
Cell culture and induction of differentiation 
Tera2.cl-SP12 cells were seeded at a density of 500,000 cells per T25 flask or 
200,000 cells per well of a 6-well plate and cultured in media as previously 
described (Section 3.2). Induction of differentiation was carried out by addition of 
lOmM all-trans retinoic acid (Sigma) to the culture medium. Cultures were either 
maintained in proliferative media for four days or in differentiation medium for 
seven days. 
mRNA extraction 
Media was removed from cells, washed once with PBS and mRNA was extracted. 
To lyse the cells, I ml TRI® reagent (Sigma) per lOcm^ samples were incubated for 
10 minutes at room temperature and the cell lysate passed several times through a 
pipette. The lysate was transferred to a 1.5ml eppendorf tube and centrifugated at 
12,000g for 10 minutes at 4°C. The mRNA contained within the clear supernatant, 
was transferred to a fresh 1.5ml tube and 0.2ml of chloroform per 1ml of TRI ® 
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reagent was added, tubes were vortexed for 15 seconds and incubated at room 
temperature for 15 minutes. Centrifugation at 12,000g for 15 minutes was carried 
out and the aqueous supernatant was transferred to a fresh tube. 
To precipitate the mRNA, 0.5ml of isopropyl alcohol per 1ml of TRI ® reagent 
was added, the tubes were inverted 3 times, incubated for 10 minutes and 
centrifuged at 12,000g for 10 minutes at 4°C. The supernatant was removed and 
the RNA pellet washed once with 1ml of 75% ethanol per Iml of TRI ® reagent. 
The RNA was centrifuged at 10,000g for 10 minutes at 4°C and all of the 
supernatant removed. The total RNA pellet was dried for 5-10 minutes, dissolved 
in 15-50^ 1.1 of RNase free water and incubated for 5 minutes at 55°C. 
The extracted total RNA was then stored at -80°C until required. 
DNase treatment 
DNase treatment was carried out using a TURBO DNase Treatment Kit (Ambion 
www.ambion.com) and was conducted as follows: 10(0,1 of the extracted RNA was 
aliquoted into a fi-esh tube; 1^ 1 of lOx TURBO DNase Buffer and \ of TURBO 
DNase were added and mixed gently. The samples were incubated for 20 minutes, 
at 37°C, inactivated, by addition of l | i l DNase inactivation reagent, mixed and 
incubated for 2 minutes at room temperature with occasional mixing. The samples 
were then centrifuged at 10,000g for 90 seconds and the RNA transferred to fresh 
tubes. 
Reverse transcription 
The RNA sample was quantified using a NanoDrop ® spectrophotometer ND-
1000 and the volume to obtain 4|ig calculated. Using a Taqman reverse 
transcription kit (Applied Biosystems) the following reverse transcription master 
mix was prepared (quantities are given per reaction): 2|j,l RNase-free water; 4.4|al 
lOx TaqMan RT buffer; 4.0^1 dNTPs (2.5mM); 1.0|al random hexamers; 0.4(il 
RNase inhibitor (20U/L); and 0.5|xl Reverse Transcription enzyme (50U/^1). The 
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master mix was aliquoted, 4fig of RNA added and RNase free water was used to 
make the total volume up to 20^1. These were then vortexed and centrifuged at 
15,000 RPM for 5 minutes. Thermocycling was carried out in an Eppendorf 
Thermocycler as follow: 25°C for 10 minutes; 48°C for 30 minutes; and 95°C for 5 
minutes. 
qRT-PCR 
A master mix was prepared containing: 40\xl (200nm) forward primer; 40|il 
(200nm) reverse primer (VHBio, Gateshead); 5^1 SYBR green PGR master mix 
(Applied Biosystems); and 3.2|il Molecular biology grade water (Sigma). This 
master mix was then aliquoted to 9|il per well of a qRT-PGR plate (Applied 
Biosystems). Primers were used as listed (Table 4.1). A 'no template control' was 
carried out by loading 1 |al of dH20 instead of any cDNA sample to confirm there 
was no contamination. cDNA samples were diluted 1:4 and standards prepared of 
the following dilutions: 1:0, 1:4, 1:9, 1:19, 1:49, 1:99; and 1:999. l | i l of cDNA 
sample or standard was loaded per well of a MicroAmp Fast 96 well Reaction 
plate (0.1ml, Applied Biosystems) and loading was repeated in triplicate. Plates 
were sealed with MicroAmp Optical Adhesive Film (Applied Biosystems) and 
centrifuged at 15000 RPM for 5 minutes. PGR was carried out using an Applied 
Biosystems 7500 Fast Real-Time PGR System. A dissociation plot was produced 
to demonstrate a single product. Standard curves were produced with an R^ value 
of >0.98. A l l data was normalised to the reference gene GAPDH and subsequently 
to that of the control surface (either uncoated plastic or OmpA presenting no 
motif). 
Confirmation ofPCR specificity 
A 2% (w/v) agarose gel was prepared by adding 0.8g of agarose (162-0133, Bio-
Rad) to 35ml dH20, boiling until all the agarose had dissolved and then adding 
5ml of 5x Tris-borate (TBE (pH 8.3), 54g Tris base, 27.5g boric acid, 20ml 0.5M 
EDTA (pH 8.0)). Once cool, 1 |al/ml of ethidium bromide was added and the 
solution poured into a gel mould with comb in place. Once set 0.5x TBE was 
164-
poured onto the gel and the comb removed. The running tank was then filled with 
0.5x TBE and the samples loaded. Samples were pooled from multiple reactions, 
10|al was taken and 0.5|al of Blue Juice gel loading buffer (Invitrogen) was added. 
Samples were loaded onto the gel along with a Hyper Ladder IV lOObp standard 
(Bioline), a fixed voltage of 120V was applied and samples run until a good 
separation was achieved. 
Primer sequences 
Primer Sequences 
Annealing 
temperature 
rc) 
Product 
size (bp) 
Ref 
GAPDH 
TCG CCC CAC TTG ATT TTG GAG G 
ATG GGG A A G GTG A A G GTG GGA G 
60 266 
# 
Ki67 
TCC TTT GGT GGG CAC CTA AGA CCT G 
TGA TGG TTG AGG TCG TTC CTT GAT G 
56 155 
P0U51 
(Oct4) 
GAG AAC CGA GAG AGA GGC AAC C 
CAT AGA CGC TGC TTG ATC GCT TG 
60 145 
359 
TUJl 
GGC CAA GTT CTG GGA AGT C 
CGT TGT AGT AGA CGC TGA TCC 
60 108 
ibU 
TH Sequence not available 60 74 
Table 4.1 Primer and sequences used for real time RT-PCR. Table gives information of primers 
used, annealing temperature and expected product size. # http.V/medaen.upent.be/rtprimerdb/ 
Statistical analysis 
The distribution of data was tested using the ICruskal-Wallis test. Where there 
were too few samples for distribution evaluation, to increase the number o f data 
points the mean value of each group was calculated and subtracted from each 
value, thus increasing the number of data points by two. The additional values 
have a mean of 0 and do not change the variance. For normally distributed data an 
ANOVA test was performed with Bonferroni post-hoc analysis. p<0.05 (*), 
p<0.005 (**) and p<0.001 (***) were used to indicate levels o f statistical 
significance. 
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4.3 Results 
Presentation of extracellular matrix components to control embryonal carcinoma 
stem cell behaviour in vitro 
Surfaces were prepared presenting the same ECM components as previously 
investigated (Chapter 3). Tera2.cl-SP12 cells were seeded onto the surfaces under 
both uninduced (proliferative) and retinoic acid induced (differentiation) 
conditions. A l l of the surfaces tested proved adequate for cell attachment and cell 
culture. 
4.3.1 pill gene expression of embryonal carcinoma cells cultured on surfaces with 
adsorbed extracellular matrix components 
Upon induction of differentiation using retinoic acid, Tera2.cl-SP12 cells are 
known to differentiate towards a neuronal lineage. To investigate neuronal 
differentiation the gene expression of (5111 tubulin was assessed. When Tera2.cl-
SP12 cells were grown under proliferative conditions, the observed expression of 
p l l l tubulin was low. Addition of retinoic acid to the culture media resulted in 
differentiation of Tera2.cl-SP12 cells and the gene expression of p i l l tubulin 
increased on all surfaces (Figure 4.1, A). Under proliferative conditions, in 
comparison to uncoated surfaces, collagen I , fibronectin and laminin all resulted in 
an increase in p i l l tubulin expression, where as Matrigel™ had a negative effect 
and collagen IV had no effect (Figure 4.1, B). Although laminin had the greatest 
effect on p i l l expression, a 0.7-fold increase, statistical analysis revealed that none 
of the surfaces differed significantly from control levels. Following induction of 
differentiation an increase in p i l l tubulin gene expression was observed on all 
surfaces except Matrigel™ (Figure 4.1, C). Similar to cells grown under 
proliferative conditions, there was no significant difference between the tested 
ECM surfaces and the uncoated control. 
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Figure 4.1 Neuronal differentiation of TERA2.cl-SP12 cells cultured on ECMprotein adsorbed 
surfaces as assessed by pill tubulin gene expression. A) The gene expression of TERA2.ci-SP 12 
cells cultured under proliferative conditions for four days is compared to cells cultured for seven 
days under retinoic acid induced differentiation conditions. B) Fold change in gene expression 
relative to uncoated surfaces of Tera2.cl-SP12 cells cultured under proliferative conditions. C) 
Fold change in gene expression relative to uncoated surfaces of Tera2.cl-SP12 cells cultured under 
retinoic acid induced differentiation. Data represents mean values of 3 repeats normalised to 
GAPDH, Error Bars: SD. 
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4.3.2 Tyrosine hydroxylase gene expression of embryonal carcinoma cells 
cultured on surfaces with adsorbed extracellular matrix components 
An alternative marker of neuronal differentiation is tyrosine hydroxylase. Upon 
retinoic acid induced differentiation, tyrosine hydroxylase gene expression 
increased. The difference between gene expression of cells cultured under 
proliferative and differentiation conditions was the smallest when cells were 
cultured on fibronectin or Matrigel™ (Figure 4.2, A) . Under proliferative 
conditions, when compared to control levels, all ECM components tested resulted 
in an increase in tyrosine hydroxylase gene expression. Collagen IV resulted in a 
2-fold increase and Matrigel™ resulted in a 4-fold increase. Although these are 
large increases they were not found to be statistically different from the control 
level. Fibronectin resulted in a dramatic 10-fold increase in tyrosine hydroxylase 
gene expression, this increase was found to be significantly (p<0.05) different 
froin the control levels (Figure 4.2, B). Compared to proliferative cultures, under 
differentiation conditions, the changes in tyrosine hydroxylase gene expression 
were far less. Similar to proliferative cultures, cells grown on fibronectin 
produced the greatest increase in tyrosine hydroxylase gene expression however, 
there was no significant differences between any of the ECM surfaces tested 
(Figure 4.2, C). 
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Figure 4.2 Neuronal differentiation of TERA2.cl-SPI2 cells cultured on ECM protein adsorbed 
surfaces as assessed by tyrosine hydroxylase gene expression. A) The gene expression of 
TERA2.C1-SP12 cells cultured under proliferative conditions is compared to cells cultured under 
retinoic acid induced differentiation conditions. B) Fold change in gene expression relative to 
uncoated surfaces of Tera2.cl-SP12 cells cultured under proliferative conditions. C) Fold change 
in gene expression relative to uncoated surfaces of Tera2.cl-SP12 cells cultured under retinoic acid 
induced differentiation. Data represents mean values of 3 repeats normalised to GAPDH, Error 
Bars: SD, *p<0.05. 
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4.3.3 Oc(4 gene expression of embryonal carcinoma cells cultured on surfaces 
with adsorbed extracellular matrix components 
Upon differentiation, the gene expression of the pluripotent stem cell marker Oct4 
(P0U5FJ) was seen to decrease (Figure 4.3, A) . Under proliferative conditions, 
laminin and Matrigel™ both decreased Oct4 gene expression, suggesting that these 
molecules induced differentiation. Cells cultured on collagen I had increased Oct4 
gene expression, indicating that this surface maintains pluripotency and decreased 
differentiation. However, none of these differences were found to be significantly 
different from control levels (Figure 4.3, B). Upon differentiation, all surfaces 
except Matriger'^ were observed to have similar gene expression to the control. 
Expression of Oct4 was not significantly increased by culture upon Matrigel™ 
however it was increased 7-fold above the level of the control, suggesting 
Matrigel™ maintains the cells in an undifferentiated state (Figure 4.3, C). 
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Figure 4.3 Pluripotency of TERA2.cl-SP12 cells cultured on ECMprotein adsorbed surfaces as 
assessed by POU5FI gene expression. A) The gene expression of TERA2.c l -SPI2 cells cultured 
under proliferative conditions is compared to cells cultured under retinoic acid differentiation 
conditions. B) Fold change in gene expression relative to uncoated surfaces of Tera2.cl-SPI2 cells 
cultured under proliferative conditions. C) Fold change in gene expression relative to uncoated 
surfaces of Tera2.cl-SP12 cells cultured under retinoic acid induced differentiation. Data represents 
mean values of 3 repeats normalised to GAPDH, Error Bars: SD. 
4.3.4 Ki67 gene expression of embryonal carcinoma cells cultured on surfaces 
with adsorbed extracellular matrix components 
Proliferation of cells can be evaluated by the gene expression of the cell 
proliferation marker Ki67. Upon differentiation, there was a slight reduction in 
Ki67 gene expression, it is expected that as cells start to differentiate their 
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proliferation rate wi l l be reduced (Figure 4.4, A) . Under proliferative conditions, 
all of the surfaces tested produced an increase in proliferation when compared to 
control levels. Fibronectin and Matrigel™ both resulted in a significant (p<0.05) 
2.5-fold increase in Ki67 gene expression (Figure 4.4, B). Upon differentiation, all 
surfaces tested produced an increase in proliferation; fibronectin and Matrigel™ 
both produced significant increases in proliferation (3.5- and 3-fold (p<0.005), 
respectively. Figure 4.4, C), similar to the results seen under proliferative 
conditions. 
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Figure 4.4 Proliferation of TERA2.cl-SP12 cells cultured on ECM protein adsorbed surfaces as 
assessed by Ki67 gene expression. A) The gene expression of TERA2.c l -SPl2 cells cultured 
under proliferative conditions is compared to cells cultured under retinoic acid differentiation 
conditions. B) Fold change in gene expression relative to uncoated surfaces of Tera2.cl-SPI2 cells 
cultured under proliferative conditions. C) Fold change in gene expression relative to uncoated 
surfaces of Tera2.cl-SPl2 cells cultured under retinoic acid induced differentiation. Data represents 
mean values of 3 repeats normalised to GAPDH, Error Bars: SD, *p<0.05. **p<0.005. 
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Biomimetic surfaces presenting motifs from extracellular matrix proteins to 
control embryonal carcinoma stem cell behaviour in vitro 
In Chapter 2, biomimetic surfaces presenting motifs from the ECM proteins: 
collagen I (Orla 31); collagen IV (Orla 32); fibronectin (Orla 34); and laminin 
(Orla 36) were demonstrated to be presented in an orientation to which cells could 
interact. Embryonal carcinoma stem cells, Tera2.cl-SP12, were cultured on each 
surface under proliferative and retinoic acid induced differentiation conditions. A l l 
surfaces proved adequate for cell attachment and culture. An analysis was carried 
out in a similar fashion to that used for surfaces coated with adsorbed proteins. 
4.3.5 pill gene expression of embryonal carcinoma cells cultured on surfaces 
presenting motifs from extracellular matrix proteins 
Similar to surfaces presenting ECM components, retinoic acid induced 
differentiation increased p i l l tubulin gene expression on all surfaces (Figure 4.5, 
A). For proliferative cultures, comparison of p i l l gene expression relative to the 
control surface demonstrated that only minor changes are observed (Figure 4.5, B). 
Under differentiation conditions, all surfaces behaved similar to the control 
surface, except Orla 32. Orla 32 induced a 2-fold increase in p i l l gene expression 
when compared to control levels, although this proved not to be a significant 
increase (Figure 4.5, C). 
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Figure 4.5 Neuronal differentiation of TERA2.cl-SP12 cells cultured on biomimetic surfaces 
presenting peptide motifs from ECM protein as assessed by pill tubulin gene expression. A) 
The gene expression of TERA2.cl-SP12 cells cultured under proliferative conditions is compared to 
cells cultured under retinoic acid differentiation conditions. B) Fold change in gene expression 
relative to uncoated surfaces of Tera2.cl-SP12 cells cultured under proliferative conditions. C) 
Fold change in gene expression relative to uncoated surfaces of Tera2.cl-SP12 cells cultured under 
retinoic acid induced differentiation. Data represents mean values of 3 repeats normalised to 
GAPDH, Error Bars: SD. 
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4.3.6 Tyrosine hydroxylase gene expression of embryonal carcinoma cells 
cultured on surfaces presenting motifs from extracellular matrix proteins 
Upon retinoic acid induced differentiation, tyrosine hydroxylase gene expression 
increased on all surfaces, Orla 32 and 36 only resulted in modest increases (Figure 
4.6, A) . For proliferative cultures, comparison of tyrosine hydroxylase gene 
expression relative to the control surface demonstrated that the surfaces were 
having an effect on neuronal differentiation: Orla 31 and 32 increased gene 
expression 1-fold; Orla 36 increased gene expression 3-fold; and Orla 34 increased 
gene expression 7-fold (Figure 4.6, B). Under differentiation conditions, none of 
the effects observed for proliferative cultures were seen and all surfaces behaved 
similar to the control surface (Figure 4.6, G). Statistical analysis proved none of 
the differences observed were significant. 
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Figure 4.6 Neuronal differentiation of TERA2.cl-SP12 cells cultured on biomimetic surfaces 
presenting peptide motifs from ECM protein as assessed by tyrosine hydroxylase gene 
expression. A) The gene expression of TERA2.cl-SP12 cells cultured under proliferative 
conditions is compared to cells cultured under retinoic acid differentiation conditions. B) Fold 
change in gene expression relative to uncoated surfaces of Tera2.cl-SP12 cells cultured under 
proliferative conditions. C) Fold change in gene expression relative to uncoated surfaces of 
Tera2.cl-SP12 cells cultured under retinoic acid induced differentiation. Data represents mean 
values of 3 repeats normalised to GAPDH, Error Bars: SD. 
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4.3.7 Oct4 gene expression of embryonal carcinoma cells cultured on surfaces 
presenting motifs from extracellular matrix proteins 
Upon retinoic acid induced differentiation, the pluripotency gene Oct4 decreased 
on all surfaces (Figure 4.7, A) . Under proliferative conditions, all surfaces 
increased Oct4 gene expression when compared to the control levels, however, the 
increases were less than 1-fold for all surfaces tested (Figure 4.7, B). Under 
differentiation conditions, all surfaces behaved similar to the control surface, 
except Orla 31 and 36 which decreased gene expression relative to control levels 
by less than 1-fold (Figure 4.7, C). Statistical analysis proved none of the 
differences observed were significant. 
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Figure 4.7 Pluripotency of TERA2.cl-SPl 2 cells cultured on ECM protein adsorbed surfaces as 
assessed by POUF51 gene expression. A) The gene expression of TERA2.cl-SP12 cells cultured 
under proliferative conditions is compared to cells cultured under retinoic acid differentiation 
conditions. B) Fold change in gene expression relative to uncoated surfaces of Tera2.cl-SP12 cells 
cultured under proliferative conditions. C) Fold change in gene expression relative to uncoated 
surfaces of Tera2.cl-SP12 cells cultured under retinoic acid induced differentiation. Data represents 
mean values of 3 repeats normalised to GAPDH, Error Bars: SD. 
4.3.8 Ki67 gene expression of embryonal carcinoma cells cultured on surfaces 
presenting motifs from extracellular matrix proteins 
Upon retinoic acid induced differentiation, the gene expression of proliferation 
marker Ki67 decreased on all surfaces (Figure 4.8, A) . Under proliferative 
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conditions, the gene expression of the proliferative marker Ki67 decreased on all 
surfaces when compared to the control levels, however, the decreases were less 
than 1-fold for all the surfaces tested (Figure 4.8, B). Under differentiation 
conditions, the only surface that resulted in a large change was Orla 32, which 
increased Ki67 gene expression 1.5-fold, however, this was not a significant 
change when compared to control levels (Figure 4.8, G). 
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Figure 4.8 Proliferation of TERA2.cl-SP12 cells cultured on ECM protein adsorbed surfaces as 
assessed by Ki67 gene expression. A) The gene expression of TERA2.cl-SP12 cells cultured 
under proliferative conditions is compared to cells cultured under retinoic acid differentiation 
conditions. B) Fold change in gene expression relative to uncoated surfaces of Tera2.cl-SPI2 cells 
cultured under proliferative conditions. C) Fold change in gene expression relative to uncoated 
surfaces of Tera2.cl-SPI2 cells cultured under retinoic acid induced differentiation. Data represents 
mean values of 3 repeats normalised to GAPDH, Error Bars: SD. 
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4.3.9 Primer validation 
For all primer sequences used, a dissociation plot was obtained with one peak, this 
demonstrates that only one product was formed (Figure 4.9, A) . To verify the 
amplified product was of the correct size, gel electrophoresis was conducted and 
the product size compared to the expected size (Figure 4.9, B). Other than the 
single band at the correct size, no additional bands were observed throughout the 
gel. 
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Figure 4.9 Primer validation. A) Sample dissociation plot showing only one melting point. B) 
Agarose gel electrophoresis confirming product size. lOObp standards were loaded (St.), GAPDH 
lane 1 (expected size 266bp), pi l l tubulin lane 2 (expected size (108bp), tyrosine hydroxylase lane 
3 (expected size 74pb), Ki67 lane 4 (expected size 155bp), Oct4 lane 5 (expected size 145bp). 
- 180-
Summary of results 
Surface 
Gene 
II TH Oct4 Ki67 
Pro D i f f Pro D i f f Pro D i f f Pro D i f f 
Collagen I NC NC NC NC NC NC NC NC 
Collagen IV NC NC NC 2 NC NC NC NC 
Fibronectin NC NC NC 10* NC NC 2.5* 3.5** 
Laminin NC NC NC NC NC NC NC NC 
Matrigel"^ NC NC NC 4 7 NC 2.5* 2** 
Surface 
Gene 
II TH Oct4 Ki67 
Pro D i f f Pro D i f f Pro D i f f Pro D i f f 
Orla 31 
(Collagen I) 
NC NC 1 NC NC NC NC NC 
Orla 32 
(Collagen IV) 
NC 2 1 NC NC NC NC 1.5 
Orla 34 
(Fibronectin) 
NC NC 7 NC NC NC NC NC 
Orla 36 
(Laminin) 
NC NC 3 NC NC NC NC NC 
Table 4.2 Summary of results for gene expression on surfaces coated with ECM components 
and biomimetic surfaces presenting motifs from ECM proteins. Tables show the fold increase in 
gene expression of. p i l l tubulin ((3111); tyrosine hydroxylase (TH); Oct4 (Oct4); and Ki67 (Ki67) 
for surfaces that resulted in an increase of 1-fold or greater. *p<0.05, **p<0.01 indicate the 
significant levels, NC = no change. 
- 181 
4.4 Discussion 
In this study, it is demonstrated that the gene expression of differentiation, 
pluripotency and proliferative markers is regulated by the ECM components that 
are presented to Tera2.cl-SP12 cells. In agreement with previous studies, retinoic 
acid induced differentiation resulted in an increase in mRNA expression of 
neuronal markers and a decrease in the mRNA expression of the pluripotency 
marker Oct4 As expected, the response of the cells to the surface was 
dependent upon the ECM component presented. The response of Tera2.cl-SP12 
cells to alternative ECM proteins was also seen to be dependent on the culture 
conditions in which the cells were grown. Different responses were observed for 
proliferative and differentiated cultures, for example, increases in gene expression 
for cells under proliferative conditions were not always observed for cells grown in 
differentiation conditions and vice versa. 
The ECM is important in the differentiation of EC stem cells. Studies have 
demonstrated that upon differentiation EC stem cells increase their synthesis and 
secretion o f laminin and collagen IV by 72 hours, the level of laminin and 
collagen IV reach a maximum level Although both collagen IV and laminin 
are upregulated, it has been shown that these networks are independent of each 
other Conflicting reports exist for fibronectin, which has been shown to be 
synthesised by both undifferentiated and differentiated EC stem cells with an 
upregulation following differentiation " ° . Some studies have shown that EC stem 
cells do not synthesise fibronectin until they differentiate This data indicates 
that ECM proteins are involved in the differentiation process. EC stem cells 
cultured on surfaces coated with alternative ECM components provide a model 
system to study how these affect differentiation. 
The ECM component that influenced the greatest number of genes was 
Matrigel™. Given the large number of different components, including both 
proteins and growth factors, Matrigel™ is subjecting the cells to more inductive 
signals than single ECM proteins alone. Matrigel™ has been shown to increase 
both proliferation and differentiation, whereas, in the same assay, collagen I and 
laminin had no effect 
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Matrigel™ is used for feeder free maintenance of ES cells and has been proposed 
to be better at maintaining the pluripotent phenotype when compared to 
conventional murine embryonic fibroblasts (MEFs) •^ ^^  This is supported 
herein as under differentiation conditions, cells cultured on Matrigel™ had a 7-
fold increase in Oct4 gene expression when compared to control levels. 
It has been proposed that the culture of stem cells in 3D gels promote self renewal 
and maintenance of a pluripotent phenotype Gel formation is not essential in 
maintaining an undifferentiated phenotype of stem cells as it has been 
demonstrated that: collagen I and gelatin (which do form gels) result in cell 
behaviour similar to laminin and fibronectin (which do not form gels) When 
Matrigel™ is diluted it loses its gel forming ability, in this section it was used at a 
concentration (3:1) that wi l l form a gel. The volume of Matrigel™ that was used 
in this section was recommended by the manufacturer to produce a thin layer 
coating whilst maintaining a gel resulting in optimal formation to ensure that the 
interactions due to the 3D structure were kept to a minimum. Therefore the 3D 
structure could have helped maintain pluripotency and increase proliferation 
however this wi l l have been minimal. 
Similar to Matrigel™, fibronectin upregulated the gene expression of Ki67 and 
tyrosine hydroxylase, this was unexpected as fibronectin is not a component of 
Matrigel™, whereas, collagen IV and laminin, which are components of 
Matrigel™ did not have an effect similar to Matrigel™. However, as both the 
whole protein and the Orla 34 surface presenting the fibronectin motif PHSRN had 
a positive effect on EC stem cells. When investigating the attachment of PC 12 
cells, the surface Orla 34 was found to have the greatest effect on cell attachment. 
As this surface also has the greatest effect on differentiation and proliferation of 
EC stem cells, this suggests that this motif is presented in a manner, which is either 
superior to or more faithful to the natural motif found in the whole molecule of 
fibronectin. 
There have been few investigations of how the peptide motifs tested herein affect 
cell behaviour in terms of neuronal differentiation, maintenance of pluripotency 
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and proliferation. There are some reports where peptides have been found to 
influence cell proliferation. RGDS is known to increase the proliferation o f 
murine fibroblasts and PHSRN in combination with RGD increases 
proliferation of human fibroblasts and HaCaT cells This data indicates that the 
peptide motifs can be used to control proliferation. 
In comparison to whole proteins, presentation of individual motifs had little effect 
on the gene expression of Tera2.cl-SP12 cells. Given the complexity and the 
number of fiinctional motifs presented by whole ECM proteins, it is not surprising 
that individual motifs did not have as great an effect as the whole proteins. Similar 
to the protein fibronectin, presentation of the fibronectin motif Orla 34 increased 
the gene expression of tyrosine hydroxylase. In Chapter 3, it was found that Orla 
34 resulted in the greatest level of cell attachment of PCI2 cells, this data 
demonstrates that the conformation of motif presentation could be an important 
factor for the observed results. 
Studies have shown that, laminin, in comparison to collagen I , collagen IV, 
fibronectin and glass, significantly increased confluence during culture of EC cells. 
The observed effects were inhibited with the addition of soluble YIGSR, indicating 
that the motif YIGSR can control proliferation These results provide ftirther 
evidence that peptides can be used to control proliferation, although these results 
are not supported herein as little effect was observed when cells were cultured on 
biomimetic surfaces presenting peptides. Although EC cells were used, it was a 
different cell line from the one used in this section, another difference is the 
method of motif presentation. In the study by Sweeney et al.'^*" a linear YIGSR 
peptide in solution was used whereas, herein the peptides are presented in a loop 
tethered to a surface and for the reasons previously discussed this may account for 
the differences observed. A further factor that may influence the results is cell 
number, however all the data herein has been normalised to GAPDH and therefore 
the level of attachment wi l l not affect this data. 
When investigating tyrosine hydroxylase expression, all motifs investigated 
increased gene expression when cultured under proliferative conditions however 
these effects were not maintained following differentiation. Other groups have 
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noted similar effects. Following three days differentiation of ES cells, the level of 
differentiation was greater on fibronectin when compared to laminin, whereas 
following five days differentiation, the level of differentiation was greater on 
laminin than fibronectin 
In this study neither the whole laminin protein nor motif had an effect on tyrosine 
hydroxylase gene expression levels. Retinoic acid induced differentiation of EC 
stem cells is widely used, however, there are alternative methods for induction of 
neuronal differentiation, such as the application of sonic hedgehog with FGF8 
cyclic-AMP (cAMP) or NGF Previously, in a study using calf adrenal 
chromaffin cells, culture of these cells on laminin coated surfaces has been shown 
to increase the level of tyrosine hydroxylase In the system tested herein, 
tyrosine hydroxylase gene expression does increase upon retinoic acid induced 
differentiation. It is possible that in embryonal carcinoma cells, the combination 
of laminin and retinoic acid is insufficient to increase tyrosine hydroxylase gene 
expression and an alternative soluble molecule such as FGF8 is needed to 
potentiate the effects of laminin. 
Many cell processes involve a change in the ECM. A cell can change the ECM 
using matrix metalloproteinases (MMPs) A subgroup of MMPs are 
collagenases and these are involved in the remodeling of collagen. MMP-1 
(collagenase-1) is known to cleave collagen. The entrance to the binding of 
MMP-1 is only 5A, each of the three chains of collagen are SA in width, therefore 
MMP-1 carmot bind to the whole collagen triple helix. A proposed mechanism is 
that MMP-1 induces a local conformational change in the structure of collagen and 
unwinds the triple helix so that it can then bind to the individual chains to cleave 
the helix When peptide motifs are presented by the OmpA molecules this is in 
a conformation that is dissimilar to that found in situ. This could result in MMP 
being ineffective in remodeling the surface upon which the cells are growing and 
could alter the cell behaviour in comparison to adsorbed proteins, accounting for 
some of the observed differences. Contradictory to this, when rabbit synovial 
fibroblasts (RSF) are cultured on surfaces coated with the fibronectin fragment 
120FN (containing the adhesion domain RGD) an increase in MMP expression is 
seen when compared to cells on surfaces coated with whole fibronectin molecules. 
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suggesting that a domain outside of fibronectins adhesion domain can suppress 
MMP expression. Binding to fibronectin is mediated by aSpi, the suppression of 
M M ? activity was found to be controlled by the integrin a4pi This study 
presents the possibility that culture of cells on surfaces coated with whole protein 
molecules could suppress the expression of MMPs, decreasing matrix remodeling 
and subsequently decreasing the ability of cells to remodel the surface. 
The greatest effects were observed when EC stem cells were cultured on surfaces 
with adsorbed proteins and relatively small effects were observed when cells were 
cultured on surfaces presenting peptide motifs. As integrins interact with the 
peptide presenting surfaces and relatively small effects are observed this indicates 
that integrin binding plays a minor role in the differentiation and proliferation of 
EC stem cells under the conditions tested herein. For example, EC stem cells 
cultured on surfaces with adsorbed fibronectin show a significant increase in 
neuronal differentiation as assessed by TH expression and also a significant 
increase in proliferation as assessed by the proliferative marker Ki67. In contrast, 
cells grown on surfaces presenting the fibronectin motif PHSRN only show a 
minor increase in neuronal differentiation (an increase in TH expression) and no 
increase in proliferation is seen. Integrin binding should not be discounted as 
being involved in these processes however, when the motifs were presented in this 
conformation they were not sufficient to elicit a large effect. In support of the 
argument that integrin binding does not greatly affect EC stem cell differentiation 
a study conducted by Burdsal et al ^^ "^  showed that upon differentiation there was 
an upregulation in integrin expression. Following differentiation, p i integrin 
expression was seen to increase by 1.5 folds and the a3 showed a 24 fold increase. 
Although differentiation induced a large increase in integrin expression, no 
corresponding increase in adhesion was observed for the differentiated EC stem 
cells. The authors concluded that although integrin expression was increased the 
lack of a resultant increase in attachment demonstrated that integrin binding 
mediated attachment could not account for the morphological difference observed 
between undifferentiated and differentiated EC stem cells. This supports the work 
herein where peptide surfaces whose effects are mediated via integrins have little 
effect compared to surfaces where the whole protein molecule is present, 
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containing multiple motifs that can control cell differentiation via non-integrin 
mechanisms. 
Further support that integrin binding in not necessary for the control of 
differentiation comes from experiments where integrins have been deleted. 
Deletion of the p i integrin from the F9 EC stem cell line results in a reduction in 
cell attachment and cell spreading on surfaces coated with collagen laminin and 
fibronectin. Under uninduced conditions the deletion of the pi integrin does not 
affect the expression of the undifferentiated marker SSEAl, supporting the 
hypothesis that integrin binding does not affect differentiation. However, when the 
cells were induced to differentiate differences were observed following p i integrin 
deletion. When control cells were treated with RA and dbcAMP, factors known to 
induce differentiation towards parietal endoderm the control cells showed a 
decrease in the undifferentiated marker SSEAl whereas EC stem cells where the 
integrin p i had been deleted were unresponsive to these inductive factors and 
maintained expression of the undifferentiated marker SSEAl Under the 
conditions used by Stephens et al their study demonstrated that integrin 
engagement is not essential to maintain EC stem cells in the undifferentiated state. 
However this study does show that integrin engagement is necessary for certain 
factors to elicit their effects. Therefore it can be concluded that integrin 
engagement can affect EC stem cell differentiation however, this is dependent 
upon the inductive factors used. In terms of the experiments presented herein this 
suggests that RA induction of Tera2.cl.SP12 cells is not dependent upon integrin 
engagement however, under different differentiation inductive conditions integrin 
binding and therefore surfaces presenting ECM peptide motifs could have a greater 
effect. 
Care should be taken when interpreting these results as although cell behaviour in 
the in vitro and in vivo environments is similar (as previously discussed), in vitro 
cell culture is highly simplified and not identical to the in vivo environment. 
Coating surfaces with ECM molecules may not be sufficient to elicit an effect on 
development and further factors are necessary, for example, coating surfaces with 
laminin does not produce dopaminergic-like neurons from neural stem cells 
however with addition of both heparin and bFGF, tyrosine hydroxylase expression 
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is observed. When each of these factors is used individually no effect is seen, thus 
demonstrating a need to combine factors to produce the required effects 
COMPARISON OF RESULTS GAINED TO THE HYPOTHESIS UNDER 
INVESTIGATION 
It was predicted that as large teratomas are produced when EC stem cells are co-
transplanted with Matrigel™, the culture of EC stem cells on surfaces coated with 
Matrigel'^^ would increase Ki67 gene expression. This was observed and indicates 
that the large teratomas produced could be due to increased proliferation of the 
transplanted cells. Fibronectin also induced an increase in Ki67 gene expression, 
however, when co-transplanted with EC stem cells no teratoma formation was 
observed. This indicates that increased proliferation alone is not sufficient to result 
in a teratoma. However, contrary to the predictions, a reduction in Ki67 gene 
expression was not observed for cells cultured on collagen I or laminin, which 
results in a reduction in teratoma size. EC stem cells co-transplanted with collagen 
I appeared to show a reduction in their differentiation potential. These results are 
part supported, following seven days retinoic acid induced differentiation, tyrosine 
hydroxylase expression is reduced on collagen I surfaces. However, a reduction is 
also observed for cells cultured on laminin coated surfaces. It was also predicted 
that cells cultured on collagen 1 would have an increased gene expression of Oct4 
due to a decrease in differentiation; this was not observed when cells were cultured 
on protein coated surfaces. The peptide motifs from collagen I , collagen IV, 
fibronectin and laminin were investigated to demonstrate whether these motifs 
have a similar effect to the whole proteins. This was partly demonstrated, as EC 
stem cells cultured on the protein fibronectin and the fibronectin motif PHSRN 
resulted in the greatest gene expression of tyrosine hydroxylase when compared to 
the other surfaces tested. 
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C H A P T E R 5 - G E N E R A L DISCUSSION 
Stem cells hold great potential for the cure of disease, however, the translation of 
stem cells theoretical potential in the laboratory to practical clinical use has been 
limited. There is a need for greater laboratory research to be done using these cells 
in order understand how to control their behaviour and ultimately to achieve 
success in the cure o f disease. This study shows how the ECM regulates cell 
behaviour, specifically demonstrating how ECM proteins and their motifs regulate 
cell behaviour. 
It is demonstrated that in vivo, the environment into which human pluripotent stem 
cells are transplanted affects their differentiation and proliferation. The ECM is 
suggested as a key factor controlling stem cell behaviour in vivo and using co-
transplantation of hEC stem cells with alternative ECM components it is 
demonstrated that the ECM is capable of controlling stem cell behaviour. 
Unexpectedly, when the transplantation of hEC stem cells is carried out in the 
presence and absence of growth factors little difference is noted between these two 
conditions, thus demonstrating that under these conditions, the ECM is more 
important than growth factors in controlling hEC stem cell proliferation and 
differentiation. Taken together, these results strongly indicate that ECM proteins 
are key factors in controlling stem cell behaviour. 
To further investigate how the ECM controls cell behaviour, in vitro analysis is 
carried out and surfaces, composed of both adsorbed ECM proteins and peptide 
motifs, are tested. It is proven that peptide motifs can be presented from ECM 
proteins via biomimetic surfaces in a functional fashion to control cell attachment 
and neurogenesis. In vivo, cells are contacted by multiple different ECM proteins; 
to mimic this in vitro surfaces of peptide motifs were prepared from a number of 
different ECM proteins and presented simultaneously on a single surface. It was 
expected that surfaces presenting multiple motifs would allow greater control of 
stem cell behaviour, however, this was not the case and the results were 
counterintuitive. These results using ECM proteins and their peptide motifs 
demonstrated that in vitro analysis can be used to investigate and control cell 
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behaviour. Importantly, these results indicated that certain motifs were inactive in 
controlling cell attachment and neurogenesis. 
To start to explain some of the observations from the in vivo experiments, in vitro 
analysis was carried out using surfaces with adsorbed ECM components and 
biomimetic surfaces presenting peptides from ECM proteins that had been 
demonstrated as capable of controlling cell attachment or neurogenesis. Using 
real-time PCR, some parallels were drawn between cells transplanted in vivo and 
those cultured in vitro. In vivo, teratomas produced with the co-injection of 
Matrigel™ were the largest of all teratomas produced. In vitro, culture o f hEC 
stem cells on Matriger*^ coated surfaces, showed significant upregulation in the 
gene expression of the proliferative marker Ki67. This indicates that the large 
teratomas produced in vivo could be due to Matriger"^ increasing the rate of 
proliferation of hEC stem cells. 
In vivo Matrigel™ was shown to increase the rate of teratoma formation. In vitro, 
Matriger'^ was found to upregulate the gene expression of the differentiation 
marker TH, the pluripotent marker Oct4 and the proliferation marker Ki67. In 
vitro, fibronectin upregulated the gene expression of TH and Ki67 (similar to 
Matrigel™) however, unlike Matrigel™, it did not up regulate Oct4. In vivo, 
fibronectin was unable to increase the success rate of teratoma formation. In 
agreement with Choo et al. these results indicate that the upregulation of Oct4 
gene expression and hence the pluripotent cell population is a key factor in 
teratoma production. Further evidence that Oct4 expression is key in teratoma 
formation comes from the work of Kleppner et al. where they demonstrated that 
hEC stem cells differentiated with retinoic acid reduces the rate of teratoma 
formation. 
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SUMMARY OF KEY FINDINGS 
• The anatomical location into which human pluripotent stem cells are 
transplanted influences their behaviour. 
• Transplantation of human pluripotent stem cells intrahepatically produces 
large teratomas, which are composed of immature cell types. 
• Co-transplantation of hEC stem cells with collagen I or laminin reduced the 
size of teratomas formed and reduced the mamrity of differentiation with 
little positive staining for the mature neural marker NF200. 
• Co-transplantation of hEC cells with Matrigel™ increased the success rate 
of teratoma formation; the size of teratomas formed; and did not affect the 
composition of the teratoma. 
• Growth factors presented in Matrigel™ had little effect on: the success rate 
of teratoma formation; teratoma size; or teratoma composition. 
• Biomimetic surfaces produced by Orla Protein Technologies can present 
peptides from ECM proteins to control: cell attachment; neurite outgrowth; 
and neuronal differentiation. 
• In vivo observations that Matrigel^"^ increased the success rate of teratoma 
formation and teratoma growth rate were in part explained by in vitro 
analysis, where Matrigel™ increased gene expression of the pluripotent 
stem cell marker Oct4 and the proliferative marker K.i67. 
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FUTURE WORK 
This work explores the use of teratomas as a model system to investigate how the 
ECM controls cell behaviour. Although the teratoma model is widely used to 
determine the potency of stem cells, little work has been conducted to assess the 
mechanisms underlying this system. Although, increasing proliferation rates 
through contacts with the ECM are proposed as resulting in rapid teratoma growth, 
this could be investigated further. In vivo, positive staining was obtained for the 
proliferative marker Ki67 in all teratomas produced however, this data was not 
quantitative. In vivo, quantitative data is difficult to obtain, however, flow 
cytometry could be used to analyse cells cultured on Matrigel™ in vitro to obtain 
the increase in Ki67 in comparison to that of control levels. Teratoma composition 
was analysed using a range of antibodies to undifferentiated and differentiated cell 
types known to be present in teratomas produced by human stem cells; this 
approach could be extended with the inclusion of previously untested markers, 
such as, specific keratin markers to provide a more in-depth analysis of the 
teratoma composition. 
No teratoma formation was observed with PuraMatrix™. It is possible to 
incorporate ECM proteins into PuraMatrix™. To further investigate this system, 
laminin could be incorporated into the PuraMatrix™ hydrogel with the prediction 
of an increase in the success rate of teratoma formation. To further demonstrate 
how peptides from ECM proteins affect cell behaviour, these could be immobilised 
onto gold nanoparticles and co-transplanted with human stem cells to modulate 
teratoma formation. In vitro, the collagen IV motif, when presented via 
biomimetic surfaces (Orla 32) increased the expression of Ki67, it would be 
predicted that the inclusion of this would increase proliferation of the teratoma. 
Investigations herein demonstrate that biomimetic surfaces can be used to control 
cell behaviour. The expression of p i l l tubulin was used to indicate neuronal 
differentiation. This could be investigated in greater detail, although an increase in 
PIII expression was taken as indicating an increase in neuronal differentiation this 
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may not necessarily be the case. An increase in the percentage of cells expressing 
p i l l could be due to: selective death; decreased proliferation; or inliibition of 
attachment of non-pill positive cell types. This system could be invesfigated 
further with a more detailed analysis involving the investigation o f these possible 
factors. 
A l l data was analysed by hand and the sample sizes chosen were sufficient to make 
the analysis relevant but they were a sample and did not include the whole 
experiment, automated image analysis could be used to increase the sample size. 
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